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SUMMARY 
The nuclear lamina, a thin filamentous protein layer beneath the nuclear envelope, 
physically supports the cell nucleus and has a central role in nuclear organization and 
gene regulation. The major constituents of this meshwork are type V intermediate 
filament proteins, known as lamins. Mutations in the LMNA gene, which encodes A-
type lamins, or in the ZMPSTE24 gene, which encodes a zinc metalloprotease involved 
in the maturation of A-type lamins, are linked to a wide spectrum of tissue-specific and 
systemic diseases collectively called laminopathies. Disease manifestations include 
muscular dystrophies, lipodystrophies, dilated cardiomyopathies and the premature 
aging syndromes Hutchinson-Gilford progeria (HGPS) and restrictive dermopathy 
(RD). The wide variety of diseases caused by mutations in the LMNA gene illustrates 
the pleiotropic functionality of A-type lamins in cell physiology. Although a large number 
of disease-causing mutations has been identified, the underlying pathogenic 
mechanisms are not completely understood.  
To unveil A-type regulated pathways, we have optimized and used cellular models in 
which we blocked the expression of LMNA or ZMPSTE24. This was achieved through 
sustained siRNA-mediated knockdown in human dermal fibroblasts or by 
CRISPR/Cas9-mediated genome editing in HeLa cells.  
First, we investigated the effect on redox biology. Sustained knockdown revealed that 
both persistent prelamin A accumulation and lamin A/C depletion elevated intracellular 
ROS levels, but to a different extent, and with different effects on cell fate. LMNA 
knockdown eventually induced apoptosis, while ZMPSTE24 knockdown triggered a 
senescence pathway. We hypothesize that a threshold level of intracellular reactive 
oxygen species (ROS) underlies this bifurcation and that the loss of A-type lamins 
removes an essential ROS buffering capability. 
Next, to further our knowledge on the molecular effects of LMNA deficiency, we 
compared the proteome of LMNA knockdown fibroblasts with mock-treated controls 
using quantitative stable isotope labelling-based shotgun proteomics. This revealed 
that the largest fraction of differentially produced proteins was involved in actin 
cytoskeleton organization. Interestingly, functional validation showed that loss of A-
type lamins perturbed the coordination between focal adhesion formation and 
cytoskeletal tension. We believe that this imbalance may contribute to the 
mechanosensing defects that are observed in certain laminopathies.  
Finally, to identify molecular changes associated with ZMPSTE24 deficiency at the 
cellular level we analysed genome-edited ZMPSTE24 knockout cells with label-free 
confocal Raman microscopy. We identified a decreased lipid content in ZMPSTE24-
deficient HeLa cells attributed to a significant reduction in lipid droplet number and size. 
Counterintuitively, this was accompanied with increased expression of several lipid 
droplet biogenesis genes. We believe that overexpression of these genes is a 
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compensatory mechanism against the accelerated lipolysis induced by prelamin A 
accumulation. 
In summary, we show that redox balance, focal adhesion and cytoskeletal tension are 
affected by loss of A-type lamins. We hypothesize that these pathways are interlinked 
and that ROS can be partly responsible for the uncoupling between cell adhesion and 
cytoskeletal tension. Furthermore, reduced focal adhesion and high ROS levels trigger 
apoptosis. Persistent prelamin A accumulation on the other hand, triggers a 
senescence pathway and interferes with lipid storage, in line with prelamin A-linked 
lipodystrophies. These findings open up new treatment strategies for laminopathies, in 
particular for muscular dystrophies, dilated cardiomyopathies and mandibuloacral 
dysplasia type B. These treatments strategies include reducing ROS levels, restoring 
mitochondrial function, increasing proteasome activity and increasing autophagy. 
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SAMENVATTING 
De nucleaire lamina is een dunne filamenteuze proteïne laag onder de nucleaire 
enveloppe, die ondersteuning geeft aan de celkern. Ze speelt een centrale rol bij de 
organisatie van de celkern en bij genregulatie. De belangrijkste componenten van dit 
netwerk zijn de type V intermediaire filament-eiwitten, die gekend zijn als de lamines. 
Mutaties in het LMNA gene, dat codeert voor de type A lamines, of in het ZMPSTE24 
gen, dat een rol speelt bij de maturatie van type A lamines, veroorzaken een breed 
spectrum aan ziektes, genaamd laminopathieën. Tot deze ziekten behoren musculaire 
dystrofieën, lipodystrofieën, gedilateerde cardiomyopathie en de premature 
verouderingsziekten Hutchinson-Gilford progeria (HGPS) en restrictieve dermopathy 
(RD). Het brede gamma aan ziektes toont aan dat type A lamines betrokken zijn bij ver 
uiteenlopende cellulaire processen. Alhoewel een groot aantal mutaties gekend zijn, 
blijft het gissen naar de onderliggende mechanismen die aan de basis liggen van de 
pathogenese. 
Om een beter inzicht te verschaffen over welke pathways gereguleerd worden door 
type A lamines, hebben we cellulaire modellen ontwikkeld, waarin de expressie van 
LMNA of ZMPSTE24 verstoord werd. Hiervoor hebben we gebruik gemaakt van 
siRNA-gemedieerde knockdown in humane dermale fibroblasten of CRISPR/Cas9-
gemedieerde genoom editing in HeLa cellen.  
In eerste instantie werd het effect op redox biologie bestudeerd. De knockdown 
modellen toonden aan dat zowel hardnekkige prelamine A accumulatie, als verlies van 
type A lamines, leidden tot een verhoogde hoeveelheid reactieve zuurstofverbindingen 
(ROS), waarbij de omvang en het effect op celproliferatie afhankelijk was van het type 
knockdown. LMNA-knockdown resulteerde uiteindelijk in apoptosis, terwijl 
ZMPSTE24-knockdown senescentie induceerde. Waarschijnlijk bepaalt de 
grootteorde van de toename van ROS het lot van de cel, waarbij een sterke toename 
van ROS apoptosis induceert, terwijl een gematigde toename leidt tot senescentie. 
Daarnaast gaat het verlies van type A lamines gepaard met het verlies van een 
essentiële ROS buffer.    
Daarnaast werd met behulp van kwantitatieve shotgun proteomics, gebaseerd op 
stabiele isotoop labeling, het proteoom van LMNA-knockdown fibroblasten vergeleken 
met controle fibroblasten, om de moleculaire effecten van LMNA-deficiëntie beter in 
kaart te brengen. Hieruit bleek dat de grootste fractie aan differentieel geproduceerde 
eiwitten waren betrokken bij de organisatie van het actine-cytoskelet. Functionele 
validatie wees op een verstoord evenwicht tussen focale adhesie en cytoskeletaire 
spanning. Deze onbalans draagt hoogstwaarschijnlijk bij aan de defecte 
mechanosensing, geobserveerd in bepaalde laminopathieën.  
Tenslotte werd beroep gedaan op confocale Raman microspectroscopie. Met deze 
technologie werden de moleculaire veranderingen geassocieerd met ZMPSTE24-
deficiëntie in kaart gebracht. Analyse van HeLa cellen met een ZMPSTE24-knockout, 
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wees op een verlies van vetopslag. Dit was te wijten aan een significante verlaging in 
het aantal en het oppervlak van intracellulaire vetlichaampjes. Contra-intuïtief werd dit 
verlies vergezeld door een verhoogde expressie van genen betrokken bij de biogenese 
van vetlichaampjes. Deze genen vertonen hoogstwaarschijnlijk een verhoogde 
expressie om de verhoogde vetafbraak te compenseren, die door prelamin A 
accumulatie geïnduceerd wordt.  
Samengevat tonen we met dit werk aan dat redoxbalans, focale adhesie en 
cytoskeletaire spanning, beïnvloed worden door verlies van type A lamines. We 
postuleren dat ROS verantwoordelijk is voor de ontkoppeling tussen celadhesie en 
cytoskeletaire spanning. Verhoogde ROS en verminderde celadhesie kunnen 
apoptosis induceren. Daarnaast hebben we aangetoond dat aanhoudende prelamine 
A accumulatie senescentie induceert en de intracellulaire vetopslag verstoort, in lijn 
met de prelamine A-gerelateerde lipodystrofieën. Onze bevindingen maken nieuwe 
behandelingsstrategieën mogelijk. Deze omvatten het reduceren van ROS, het 
herstellen van de mitochondriale functie, het verhogen van proteasoom activiteiten en 
het induceren van autofagie in patiëntencellen.   
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1.1. Nuclear lamins and laminopathies 
1.1.1. Nuclear lamins 
The nuclear envelope and nuclear lamina  
The nuclear envelope (NE) separates the nucleus from the cytoplasm in eukaryotic 
cells.1 It is composed of an inner nuclear membrane (INM), an outer nuclear membrane 
(ONM), the nuclear lamina and nuclear pore complexes (NPCs), which are embedded 
in the NE (Figure 1-1).2 The ONM is continuous with the endoplasmic reticulum (ER) 
and is covered with ribosomes.3 The INM contains integral and peripheral membrane 
proteins, which have specific nuclear functions.2 The distance between INM and ONM 
is around 40-50 nm, and both membranes join at the NPCs.4 NPCs are large (~50 
MDa) proteinaceous assemblies that allow passive diffusion of ions and small 
molecules up to 50kDa  and facilitate receptor-mediated bidirectional exchange of 
larger molecules (proteins and ribonucleoprotein complexes) between the 
nucleoplasmic and cytoplasmic compartments.5,6  
The nuclear lamina is a dense proteinaceous meshwork that lines the INM in metazoan 
cells.7,8 The nuclear lamina gives mechanical support to the nucleus, and is involved 
in many nuclear activities, including chromatin organization, transcription and 
replication.9,10 Its thickness varies in between 10 and 20 nm in somatic cells.10,11 The 
major constituents of the nuclear lamina are lamins, type V intermediate-filament 
proteins.12 A small fraction of lamins is also present in the nucleoplasm, on 
invaginations of the NE forming a so-called nucleoplasmic reticulum, or as dispersed 
(veil-like) structures.13–16 The nuclear reticulum has been proposed to facilitate nuclear 
processes such as nuclear transport or calcium storage.15 Next to lamin proteins, the 
nuclear lamina contains a large number of inner-membrane proteins, which help 
anchor lamin filaments to the NE.17  
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Figure 1-1. Schematic overview of the NE and some of its major constituents. Reprinted 
from Stewart et al. (2007).18  
Lamin isoforms: expression, prevalence and structure  
Nuclear lamins are subdivided into A- and B-type according to their sequence 
homology, tissue expression pattern and structural properties.19 A-type lamins are 
characterized by a neutral isoelectric point, while B-type lamins are rather acidic.20 
Lamin A and lamin C are the two major A-type protein isoforms and are alternative 
splice products of the same gene, namely LMNA. Alternative splicing can also produce 
two less abundant isoforms, lamin AΔ10 and C2.14,19,21 The major B-type lamins are 
lamin B1 and lamin B2, which are often collectively referred to as lamin B. These 
proteins are expressed by LMNB1 and LMNB2, respectively. The latter gene also gives 
rise to the alternatively spliced isoform lamin B3.19,20,22 So, the principal lamin isoforms 
are lamin A, lamin B (B1 and B2) and lamin C. The alphabetical order relates to their 
respective molecular weight, which is 70 kDa for lamin A, 68 kDa for lamin B2, 67 kDa 
for lamin B1, and 65 kDa for lamin C.23 
Expression patterns of nuclear lamins are dependent on the stage of development and 
are cell-type specific. During each stage of development at least one B-type lamin is 
highly expressed.24–26 In contrast, A-type lamins are absent in undifferentiated 
embryonal stem cells and LMNA expression levels correlate with differentiation status. 
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For example, certain adult cell types that are not fully differentiated produce little or no 
A-type lamins, such as epithelial cells in the lungs, liver, kidneys, intestine, heart and 
brains of mouse embryos before birth.27,28 Furthermore, most non-hematological 
malignancies are associated with reduced expression and aberrant localization of A-
type lamins.29 Reduced LMNA expression can contribute to the proliferative capacity 
and dedifferentiation ability of cancer cells and has been observed in adenocarcinoma 
of stomach and colon, squamous and adenocarcinoma of the esophagus, lung cancer, 
testicular germ cell tumors, and cancerous prostate tissues.29 Conversely, several 
adenocarcinoma cell lines and carcinoma cell lines show lamin AΔ10 expression.30 
The alternatively spliced isoforms lamin C2 and lamin B3 are exclusively expressed in 
spermatocytes.20,31 Next to the stage of development and differentiation status, the 
ratio between A- and B-type lamin expression scales with tissue stiffness: stiff tissues, 
such as bone and cartilage, have nuclei which are rich in A-type lamins, whereas soft 
tissue, such as brain and liver, have nuclei which are poor in A-type lamins.10,32  
 
Figure 1-2. Threefold structure of A-type lamins (lamin A/C) and B-type lamins ( lamin 
B1/B2).  
Nuclear lamins have been highly conserved throughout evolution.20 Like all 
intermediate filament proteins, lamins have a typical threefold structure (Figure 1-2). 
They contain a central highly α-helical coiled-coil rod domain (~50 nm in length), 
composed of four subhelical regions, flanked by a short (~30 amino acids) globular 
amino-terminal “head” and a 185-277 residues long carboxy-terminal “tail” 
domain.10,19,20 The subhelical regions in the central domain comprise heptad repeats 
and are assigned as coil 1A, 1B, 2A, and 2B. The coils are separated from each other 
by three short linker segments termed L1, L12, and L2.19,33 The tail domain contains a 
globular immunoglobulin fold (Ig-fold), which is 3.5 nm in diameter.10,19,34 Between the 
central rod domain and the Ig-fold, a nuclear localization signal (NLS) can be found, 
which is required for transport into the nucleus.19,35 Similar to most intermediate 
filament proteins, lamins can self-assemble into higher-order structures. In solution, 
lamins form coiled-coil dimers by parallel and in-register association of two central rod 
domains into a left-handed superhelix, exhibiting two Ig-fold domains. Further 
assembly of the lamin dimers in a head-to-tail fashion results in polarized arrays, which 
interact in an antiparallel fashion to form apolar tetrameric protofilaments, causing the 
characteristic beaded appearance of lamin assemblies.10,19 Recently, cryo-electron 
tomography of nuclei of vimentin-null mouse embryonic fibroblasts (MEFs) (to obtain 
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an unobstructed view of the lamin meshwork) indicated that A- and B-type lamins 
assemble into tetrameric filaments of 3.5 nm thickness.10 The assembly of nuclear 
lamins into dimers, head-to tail polymers, and protofilaments is shown in Figure 1-3, 
together with their incorporation into the lamin meshwork. Although the structural 
assemblies of A- and B-type lamins are very similar, they form distinct networks within 
the lamina meshwork.10,36 However, in MEFs some areas of the lamina present a small 
amount of overlap between A- and B-type lamins.36    
 
Figure 1-3. A: Cryo-tomogram of the lamin meshwork containg lamins (grey), NPCs 
(blue) and the INM and ONM (transparent grey). B: Assembly of nuclear lamins into 
dimers, head-to-tail polymers, and protof ilaments. Reprinted from Turgay et al. 
(2017).10  
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Processing and incorporation of lamins into the nuclear lamina  
Lamins A, B1 and B2 are produced as precursor proteins (pre-lamins), which all 
possess a carboxy-terminal CAAX box (C: cysteine; A: aliphatic amino acid; X: random 
amino acid, typically serine, glutamine, methionine of alanine) that is prone to extensive 
posttranslational modifications. These modifications are essential for the formation of 
mature functional lamins.19,37,38 The modification of the CAAX box is strictly regulated 
and starts with farnesylation of the cysteine residue through the action of a 
farnesyltransferase.38 Next, the AAX residues of the CAAX box are removed by a 
CAAX prenyl protease (endopeptidase). Two CAAX prenyl proteases have been 
identified in humans: Ras-converting enzyme 1 (RCE1) and Zinc metalloprotease 
related to the STE24 homolog in yeast (ZMPSTE24).19,39 Subsequently, the carboxy-
terminal cysteine is carboxymethylated by isoprenylcysteine carboxyl 
methyltransferase (ICTM).40 Carboxymethylation is the endpoint in the maturation 
process of B-type lamins. In contrast, prelamin A undergoes a last endoproteolytic 
cleavage, exclusively catalyzed by ZMPSTE24, after incorporation in the nuclear 
lamina, resulting in removal of 15 amino acids from the carboxyl terminus, including 
the farnesylcysteine methyl ester.19,39 The maturation process of lamin A, lamin B1 and 
lamin B2 is shown in Figure 1-4.  
Given the fact that lamin maturation is evolutionary conserved, it is highly likely that 
the pathway serves an important function.41 Several cell culture studies have 
suggested that the addition of the hydrophobic farnesyl group to prelamin is important 
for targeting these proteins to the INM. Furthermore both ZMPSTE24 and ICTM are 
present in the INM, next to the ER membrane, indicating that their action might take 
place even after lamin incorporation into the nuclear lamina.41–44 However, these 
studies only focused on prelamin A farnesylation and the importance of B-type lamins 
has been neglected.44 Furthermore, mouse models did not support this notion. For 
example, knock-in mice that only produce non-farnesylated prelamin A do not show 
perturbed incorporation of prelamin A.41,45 Similarly, lamin C, which is not farnesylated, 
can be targeted to the nuclear rim in mice that do not produce lamin A.41,46 Moreover, 
bypassing prelamin A synthesis by direct synthesis of mature lamin A in mice, leads to 
nuclear blebs in MEFs, yet with normal nuclear rim positioning of lamin A in tissue. The 
occurrence of nuclear blebs in these cells is likely the result of local defects in lamina 
organization.47 A recent study has shown that trafficking of lamin A to and its assembly 
in the NE is regulated by sorting nexin 6 (SNX6). SNX6-mediated trafficking did not 
require farnesylation of prelamin A, since mature lamin A was also transported.48 In 
contrast with A-type lamins, farnesylation of lamin B1 has shown to be important for 
neuronal migration in the developing brain of mice. Knock-in mice expressing non-
farnesylated lamin B1 die soon after birth and have striking nuclear abnormalities in 
neurons: the nuclear lamina appeared pulled away from the chromatin leaving the DNA 
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exposed in the cytoplasm.44 In contrast to lamin A, lamin B1 is not transported by 
SNX6, therefore farnesylation of lamin B1 is likely essential for INM targeting.48  
Next to the aforementioned posttranslational modifications, lamins can also be 
phosphorylated, sumoylated, ADP-ribosylated and possibly glycosylated.19 For 
example phosphorylation of lamins by cyclin-dependent kinase 1 (CDK1) and protein 
kinase C (PKC) is required to trigger disassembly of the nuclear lamina at the onset of 
mitosis.19,23,49,50 
 
Figure 1-4. Schematic overview of the maturation process of lamin A, lamin B1 and 
lamin B2. The grey box represents the NLS and the blue box the Ig -fold. The number 
beneath the lamin structure represent the respective amino acid posit ion. Modified from 
Dechat et al. (2010).19  
1.1.2. Functions of lamins 
Nuclear lamins and their associated proteins play a role in chromatin organization, 
distribution of NPCs within the NE, positioning of the nucleus in cells and reassembly 
of the NE after mitosis. They are also involved in essential cellular processes, such as 
DNA replication and RNA-polymerase-II-dependent gene expression, and interact with 
proteins involved in a wide range of cellular pathways.51 Lamins can also function as 
mediators of oxidative stress, which will be extensively discussed in chapter 2.52   
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Regulation of nuclear shape and mechanical stability 
Similar to cytoplasmic intermediate filaments, nuclear lamins have a mechanical role. 
More specifically, lamins provide and maintain structural stability of the nucleus. A-type 
and B-type lamins have a different effect on the mechanical properties of the nucleus. 
Lamin B1-deficient MEFs exhibit normal nuclear mechanics, although a significant 
increase in nuclear blebs is observed.53 In contrast, cells lacking A-type lamins exhibit 
increased numbers of misshapen nuclei and have increased nuclear plasticity.54 
Furthermore, nuclei in Lmna-/- MEFs are more prone to mechanical stress causing 
increased nuclear dysmorphy and decreased viability. These cells also show 
decreased mechanical stiffness. Overexpression of lamin A or lamin C can partly 
restore the phenotype of Lmna-/- MEFs.19,55–57 Nuclear deformability is also observed 
in embryonic stem cells that lack expression of A-type lamins. After terminal 
differentiation there’s a 6-fold increase in nuclear stiffness.19,58 Next to the lack of lamin 
A/C, production of mutant lamin A isoforms, such as progerin, or accumulation of 
prelamin A, as observed in certain diseases (discussed later on), can result in 
dysmorphic nuclei. Most common nuclear abnormalities observed are honeycombs, 
blebs, donut-like nuclei.14,57,59–61 An exponent of the enfeebled nucleus is the 
occurrence of nuclear ruptures, temporary breaches of the NE barrier, in cells lacking 
A-type lamins, and to a lesser extent in cells expressing mutant lamin A isoforms.62 
The nuclear lamina is also connected with the cytoskeleton through the “link of 
nucleoskeleton and cytoskeleton” (LINC) complex (see Figure 1-1). This complex 
bridges the perinuclear space and consists of SUN1 and/or SUN2 proteins bound to 
KASH proteins (nesprin1-4), which localize to the INM and ONM, respectively.4,63 A-
type lamins interact with SUN1/2, which are connected to cytoplasmic actin filaments 
through nesprin 1 and 2.18 Furthermore, biochemical studies have shown that A-type 
and B-type lamins can bind directly to actin filaments.64 Nesprin 3 connects 
intermediate filaments with SUN1/2 through the binding of plectin, and in 
Caenorhabditis elegans it has been shown that ZYG-12 connects microtubules to the 
nucleus through dynein.65   
Chromatin organization and positioning 
By regulating chromatin organization, nuclear lamins influence gene expression and 
cell differentiation.66 Gene-poor chromatin regions and heterochromatin are 
preferentially located around the nucleoli and at the nuclear periphery in eukaryotic 
cells.67,68 Nuclear lamins interact with chromatin directly by binding DNA or indirectly 
by binding DNA-associated proteins. More specifically, DNA sequences in matrix 
attachment regions (MARs) can be bound by lamins via their rod domain.69,70 DNA-
associated proteins include histone proteins, barrier to autointegration factor (BAF), 
LEM-domain proteins (lamina associated polypeptide 2 (LAP2), emerin, MAN1), or 
lamin B receptor (LBR).51,71–73  
Genomic regions associated with the nuclear lamina are termed lamina-associated 
domains (LADs). These regions are anchored to the nuclear lamina by lamin B1 and 
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are typified by low gene expression and heterochromatin specific histone markers. 
LADs range from 0.1-10 Mb in size and contain all together thousands of genes.74,75 
Genes in LADs are 5- to 10-fold less active than genes outside LADs and the mean 
gene density outside LADs is about twice the gene density inside LADs. These 
domains are confined and demarcated by the insulator protein CCCTC-binding factor 
(CTCF), by outward oriented promoters, or by CpG islands.74 In replicative senescent 
cells LMNB1 expression is significantly decreased. This is accompanied by large-scale 
changes in gene expression and chromatin reorganization.76 However, the changes in 
gene expression can also be attributed to altered sequestration of transcription factors, 
as discussed later on.  
In contrast to lamin B1, lamin A/C preferentially associates with gene-rich chromatin 
regions, and disruption of lamin A-dependent heterochromatin tethering results in 
decreased expression of muscle genes in mouse myoblasts.19,68,77 The amount of 
heterochromatin at the nuclear periphery is also significantly reduced in lamin A/C-
deficient fibroblasts and central chromosome territories are more condensed and 
repositioned closer to the nuclear gravity center.78 Furthermore, loss of A-type lamins 
alters genome dynamics, inducing a dramatic transition from slow anomalous diffusion 
to fast and normal diffusion.54,79 Similarly, fibroblasts from Hutchinson-Gilford Progeria 
Syndrome (HGPS) patients, which express a truncated, permanently farnesylated form 
of prelamin A (progerin), exhibit a dramatic loss of heterochromatin. These changes 
are accompanied by alterations in histone modifications, like a decrease of H3 
trimethylated on lysine 9 (H3K9me3) and H3K27me3. Remarkably, an increase in 
H4K20me3 was observed, an epigenetic mark for constitutive heterochromatin.80 
Interference with proper lamin A processing also causes alterations in chromatin 
organization. For example, inhibition of prelamin A farnesylation, by the 
farnesyltransferase inhibitor FTI-277, causes redistribution of heterochromatin 
domains at the nuclear interior. On the other hand, The ZMPSTE24 inhibitor N-acetyl-
S-farnesyl-L-cysteine methylester (AFCMe) causes loss of heterochromatin domains, 
comparable to the observations in HGPS fibroblasts.81    
Taken together, nuclear lamins are indispensable for proper chromatin organization, 
and in addition they have a strong effect on epigenetic histone modification. Altered 
lamin levels induce chromatin redistribution, which eventually results in altered gene 
expression.    
Mitosis, DNA replication and DNA damage repair 
Nuclear lamins are involved in DNA replication. Observations in primary fibroblasts 
indicated that DNA synthesis is initiated in a limited number of foci containing 
nucleoplasmic lamin A/C and retinoblastoma protein (pRb) family members, which 
surround the nucleoli. 82 Lamin B1 has also been associated with replication foci in 
mouse 3T3 cells during late synthesis phase. 83 Lamins can also bind directly with 
proliferating cell nuclear antigen (PCNA) through their Ig-fold motif. This protein is 
necessary for the chain elongation phase of DNA replication. Interestingly, an excess 
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of the lamin domain containing the Ig-fold can inhibit DNA replication in a 
concentration-dependent fashion.84 Besides it has been shown that lamin A/C has a 
role in the restart of stalled replication forks, since replication restart is defective in 
Lmna-deficient MEFs after induction of replication stress.85  
During mitosis, during the transition from prophase to prometaphase, the nuclear 
lamina disassembles through phosphorylation of lamins and A-type lamins become 
freely soluble, in contrast B-type lamins remain associated with nuclear membrane 
structures through LBR.14,86   
Nuclear lamins also influence DNA repair. Loss of A-type lamins induces an increase 
in the number of DNA damage repair foci, containing phosphorylated H2AX (γH2AX), 
pointing at an increase in DNA damage.87 Nuclear ruptures can contribute to this 
increase in DNA damage, as observed in migrating lamin A-depleted cancer cells.88,89 
In addition, lamin A/C deficiency was associated with an increase in aneuploidy, 
chromosomal aberrations, telomere shortening and redistribution of telomeres at the 
nuclear periphery.90,91 It has been shown that loss of A-type lamins results in 
upregulation of cathepsin L (CTSL) expression, which induces a decrease in DNA 
double strand breaks (DSB) repair via non-homologous end joining (NHEJ).90,91 Next 
to CTSL, BRCA1 and RAD51 also show decreased gene expression, resulting in 
decreased DSB repair through homologue recombination.90,91 The aforementioned 
stalled replication forks in Lmna-/- MEFs is caused by defective recruitment of repair 
factors (Mre11, CtIP, Rad51, RPA, and FANCD2), which delays the removal of γH2AX 
foci.85 Similar to A-type lamin depletion, expression of disease-causing lamin A 
mutants has been linked to increased DNA damage and chromosomal aberrations and 
an increased susceptibility to genotoxic agents.92,93 HeLa cells expressing lamin A 
mutants exhibited a decrease in γH2AX foci, when exposed to cisplatin or UV 
irradiation. Likely this is caused by mislocalization and/or impaired expression of 
ataxia-telangiectasia- and Rad3-related protein (ATR), which is involved in DNA 
damage sensing. A decrease is in γH2AX foci in turn, results in impaired recruitment 
of p53-binding protein 1 (53BP1).93 Recruitment of 53BP1 and RAD51 to DNA damage 
foci is also impaired in Zmpste24-/- MEFs and in HGPS fibroblasts. This results in a 
delayed checkpoint response and inconsistent DNA damage repair. Wild-type MEFs 
ectopically expressing unprocessable prelamin A (carboxyl-terminal Ser-Ile-Met was 
replaced by Phe-Phe-Met) show similar defects in checkpoint response and DNA 
damage repair.92 Furthermore, experiments in Zmpste24-/- mice have shown that 
prelamin A accumulation is responsible for p53 activation, and results in cellular 
senescence. The progeroid phenotype are largely rescued in Zmpste24-/- Lmna+/- mice 
and partially reversed in Zmpste24-/- p53-/- mice.94 
Transcription, gene regulation and mechanotransduction 
As mentioned before, both A-type and B-type lamins influence gene expression 
through chromatin organization. However nuclear lamins can also regulate expression 
of specific genes directly, by sequestering transcription factors at the INM.31,95 For 
example, sequestration of c-Fos by lamin A/C prevents dimer formation between c-Fos 
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and c-Jun, which in turn suppresses Activation protein 1 (AP1) transcription factor 
activity.96 In line with this Lmna-/- MEFs exhibit increased AP-1 activity. 96,97 AP-1 is 
involved in multiple essential cellular processes, including cell proliferation and 
differentiation. Lamin A/C can also interact directly with the transcription factor MOK2 
and prelamin A specifically binds sterol regulatory element-binding protein 1 
(SREBP1).98–100 Sequestration of these transcription factors represses transcription of 
their respective target genes.95,98,100 More specifically, sequestration of SREBP1 by 
prelamin A induces a decreased expression of peroxisome proliferator-activated 
receptor-γ (PPARγ), which is involved in cholesterol metabolism.95,100 Lamin B1 can 
associate with octamer-binding transcription factor-1 (OCT1) at the nuclear periphery. 
Again this anchorage represses expression of OCT1 target genes.101 Besides direct 
interaction with transcription factors, lamins can also interact with transcription factors 
via lamin-associated proteins such as emerin, MAN1, LAP2β, and pRb. For example, 
emerin regulates β-catenin activity by restricting its accumulation in the nucleus, and 
MAN1 can interact with SMADs and thereby antagonizes bone morphogenetic protein 
(BMP)- and transforming growth factor beta (TGFβ)-signalling.31,95,102,103    
Nuclear lamins are also involved in mechanotransduction. Mechanotransduction can 
be defined as the intracellular signaling response of cells to mechanical stimuli.104 This 
signal transduction plays an important in role in maintaining tissue function, in particular 
in mechanically active tissues such as myocardium and skeletal muscle. Mutations in 
NE proteins such as nuclear lamins or emerin, can perturb mechanotransduction.105 
For example, lamin A/C-deficient fibroblasts show attenuated NFκβ-regulated 
transcription in response to mechanical or cytokine stimulation, despite increased 
transcription factor binding. Next to attenuated NFκβ-regulated transcription, LMNA 
mutations have been associated with hyperactivation of extracellular signal-regulated 
kinase 1/2 (ERK1/2) in fibroblasts.106 Abnormally increased ERK1/2 activity has also 
been observed in hearts of LmnaH222P/H22P mice, a mouse model for Emery-Dreifuss 
muscular dystrophy (EDMD).107,108 ERK1/2 are protein kinases that participate in the 
mitogen-activated protein kinase (MAPK) pathway, which is involved in 
mechanotransduction in various cell types.104,109 Next to increased susceptibility to 
mechanical stress, perturbed mechanotransduction contributes to the phenotype of 
muscular dystrophy, which is associated with multiple LMNA mutations.55       
1.1.3. Laminopathies 
Mutations in lamins that lead to reduction of mature lamins and/or accumulation of 
aberrant immature prelamins, can induce a wide range of diseases, which are 
collectively termed laminopathies. These diseases belong to a larger family of nuclear 
envelopathies, which also cover diseases caused by mutations in genes encoding 
other NE proteins, such as emerin (EMD), LBR, MAN1, LAP2, and aladin WD repeat 
nucleoporin (AAAS).14 Most laminopathies are related to A-type lamins, since 
mutations in B-type lamins are most often lethal.110,111 Therefore, we will only discuss 
LMNA-related laminopathies. LMNA-related laminopathies can be subdivided in 
primary laminopathies, which are caused by mutations in the LMNA gene, and 
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secondary laminopathies which are caused by mutations in genes encoding prelamin-
processing proteins, e.g. ZMPSTE24.14 About 350 disease-associated point mutations 
have been identified in the LMNA gene. The majority of these mutations, almost 90%, 
are missense mutations distributed throughout the gene.112,113 The bulk of these 
mutations are autosomal dominant and can be inherited or congenital.114 Disease-
causing mutations can either be haploinsufficient loss-of-function mutations or 
dominant negative gain-of-function mutations. For example, limb girdle muscular 
dystrophy 1B (LGMD1B) has been associated with dominant loss-of-function 
mutations, while HGPS is caused by dominant negative gain-of-function mutations, 
resulting in the accumulation of progerin. There are currently 17 distinct diseases 
described which are linked to mutations in the LMNA gene including dilated 
cardiomyopathy (DCM), muscular dystrophy, Charcot-Marie-Tooth peripheral 
neuropathy type 2B1 (CMT-2B1), lipodystrophy and premature aging syndromes.113 
So, disease manifestations can be systemic or tissue-specific. Among the muscular 
dystrophies we have EDMD and the aforementioned LGMD1B, these diseases also 
present DCM.115,116 Lipodystrophy syndromes include Dunnigan-type familial partial 
lipodystrophy (FPLD) and mandibuloacral dysplasia with type A lipodystrophy 
(MADA).117,118 Premature aging syndromes include HGPS, atypical Werner syndrome 
(AWS), and atypical progeroid syndromes (APS).119–122 Noteworthy, some MADA 
patients also exhibit accelerated aging and progeroid syndromes show generalized 
lipodystrophy, suggesting common pathological mechanisms.123–125 ZMPSTE24-
related secondary laminopathies include mandibuloacral dysplasia type B (MADB), 
which is distinguished from type A by the pattern of fat distribution throughout the body, 
atypical HGPS and the lethal neonatal disease restrictive dermopathy (RD).31,126–131 
Premature aging syndromes have the earliest onset, worst outcome, and are very hard 
to treat. DCM patients, on the other hand, present symptoms at later age and standard 
care for heart failure is applied.132 Hence, next to the affected tissues, the severity and 
onset of laminopathies are highly variable. Laminopathies caused either by decreased 
lamin A/C expression or prelamin A accumulation will be discussed in more detail, 
since these diseases are more relevant in the context of this thesis. 
Molecular mechanisms underlying laminopathies 
Different mechanisms have been proposed to explain the pathogenesis of 
laminopathies. According to the “structural mechanism”, loss of A-type lamin function 
affects structure and rigidity of the cell nucleus, causing nuclear ruptures and 
decreasing resistance to mechanical stress. This has been described in A-type lamin 
deficient cells, and is one of the underlying mechanisms in muscular dystrophies and 
DCM.14,19,55–57 The “cell proliferation mechanism” is based on the observation that most 
laminopathies are characterized by impaired cell proliferation. For example, fibroblasts 
from progeria patients and progeria mouse models show premature senescence.133,134 
Next to cell proliferation, cell differentiation can be impaired. Mutations in LMNA can 
perturb interaction with pRb, impairing myoblast differentiation and promoting 
apoptosis.135 The latter can also contribute to the pathogenesis of muscular 
dystrophies and DCM. According to the “gene expression mechanism”, pathogenesis 
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is a result of changes in gene expression due to altered interaction between nuclear 
lamins and transcription factors and impaired chromatin organization. This can 
influence multiple cellular processes. For example, accumulation of prelamin A can 
affect lipid metabolism through permanent SREBP1 sequestration95,100, or loss-of-
function mutations can impair mechanotransduction, as observed in muscular 
dystrophies. Next to altered sequestration of transcription factors or impaired 
chromatin organization, gene expression can also be altered by nuclear ruptures, 
through temporal molecular exchange between the cytoplasm and the nucleus. This 
can result in redistribution of transcription factors to the cytoplasm or to the nucleus 
and thereby affect gene expression.61,62 Finally the “toxicity mechanism” claims that 
accumulation of mutant lamin isoforms, such as progerin, or prelamin A is cytotoxic. 
Indeed accumulation of these proteins induces nuclear shape defects and is 
associated with cellular senescence and oxidative stress.136–138   
Laminopathies caused by haploinsufficiency of A-type lamins  
The most prevalent laminopathy is DCM. Idiopathic DCM affects 1 in 2500 individuals 
and 50% of all cases of idiopathic DCM are familial dilated cardiomyopathy 
(FDM).139,140 It has been estimated that 8% of all FDM cases are caused by mutations 
in LMNA, thus approximately 1 case in 62500 individuals suffers from LMNA DCM.139 
In the case of EDMD and LGMD1B, DCM is accompanied by different types of skeletal 
muscular dystrophy. EDMD patients are characterized by early tendon contractures, 
progressive muscle weakness and wasting in a humeroperoneal distribution.141 In 
LGMD1B patients more proximal skeletal muscles are affected compared to EDMD 
patients.116 LMNA DCM, EDMD and LGMD1B are all adult-onset diseases, and are 
actually a spectrum of the same diseases and can be caused by the same LMNA 
mutations.142 They have a high penetrance (100% of mutation carriers are affected by 
the age of 60 years) and aggressive course, often resulting in premature death or 
cardiac transplant.142 In line with the majority of laminopathies, LMNA DCM is primarily 
autosomal dominant and mainly caused by missense mutations. One homozygous 
missense mutation (H222Y) in LMNA has been linked to EDMD.115 LGMD1B has been 
associated with a mutation leading to truncation of lamin A/C (Y259X), resulting in a 
neonatal lethal phenotype in case of homozygous inheritance. LMNAY259X/Y259X 
patients lack LMNA expression, so loss of lamin A/C function likely contributes to the 
phenotype of LGMD1B patients.143 This is supported by experiments in Lmna-null and 
Lmna+/- mice, which suggest that haploinsufficiency underlies the pathogenesis of 
LMNA DCM.144,145 Next to lack of expression, some mutations interfere with the protein 
structure of A-type lamins, and thereby impair protein function. For example the 
R453W mutation in LMNA, causing EDMD, destabilizes the three-dimensional 
structure of the Ig-fold in the carboxyl-terminal tail domain of lamin A/C.146  
Loss of functional lamin A/C decreases mechanical stability of the nucleus, initially 
affecting tissues under high mechanical stress, such as striated muscles and heart 
muscle. In addition, mechanotransduction is impaired through attenuated NFκβ-
regulated transcription and hyperactivation of ERK1/2, as mentioned earlier.105–108 So 
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the primary molecular mechanisms underlying this group of laminopathies are the 
structural and gene expression mechanisms, including nuclear ruptures, as discussed 
earlier on.  
Laminopathies characterized by prelamin A accumulation 
ZMPSTE24 related secondary laminopathies, such as MADB and RD, are caused by 
accumulation of farnesylated prelamin A, since the final endoproteolytic cleavage is 
inhibited. Both diseases are autosomal recessive and can be caused by homozygous 
or compound heterozygous mutations.126,127 Interestingly, MADB is accompanied by 
partial loss of ZMPSTE24 activity, while RD is associated with complete loss.129 So the 
degree of prelamin A accumulation correlates with the severity of the disease. MADB 
is characterized by skeletal abnormalities and generalized lipodystrophy with metabolic 
syndromes such as insulin resistance, glucose intolerance, diabetes mellitus and 
hypertriglyceridemia. Some patients have features of premature aging.117,126 RD is a 
lethal neonatal genodermatosis characterized by intrauterine growth retardation, tight, 
rigid and easily eroded skin with prominent superficial vessels, bone mineralization 
defects, dysplastic clavicles, arthrogryposis and early neonatal death. RD patients 
usually die within several hours or days of birth.126,127 Prelamin A accumulation has 
also been observed in primary laminopathies, including FPLD, MADA and AWS.100,147 
However, a recent study could not recapitulate these results in fibroblasts from different 
FPLD patients (heterozygous R482W, I299V, C591F, and T528M mutations).148 
Furthermore, fibroblasts from different APS patients (heterozygous P4R, E111K, 
D136H, E159K, and C588R mutations) do not show prelamin A accumulation, 
questioning the observed prelamin A accumulation in AWS.122 On the other hand, 
prelamin A accumulation could be reconfirmed in fibroblasts from MADA patients 
(homozygous R527H mutation) in a later study.147 In contrast to MADB patients, MADA 
patients only present fat loss from the extremities of the body, and have normal or a 
slight excess in subcutaneous fat in the neck and truncal regions.131 HGPS is, without 
a question, the most notorious laminopathy. Children affected with HGPS appear 
healthy at birth. Within a year, the first clinical features of this progeroid syndrome 
appear, including failure to grow, delayed dentition, alopecia, loss of subcutaneous fat 
and sclerodermatous skin changes.14,125 The age of death ranges between 7 and 27.5 
years, with a median age of 13.4 years. Most patients die from progressive 
artherosclerosis of the coronary and cerebrovascular arteries.14,125 The syndrome is 
manly caused by a de novo single-base substitution, G608G (GGC > GGT), within 
exon 11. This mutation does not affect amino acid sequence, but results in activation 
of a cryptic splice site within exon 11. Splicing results in the production of progerin, a 
prelamin A isoform which lacks 50 amino acids near the carboxyl terminus.125 Progerin 
still contains the CAAX box and becomes farnesylated during posttranslational 
processing. However, the deleted 50 amino acids contain the ZMPSTE24 cleavage 
site, so removal of the last 15 amino acids, including the farnesyl group, is impossible. 
Thus, progerin remains permanently farnesylated and accumulates at the nuclear 
rim.149  
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MADA, MADB, RD and HGPS have overlapping phenotypes. Except for RD patients, 
MADA, MADB and HGPS patients present partial or generalized lipodystrophy.100 
Interestingly, RD patients have a slight increase in subcutaneous fat as well.119,150 
Since RD is a lethal neonatal disease, it’s likely that lipodystrophy is not yet presented. 
At cellular level these diseases all display nuclear shape defects to some extent. In 
MADA fibroblasts, prelamin A accumulates at the nuclear rim and at the nucleoplasmic 
reticulum. In addition, the LINC complex protein SUN2 is mislocalized and forms a 
honey-comb-like lattice in the nuclear membrane.147 MADB fibroblasts show major 
nuclear shape defects, such as lobulations and herniations. However lamin A/C is still 
localized at the nuclear rim.126 In RD patient fibroblasts nucleoplasm herniation and 
NE irregularities are observed, furthermore lamin A/C is distributed in clusters in the 
nucleus.119,127 HGPS fibroblasts show clear abnormalities of the nuclear membrane.125 
In addition ectopic expression of progerin in mice results in misshapen nuclei and 
nuclear blebs.151 So, accumulation of either farnesylated prelamin A or farnesylated 
progerin is toxic and affects nuclear shape, in line with the “toxicity mechanism” 
mentioned earlier. Of note, prelamin A and progerin are also present in healthy cells at 
very low levels. Interestingly, the amount of progerin increases with aging.152,153 Likely, 
progressive telomere damage during aging results in the release of certain telomere-
binding/capping proteins which influence spliceosome function, and thereby induces 
extensive changes in alternatively splicing, eventually increasing progerin 
production.153 Similarly prelamin A accumulates in hMSC during aging. This is caused 
by reduced ZMPSTE24 expression, induced by the overexpression of miR-141-3p 
during senescence.154 So, the aforementioned laminopathies partly reflect normal 
aging.   
Therapeutic strategies for laminopathies     
To date, no curative treatments exist for laminopathies. For muscular dystrophies and 
DCM the primary concern is preventing sudden cardiac death.132 To this end standard 
care for heart failure is applied, which includes angiotensin-converting enzyme 
inhibitors, angiotensin receptor blockers, beta-blockers, diuretics and aldosterone 
antagonists. As mentioned before a cardiac transplant is often a requisite.142 Potential 
new treatments include MAPK inhibitors (e.g. Selumetinib), to lower the abnormally 
increased ERK1/2 activity, and induction of autophagy (e.g. Temsirolimus), which 
improved cardiac function of LmnaH222P/H222P mice.132 Combination treatments can 
further improve efficacy.132 MADA, MADB, RD and HGPS patients can benefit from 
blocking the farnesylation of prelamin A or progerin. This can be achieved by inhibiting 
farnesyltransferase. Farnesyltransferase can be blocked by farnesyltransferase 
inhibitors (FTIs). One specific FTI, lonafarnib, has been studied in children with HGPS 
up to a phase II clinical trial.155 However, due to alternative prenylation of the CAAX 
box by geranylgeranyltransferase I the effect of FTIs can be reduced.38,156 Furthermore 
FTI treatment can trigger the formation of donut-shaped nuclei. This phenotype is 
caused by a centrosome separation defect.59 Instead of directly inhibiting 
farnesyltransferase or geranylgeranyltransferase I, interfering with the mevalonate 
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pathway is more effective. Blocking this pathway minimizes the synthesis of the non-
sterol isoprenoids farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate 
(GGPP), eventually preventing the action of farnesyltransferase and 
geranylgeranyltransferase I upstream.157 To this end, statins (e.g. pravastatin) or 
aminobisphosphonates (e.g. zoledronate) can be used.156 Statins inhibit 3-Hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) reductase, which is essential for the 
biosynthesis of mevalonate, and thereby reduce FPP and GGPP, leading to a 
reduction in protein farnesylation.157 Aminobisphosphonates inhibit two enzymes in the 
mevalonate pathway, namely FPP synthase and/or isopentenyl pyrophosphate 
(IPP).157 Statin treatment of MADA fibroblasts rescues SUN2 mislocalization and 
combined statin/aminobisphosphonate treatment improves the aging-like phenotype in 
Zmpste24-deficient mice and improved nuclear abnormalities in HGPS 
fibroblasts.147,156 Although interference with lamin farnesylation is a promising 
treatment strategy, these strategies also interfere with the farnesylation of other 
proteins, such as Ras proteins, causing unwanted side effects. Therefore, a number of 
alternative therapies have been put forward. Rapamycin, a macrolide antibiotic, has 
been shown to reverse the cellular phenotype of HGPS fibroblasts, through progerin 
clearance via autophagy.138 Rapamycin also decreased the level of farnesylated 
prelamin A in RD and MADA fibroblasts, and alleviated the nuclear shape defects 
observed in these cells.158 More recently, sulforaphane, an antioxidant derived from 
cruciferous vegetables, was tested on HGPS fibroblasts. Sulforaphane enhanced 
proteasome activity and autophagy in both healthy and HGPS cells. The treatment 
resulted in increased progerin clearance, similar to rapamycin.159 Another approach to 
reduce progerin or prelamin A accumulation is redirection of the alternative splicing of 
LMNA towards lamin C. To this end metformin can be used. This antidiabetic drug 
decreases SRSF1 expression, an RNA-binding protein which is involved in alternative 
splicing of LMNA. Through reduced SRSF1 expression, progerin expression is 
decreased.160 Finally it has been shown that resveratrol can ameliorate the phenotype 
of Zmpste24-/- mice and extend their lifespan. Resveratrol enhances the binding 
capacity between SIRT1, a NAD+-dependent histone and non-histone protein 
deacetylase, and A-type lamins, including prelamin A and progerin. Thereby SIRT1 is 
activated and physiological and metabolic functions necessary for health span are 
restored.161,162   
1.2. Modern tools for cell biology 
The past decade, modern cell systems or cytomics approaches have boosted the 
progress in life sciences. High throughput DNA sequencing technologies have 
permitted the discovery of thousands of novel disease-causing mutations and more 
recently, RNA sequencing has enabled exhaustive analysis of the coding and non-
coding transcriptome. Advances in mass spectrometry allowed high-throughput protein 
sequencing. Despite the holistic nature of genome- and proteome-wide approaches, 
which can inventorize all molecular changes upon specific perturbations or in 
pathologies, they do not provide insight into the location and dynamics. In other words, 
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they all lack spatiotemporal resolution. This gap can be bridged by the use of 
microscopy. In recent years there has been a surge in microscope automation, 
resulting in huge amounts of data. Along with this, there has a trend towards automated 
analysis of the resulting large image data sets. This has led to the development of a 
new field, called systems microscopy.  
1.2.1. Genomics 
The first DNA sequencing technology was developed in 1968, fifteen years after the 
discovery of the double helix by Francis H. Crick and James D. Watson.163 A decade 
ago the overwhelming majority of DNA sequencing relied on some version of the 
dideoxy method of Sanger.164 This method relies on the use of fluorescently (four 
colors) labelled chain-terminating nucleotide analogs, namely dideoxynucleotides 
(ddNTPs), to cause base-specific termination of primed synthesis by DNA 
polymerase.163,164 Sanger-based methods are termed first-generation sequencing. 
Newer methods are referred to as next-generation sequencing (NGS).165 These newer 
methods have the ability to produce an enormous volume of data, compared to first-
generation sequencing.165 Second-generation sequencing include Roche/454 
pyrosequencing and Illumina/Solexa sequencing. In Roche/454 pyrosequencing DNA 
is randomly sheared and ligated to linker sequences, which are captured on the surface 
of beads. The sequences are amplified within an emulsion droplet. During primed DNA 
synthesis each of the four dNTPs are sequentially presented, and incorporation is 
monitored by luminometric detection of pyrophosphate release (hence the name 
pyrosequencing).163 In Illumina/Solexa sequencing template DNA is immobilized and 
amplified via bridge amplification.165 Sequencing is based on cyclic reversible 
termination (CRT). This method relies on the use of reversible chain-terminating 
nucleotides, which contain a terminating/inhibiting group and a fluorescent dye (for 
each nucleotide a specific color). These reversible terminators are incorporated during 
primed DNA synthesis, and after a washing step incorporated nucleotides can be 
identified by imaging. A cleavage step removes the terminating group, including the 
fluorescent dye, and after a washing step, the cycle can be repeated.165 Third-
generation sequencing technologies are Single Molecule Real Time (SMRT) 
sequencing by Pacific Biosciences, the Illumina Tru-Seq Synthetic Long-Read 
technology, and the Oxford Nanopore Technologies sequencing platform. This last 
generation is characterized by high-quality genome sequencing with very long 
reads.166 Next to DNA sequencing, NGS can be used for sequencing of RNA and 
microRNA. Nowadays RNA sequencing even replaces microarray-based gene 
expression studies.165       
1.2.2. Proteomics 
Proteomics is the large-scale analysis of proteins in a cell, tissue, or whole organism. 
Proteomics as a technology is now over 20 years old and offers several advantages 
over genomics as it directly measures the functional molecules, which are the result of 
transcription, translation, and post-translational modifications.167 Proteomics can be 
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subdivided in gel-based applications, such as one-dimensional and two-dimensional 
polyacrylamide gel electrophoresis (PAGE), and gel-free methods based on tandem 
mass spectrometry (MS/MS).168 Gel-based methods identify proteins based on their 
molecular weight and in the case of two-dimensional PAGE also on their IEP. In 
contrast MS/MS-based methods can identify proteins through peptide-to-spectrum 
matching. In this process theoretic spectra are generated through in silico digestion of 
protein sequences and compared to the detected spectra. This can be performed by 
several search engines such as Mascot, X!Tandem, and OMSSA. Some proteomic 
methods can also provide quantitative information in a label-based or label-free 
manner. Label-based methods can be further subdivided into the various types of 
labeling approaches such as chemical and metabolic labeling.167 Chemical labeling 
methods include proteolytic labeling (18O stable-isotope labeling), isotope-coded 
affinity tags (ICAT), isotope-coded protein labeling (ICPL), isobaric tags for relative and 
absolute quantification (iTRAQ), and tandem mass tags (TMT). Metabolic labeling 
methods include stable isotope labeling by amino acids in cell culture (SILAC).167 The 
principle of iTRAQ- and SILAC-based quantitative proteomics is shown in Figure 1-5. 
In recent years, label-free methods have sparked interest. These methods are based 
on spectral counting and provide the deepest proteome coverage for identification, 
however its quantification performance is worse than label-based approaches. Both 
chemical and metabolic labeling are capable of accurate, precise, and reproducible 
quantification and provide deep proteome coverage for quantification.169 Next to 
general proteomics, specific posttranslational modifications can be analyzed by 
“modification-specific proteomics”. In modification-specific proteomics 
posttranslational modified proteins are enriched prior to analysis, such as 
phosphopeptides (phosphoproteomics), glycopeptides (glycoproteomics), peptides 
containing acetylated lysine, … 170 By using specific protein extraction procedures it is 
also possible to isolate protein fractions form specific subcellular regions. By doing so 
changes in protein localization can be observed. This approach is referred to as “spatial 
proteomics”.171,172 
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Figure 1-5. Schematic overview of chemical isobaric tags for relative and absolute 
quantif ication ( iTRAQ) (A) and metabolic stable  isotope labeling by amino acids in cell 
culture (SILAC) labeling (B). In the iTRAQ protocol proteins are extracted, 
enzymatically digested and peptides are labeled with isobaric tags prior to mixing. 
Peptides are separated with l iquid chromatography (LC) and identif ied with MS/MS. The 
isobaric tags cause a mass shift which allows to quantif ication. SILAC labeling takes 
place before protein extraction, through metabolic incorporation of amino acids 
(arginine and lysine) containing stable isotopes.      
1.2.3. High-throughput microscopy 
Fluorescence microscopy is indispensable for cell biology. Fluorescent microscopes 
are configured to pass excitation light through the objective lens into the sample and 
then selectively observe the emitted fluorescent light coming back through the 
objective lens from the sample.173 The most popular mode of fluorescence microscopy 
is widefield microscopy, using an inverted epifluorescence microscope, in which the 
objective images the sample from below. The choice of the objective dictates most of 
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the key properties of the microscope, and its performance is largely determined by the 
magnification and numerical aperture (NA). Objective magnification ensures that the 
image is magnified sufficiently on the camera. At least two camera pixels per resolvable 
element are required to capture the full resolution of the microscope objective (Nyquist 
rate). The NA of the objective correlates with the light-gathering power and inversely 
with the resolution limit (D) of the objective (𝑁𝐴 =
0.61𝜆
𝐷
).174 A huge drawback of 
widefield microscopy is the fact that the entire specimen is bathed in light.175 Both out-
of-focus light and light emitted by the focal plane of the sample are detected by the 
camera. This out-of-focus light makes it impossible to achieve well-resolved 3D 
images. Confocal fluorescence microscopy can resolve this issue. This mode uses a 
focused laser beam to obtain a point-like illumination, and emitted light from this point 
is detected after passage through a pinhole. Hence, light from out-of-focus planes is 
blocked by the pinhole, resulting in a point-like detection.174,175 The use of point-like 
illumination necessitates raster scanning to generate a microscopic image. To this end, 
scanning mirrors are used to scan across the sample and build up the image point by 
point.174 A disadvantage of point scanning is that it is slow. One solution, termed 
spinning disk confocal microscopy, is based spreading the laser beam over a rotating 
disk comprising a series of pinholes, through which many spots of the sample are 
illuminated simultaneously. The emitted fluorescence light is focused onto another or 
the same pinhole of the spinning disk. Simultaneous imaging and the rapid disk rotation 
allows much higher frame rates compared to CLSM.176 On the other hand most of the 
light is blocked, resulting in an ineffective illumination of the sample, although this can 
be surpassed by adding a second disk of microlenses, referred to as the Yokogawa 
modification.176,177 The principle of widefield fluorescence microscopy and CLSM is 
shown in Figure 1-6.   
To study cellular processes, the dynamic behaviour and microscopic scale need to be 
taken into account. By fixing cells a snapshot can be taken of the cellular processes at 
that specific moment. However, fixation protocols can damage and alter the cellular 
environment, complicating the interpretation of these images. Therefore, live cell 
imaging is more reliable to study the dynamic behaviour of cells. In the latter case 
automating image acquisition is indispensable. However, automation is also relevant 
for fixed cell imaging, since this enables the generation of large image data sets, which 
is termed high-throughput microscopy (HTM) (Figure 1-6).178,179 Furthermore, multiple 
features can be extracted from one microscopic field, such as multiple wavelengths, 
multiple focal planes, and morphological parameters. Automated analysis and 
exhaustive feature extraction is described as high-content analysis.180 Combining HTM 
and high-content analysis is often referred to as “deep imaging”.181            
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Figure 1-6. A: Energy diagrams of f luorescence. B: The light path and key components 
of a widefield microscopy (left) and a confocal microscopy. C: Scheme il lustrating the 
workflow of high-throughput microscopy.  
1.2.4. Raman microspectroscopy 
Although fluorescence microscopy is a very important technique in life sciences, the 
technique has several limitations. First of all, in most cases fluorescent labels 
(fluorescent dyes or fluorescent fusion proteins) are required, which is invasive and 
can be harmful or even lethal (in case of fixation) for the examined cells.182 Secondly, 
only a limited number of fluorescent labels can be combined, and the narrow 
absorption spectra make it hardly possible to efficiently excite several dyes at once, 
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except for quantum dots (QDs).183 One way to bypass these limitations is by making 
use of Raman microspectroscopy (RMS). This is a microscopic variant of Raman 
spectroscopy, and probes molecular vibrations in a biological sample per pixel, through 
the measurement of Raman scattering.184 Raman scattering was discovered in 1928 
by C.V. Raman and K.S. Krishnan, and is observed when a sample is irradiated with 
visible or near-infrared light.185 Most of the incident photons undergo elastic scattering 
(Rayleigh scattering), while a small fraction are inelastically scattered by the interaction 
with molecular bonds. During interaction energy is exchanged with the vibrational 
energy levels of the molecules in the sample. This process can result in a loss in energy 
of the scattered photon, termed Stokes-shifted Raman scattering. Exceptionally, the 
interaction can result in a gain in energy of the scattered photon causing anti-Stokes-
shifted Raman scattering, but due to the extreme rareness of this event, this type of 
scattering is hard to detect.184 The energy diagrams of the various kinds of scattering 
are shown in Figure 1-7A. Conventional RMS measured spontaneous Stokes-shifted 
Raman scattering with a CLSM-based setup. Hence, Raman spectra are recorded via 
raster scanning a sample with a laser, Raman scatter is separated from Rayleigh 
scatter via an edge/notch filter, and the Raman spectra are resolved by dispersing the 
Raman scatter by a monochromator and finally detected by a CCD camera.186 Raman 
spectra are multivariate datasets which require extensive processing prior to data 
analysis. Reconstruction of microscopic images can be obtained via complex spectral 
unmixing and clustering algorithms.187 The setup of a Raman microscope is shown in 
Figure 1-7B. Its typical output is shown in Figure 1-7C, relevant Raman bands 
corresponding with DNA/RNA, lipids and proteins are indicated with arrows. 
Due to the weak nature of Raman signals, RMS requires long acquisition times. 
Reducing acquisition time can result in insufficient signal-to-noise ratios, or spatial 
under-sampling.188 Another way to cope with the weak Raman signals is by boosting 
them through the use of nonlinear RMS, for example, coherent anti-Stokes-shifted 
Raman scattering (CARS) microscopy and stimulated Raman (SRS) microscopy. In 
the latter techniques two laser pulses with different angular frequencies are used, and 
when the difference between the angular frequencies of the two incident lasers 
coincides with that of the vibrational mode of the sample molecule, intense and 
unidirectional radiation is emitted due to a nonlinear Raman process.186 
In summary, RMS can be used to capture molecular changes in cells, tissues or 
biofluids, without the need of labeling. Therefore, RMS can complement fluorescence 
microscopy. Furthermore the technique can be used for medical diagnostics, and 
Raman spectra can be collected in vivo through the use of a Raman needle probe.188 
Previous studies have shown that RMS can be used to study a wide variety of 
diseases, but most studies focus on cancer, including brain cancer, breast cancer, lung 
cancer, skin cancer, colorectal cancer, and prostate cancer.188–191 For example, 
Raman spectra of high-grade gliomas presented a higher contribution from nucleic 
acids compared to those of normal tissue, or the ratio of the Raman band intensity of 
lung cancer tissue was different form normal tissue at 1445 cm-1 and 1655 cm-1.188 
RMS can be exploited as a diagnostic tool by developing supervised classification 
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models. To this end several techniques can be used such as support vector machines 
(SVM), linear discriminant analysis (LDA), and partial least squares discriminant 
analysis (PLS-DA). The robustness and performance of classification models largely 
depends on the sample size. It has been shown that 75 to 100 samples are needed to 
train a good, however not perfect classifier.192 The large sample size complicates the 
use of the time-consuming unstimulated RMS as a diagnostic tool favoring the use of 
stimulated RMS.          
 
Figure 1-7: A: Energy diagrams of Stokes-shifted Raman scattering, Rayleigh 
scattering, and anti-Stokes shifted Raman scattering. B: Scheme of a Raman 
microscope (Alpha R300, WITec). C: I llustration of the hyperspectral Raman image 
acquired by Raman microspectroscopy together with a typical Raman spectrum, arrows 
highlight relevant Raman bands such as the O-P-O stretching vibration at 788 cm -1, 
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corresponding with the DNA/RNA backbone193; the symmetric ring breathing in 
phenylalanine at 1000 cm -1, corresponding with protein content193 ; the amide III in-
plane deformations and in-plane C-H bending modes at 1263 cm -1, corresponding with 
proteins and unsaturated lipids, respectively184 ,194 ; the twisting and wagging modes of 
CH2  groups at 1303 cm -1, corresponding with l ipids and proteins184 ; the bending and 
scissoring modes of CH2 groups at 1444 cm -1, corresponding with l ipids and proteins 184 ; 
and the C=C stretching modes and amide I C=O stretching modes at 1668 cm -1, 
corresponding with unsaturated lipids and proteins.184   
1.3. Scope 
A-type lamins have a wide variety of functions in the nucleus, ranging from structural 
support to sequestration of transcription factors and chromatin organization. The wide 
spectrum of diseases caused by mutations in the LMNA gene is illustrative of this 
diversity of functions. Although a large number of disease-causing mutations have 
been identified, the underlying pathogenic mechanisms are still not well understood. 
This lack of knowledge complicates the development of novel therapeutic strategies. 
The goal of this work is to unveil pathways that are regulated by A-type lamins using 
modern cytomics. Previous studies mainly used patient cells, which are scarce and 
have heterogeneous genetic backgrounds, or cells retrieved from animal models. 
Therefore we developed isogenic human cellular models, through the use of siRNA-
mediated knockdown or CRISPR/Cas9-mediated genome editing.195–197 
Lamins have been documented as mediators of oxidative stress, and laminopathy 
patient cells show increased levels of reactive oxygen species (ROS). A number of 
theories have been proposed, although several questions remain unanswered, such 
as  the involvement of mitochondria in this phenomenon.52 Therefore we analyzed the 
influence of LMNA and ZMPSTE24 knockdown in human dermal fibroblasts, on the 
generation of cellular ROS and the mitochondrial membrane potential (chapter 2). We 
used a quantitative microscopy-based analysis to measure ROS levels and 
mitochondrial membrane potential in real time. This allowed us to study the 
involvement of mitochondria in the onset of oxidative stress, triggered by LMNA and 
ZMPSTE24 knockdown.    
Laminopathies have been primarily studied with genomic and transcriptomic 
techniques, such as sequencing and microarrays. However, gene expression data 
cannot be directly extrapolated to protein level changes, due to the influence of post-
translational modifications and protein turnover. Therefore, we used a SILAC-based 
quantitative proteomics approach to identify the impact of LMNA knockdown on global 
protein expression (chapter 3). Gene ontology (GO) analysis was used to identify 
disrupted pathways in LMNA knockdown fibroblasts.   
Genomics, transcriptomics and proteomics can highlight changes in DNA, RNA 
expression and protein production, respectively. However, these techniques are not 
able to point out general molecular changes in a biological sample (e.g. lipids, 
carbohydrates, …). This can be addressed by RMS. We used this technique to 
generate a molecular fingerprint of HeLa cells in which ZMPSTE24 was knocked out, 
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using CRIPR/Cas9-mediated genome engineering (chapter 4). This allowed us to 
identify high-level molecular changes triggered by prelamin A accumulation in HeLa 
cells.  
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SUSTAINED ACCUMULATION OF PRELAMIN A 
AND DEPLETION OF LAMIN A/C BOTH CAUSE 
OXIDATIVE STRESS AND MITOCHONDRIAL 
DYSFUNCTION BUT INDUCE DIFFERENT CELL 
FATES 
This work is published in: Sieprath T*, Corne TD*, Nooteboom M, Grootaert C, Rajkovic 
A, Buysschaert B, Robijns J, Broers JL, Ramaekers FC, Koopman WJ, et al. Sustained 
accumulation of prelamin a and depletion of lamin A/C both cause oxidative stress and 
mitochondrial dysfunction but induce different cell fates. Nucleus 2015; :1–11. 
* Shared first authorship 
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Abstract  
The cell nucleus is structurally and functionally organized by lamins, intermediate 
filament proteins that form the nuclear lamina. Point mutations in genes that encode a 
specific subset of lamins, the A-type lamins, cause a spectrum of diseases termed 
laminopathies. Recent evidence points to a role for A-type lamins in intracellular redox 
homeostasis. To determine whether lamin A/C depletion and prelamin A accumulation 
differentially induce oxidative stress, we have performed a quantitative microscopy-
based analysis of reactive oxygen species (ROS) levels and mitochondrial membrane 
potential (m) in human fibroblasts subjected to sustained siRNA-mediated 
knockdown of LMNA and ZMPSTE24, respectively. We measured a highly significant 
increase in basal ROS levels and an even more prominent rise of induced ROS levels 
in lamin A/C depleted cells, eventually resulting in mhyperpolarization and 
apoptosis. Depletion of ZMPSTE24 on the other hand, triggered a senescence 
pathway that was associated with moderately increased ROS levels and a transient 
mdepolarization. Both knockdowns were accompanied by an upregulation of 
several ROS detoxifying enzymes. Taken together, our data suggest that both 
persistent prelamin A accumulation and lamin A/C depletion elevate ROS levels, but 
to a different extent and with different effects on cell fate. This may contribute to the 
variety of disease phenotypes witnessed in laminopathies. 
 
2.1. Introduction 
The nuclear lamina provides structural support to the nucleus and plays a central role 
in nuclear organization and gene regulation.14 Point mutations in the LMNA gene, 
which encodes its major constituent proteins, lamin A and C, cause a broad range of 
diseases termed laminopathies.14 During maturation, lamin A (LA) is extensively 
processed, with consecutive steps of farnesylation, proteolytic cleavage of the C-
terminal three amino acids, carboxymethylation and removal of the C-terminal 15 
amino acids, including the farnesyl group.37 The final step is exclusively catalyzed by 
the zinc-metallopeptidase ZMPSTE24. Accumulation of different prelamin A (PLA) 
intermediates is correlated with disease but especially the farnesylated variants are 
presumed to be cytotoxic.198 The Hutchinson-Gilford progeria syndrome (HGPS) for 
example is caused by an accumulation of the mutant farnesylated PLA intermediate 
progerin.199 Likewise, in restrictive dermopathy (RD), loss of functional ZMPSTE24 
results in the accumulation of farnesylated PLA.127,200 The underlying disease causing 
mechanisms are still largely unknown but it is becoming increasingly more clear that 
next to its structural function and role in nuclear dynamics54, the nuclear lamina also 
modulates intracellular redox homeostasis.52 Various studies revealed that reactive 
oxygen species (ROS) levels are increased in laminopathy patient cells and during 
PLA accumulation.201–204 For example, fibroblasts from various lipodystrophy patients 
as well as cells treated with protease inhibitors demonstrate increased ROS levels.204 
Proteomic and metabolic profiling suggest that this increase can be attributed to 
dysfunctional mitochondria.128,205  
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To corroborate these findings, we developed a microscopy-based strategy for 
combined measurement of ROS and mitochondrial membrane potential (m) in 
cellular models of PLA accumulation or LA deficiency.  Using this approach, we found 
that both accumulation of PLA and reduction of mature LA increased intracellular ROS 
levels, albeit not at the same rate nor to the same extent, and also caused changes in 
m. These effects were accompanied by reduced mitochondrial respiration and 
altered gene expression of ROS detoxifying enzymes. 
 
2.2. Results 
Sustained knockdown of ZMPSTE24 and LMNA reduce cell proliferation via 
different mechanisms 
Accumulation of PLA or reduction of mature LA was achieved in human fibroblasts by 
respectively silencing the expression of ZMPSTE24 or LMNA with specific siRNAs. A 
pool of non-targeting (NTkd) siRNAs was used as control. To maintain the knockdowns 
for prolonged periods of time, repetitive rounds of siRNA transfection were performed, 
separated by 72 h to 96 h. 48 h after the first transfection there was a highly significant 
downregulation of both genes at the RNA-level: ~4-fold (~75%) for ZMPSTE24 
knockdown (ZMPSTE24kd) and ~17-fold (~94%) for LMNA knockdown (LMNAkd). 
Similar levels were found after 168 h (two rounds of transfection) (Figure 2-1A). At the 
protein level, however, the effect became more pronounced with time. Quantitative 
immunofluorescence revealed an ~1.8-fold increase in PLA levels 48 h after the initial 
transfection, and a ~4-fold increase after 264 h (3 consecutive transfections) (Figure 
2-1B). Similarly, the abundance of mature LA dropped 1.3-fold after 48 h and 
decreased more than 4-fold after 264 h (Figure 2-1C). The effects were qualitatively 
confirmed by Western blot (Figure 2-1D). Immunostaining also revealed that 
knockdowns were accompanied by progressive changes in nuclear morphology. 
Whereas LMNAkd led to nuclear elongation and erosion of peripheral chromatin, 
sustained ZMPSTE24kd led to a dramatic increase in nuclei with folds and blebs 
(Figure 2-1E & F). 
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Figure 2-1. Sustained siRNA-mediated knockdown of LMNA (LMNAkd) and ZMPSTE24  
(ZMPSTE24kd). A: Gene expression levels of LMNA and ZMPSTE24 measured by real-
time qPCR relative to non-targeting control (NTkd). B and C: PLA and LA protein levels 
in ZMPSTE24kd resp. LMNAkd cells versus NTkd control, as measured by 
immunofluorescence staining and quantitative image analysis. D: Western blot with an 
A-type lamin antibody that recognizes lamin A, lamin C and PLA, showing absence o f 
lamin A/C in LMNAkd and accumulation of PLA in ZMPSTEkd cells at the 168h time 
point. Nucleolin was used as a loading control. E: Quantif ication of the number of 
dysmorphic nuclei, expressed relative to the total number of cells. F: Representative 
images of LMNAkd, ZMPSTEkd and NTkd control cells at the 168h time point, after 
immunofluorescence staining for LA (green), PLA (red) and counterstaining with DAPI 
(cyan). Arrows indicate nuclear aberrations.  The experiments were performed in 
triplicate and a minimum of 100 cells were imaged per replicate. In the boxplots, the 
horizontal l ine indicates the median, boxes the 25th and 75th percentile, and whiskers 
the 5th and 95th percentile. Error bars indicate the standard deviation on the mean 
value. (* = p-value < 0.05; ** = p-value < 0.01; *** = p-value < 0.001) 
Both knockdowns had an adverse impact on cell proliferation, resulting in significantly 
increased population doubling times (decreased population doubling level, PDL) with 
respect to the NTkd control (Figure 2-2A). The effect of LMNAkd was markedly 
stronger than that of ZMPSTE24kd. Quantification of ß-galactosidase positive cells and 
p21-positive cells – two markers for senescence206 – revealed that only ZMPSTE24kd 
triggered cellular senescence (Figure 2-2B,C,E). LMNAkd predominantly triggered cell 
death, as evidenced by a marked increase in the number of fragmented nuclei (Figure 
2-2D & E). 
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Figure 2-2. Sustained siRNA-mediated knockdown of LMNA and ZMPSTE24 affects cell 
proliferation. A: The relative population doubling speed compared to the NT-control 
expressed as population doubling level (PDL) at different time points. B: Quantif ication 
of the number of β-galactosidase posit ive cells at 168 h, relative to the total number of 
cells. C: Quantif ication of the number of p21 positive cells at 168 h, relative to the total 
number of cells. D: Quantif ication of apoptosis, expressed by the number of fragmented 
nuclei relative to the total number of cells. E: Representative images of β -galactosidase 
stained NT control, LMNAkd and ZMPSTE24kd cells (senescent cells in blue), merged 
with DAPI channel (grey/white). Arrows indicate nuclear aberrations. Except for the 
PDL measurements, the experiments were performed in tr iplicate. Error bars indicate 
the standard deviation on the mean value. (* = p-value < 0.05; ** = p-value < 0.01; *** = 
p-value < 0.001) 
LMNAkd significantly raises basal and induced ROS levels; ZMPSTE24kd only 
causes a modest increase of the basal ROS level 
We established and validated a high-content workflow to simultaneously measure 
intracellular ROS levels and m, using the fluorescent reporter molecules CM-
H2DCFDA and TMRM, respectively (see M&M and Figure 2-9 for details). Using this 
method, we quantified ROS levels in human fibroblasts subjected to sustained 
knockdown of ZMPSTE24 or LMNA under basal conditions and after acute application 
of 20 µM of the oxidant tert-butyl hydrogen peroxide (TBHP). The latter served as proxy 
for induced ROS and was expressed as the relative increase with respect to the basal 
ROS levels. 
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LMNAkd caused a time-dependent increase in both basal and induced ROS levels. 
Whereas the increase in basal ROS levels only became significant after 168 h, the 
induced ROS levels were already significantly higher at 96 h. ZMPSTE24kd on the 
other hand, only resulted in a modest, but significant increase in basal ROS levels after 
264 h. Within the experimental time frame, this treatment did not cause a significant 
increase of induced ROS (Figure 2-3A & B). 
Next to the knockdowns, passage-matched fibroblasts from specific laminopathy 
patients (LMNAY259X/Y259X, LMNAG608G/+, LMNA+/+) were subjected to the same analysis. 
LMNAY259X/Y259X cells are incapable of producing mature lamin A/C207 and LMNAG608G/+ 
cells accumulate a truncated, farnesylated prelamin A variant termed progerin.208 In 
line with the results from the sustained knockdown, LMNAY259X/Y259X demonstrated an 
increase in both basal and induced ROS, whilst LMNAG608G/+ cells only showed an 
increase in basal ROS (Figure 2-3C & D). 
Figure 2-3. Both, LMNAkd and ZMPSTE24kd cells have increased basal ROS levels. 
LMNAkd are more susceptible towards induced ROS. A and B: Normalized basal levels 
of intracellular ROS measured by CM-H2DCFDA high content microscopy analysis and 
response towards induced ROS, measured as relative gain in intensity after 20µM 
TBHP addition at different t ime points in LMNAkd and ZMPSTE24kd cells. C and D: 
Normalized basal levels of intracellular ROS and response towards induced ROS in 
LMNAY259X/Y259X and LMNAG608G/+  cells. The experiments were performed in tr iplicate 
and a minimum of 100 cells were imaged per replicate. In the boxplots, the horizontal 
l ine indicates the median, boxes the 25th and 75th percentile, and whiskers the 5th and 
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95th percentile. (* = p-value < 0.05; ** = p-value < 0.01; *** = p-value < 0.001; the 
range of the y-axes has been adjusted to optimally display the differences) 
ZMPSTE24kd and LMNAkd affect m in a time dependent manner 
 As dysfunctional mitochondria can generate increased amounts of ROS, we estimated 
mas a functional readout, by quantifying the mitochondrial accumulation of the 
reporter dye TMRM using the high content microscopy method described above. 
Dynamic and time-dependent changes were observed for the different treatments. 
LMNAkd induced m depolarization at 96 h and 168 h and m hyperpolarization at 
264 h. On the other hand, ZMPSTE24kd resulted in a transient m depolarization at 
168 h (Figure 2-4A). In the case of patient cells, LMNAY259X/Y259X fibroblasts displayed 
slight m hyperpolarization that was not significantly different from LMNA+/+ control 
cells. In contrast, LMNAG608G/+ fibroblasts displayed significant m depolarization 
(Figure 2-4B). 
Figure 2-4. Sustained siRNA-mediated knockdown of LMNA and ZMPSTE24 induces 
time-dependent alterations in mitochondrial membrane potential  (m  and decreased 
basal mitochondrial respiration. A: Normalized  mas measured by TMRM at different 
time points in LMNAkd and ZMPSTE24kd cells. B: Normalized m  in 
LMNAY259X/Y259X and LMNAG608G/+ cells. The m experiments were performed in 
triplicate and a minimum of 100 cells were imaged per replicate. In the boxplots, the 
horizontal l ine indicates the median, boxes the 25th and 75th percentile, and whiskers 
the 5th and 95th percentile. C and D: Normalized basal respiration of LMNAkd, 
ZMPSTE24kd, LMNAY259X/Y259X and LMNAG608G/+ cells. E and F: Normalized 
respiration prof iles of LMNAkd, ZMPSTE24kd, LMNAY259X/Y259X and LMNAG608G/+ 
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cells. The experiments were performed in triplicate and the shaded region represents 
the standard error on the measurements. See the materials and methods section for 
more information about the different chemical components th at were added. (* = p-
value < 0.05; ** = p-value < 0.01; *** = p-value < 0.001; the range of the y-axes has 
been adjusted to optimally display the differences)  
ZMPSTE24kd and LMNAkd decrease basal oxygen consumption rates 
Since the TMRM measurements suggested a (transient) defect in mitochondrial 
function, we next investigated mitochondrial oxygen consumption (Figure 2-4C-F). At 
the 168 h time point, we found strong deviations between the respiration curves (Figure 
2-4C & D).  
Especially, the basal oxygen consumption rate (OCR) was significantly lower in both 
ZMPSTE24kd and LMNAkd cells (Figure 2-4E). This was also the case for 
LMNAY259X/Y259X and LMNAG608G/+ patient fibroblasts (Figure 2-4F).  
LMNAkd nor ZMPSTE24kd are correlated with significant changes in 
mitochondrial superoxide 
To verify whether a change in m was accompanied by a change in mitochondrial 
superoxide (•O2-) production, we measured the latter using the mitochondria-targeted 
•O2- sensor MitoSOX. After 168h hours, no significant change in •O2- levels was 
observed, despite a transient decrease in m in both knockdowns. After 264h 
LMNAkd cells clearly displayed a significant increase in m as well as in •O2- (Figure 
2-5). 
 
Figure 2-5. 264h of sustained siRNA-mediated knockdown of LMNA results in 
signif icantly increased mitochondrial ROS levels. A: Normalized basal levels of 
mitochondrial ROS measured by MitoSOX high content microscopy after 264h of 
knockdown. The experiments were performed in tr iplicate and a minimum of 100 cells 
were imaged per replicate. In the boxplots, the horizontal l ine indicates the median, 
boxes the 25th and 75th percentile, and whiskers the 5th and 95th percentile. 
Signif icance was calculated with the Wilcoxon rank sum test; *** = p -value < 0.001.  
LMNAkd and ZMPSTE24kd differentially affect antioxidant gene expression  
Oxidative stress arises from an imbalance between ROS production and removal. To 
find out whether the accumulation of ROS correlated with a change in expression of 
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ROS detoxifying enzymes, we performed a qPCR analysis. In general, LMNAkd more 
profoundly affected the expression of these enzymes than ZMPSTE24kd. In both 
conditions, most of the investigated genes became upregulated with the strongest 
effect being observed on the GSTT2 transcript levels. Strikingly, ZMPSTE24kd and 
LMNAkd oppositely affected the expression of the mitochondrial manganese-(Mn)-
superoxide dismutase (SOD2). This ROS-detoxifying enzyme converts superoxide 
(O2●-) into hydrogen peroxide (H2O2). Expression of SOD2 is regulated by the key 
cytokine IL6.209 Subsequent quantification of IL6 transcript levels revealed a strong 
upregulation in ZMPSTE24kd and downregulation in LMNAkd cell cultures (Fig. 5). 
The same opposite expression pattern was also observed in LMNAY259X/Y259X and 
LMNAG608G/+ patient fibroblasts (Figure 2-6). 
 
Figure 2-6. LMNAkd and ZMPSTE24kd cells show altered gene expression of ROS 
defusing enzymes. A: Gene expression levels of GPX1 , GPX5 , GSTT2,  PRDX1, PRDX2, 
PRDX3 , SOD1,  SOD2, SOD3 and IL6  were measured in LMNAkd and ZMPSTEkd cells 
by real-t ime qPCR relative to NTkd control at 168 h. B: Gene expression levels of IL6 
and SOD2  were measured in LMNAY259X/Y259X and LMNAG608G/+  f ibroblasts by real-t ime 
qPCR relative to untreated passage matched control f ibroblasts. The values in this plot 
represent the average of 3 technical replicates, but only one biological replicate 
because we only have one cell l ine for each mutation. Therefore, we cannot provide 
biologically relevant error bars. (* = p-value < 0.05; ** = p-value < 0.01; *** = p-value < 
0.001) 
Proteasome inhibition increases intracellular ROS and m 
To check whether proteasome inhibition could induce ROS or alter m, human 
fibroblasts were treated with 10µM MG132 for 16h and analyzed using the microscopy 
based assay described earlier. Similar to the results obtained in LMNAkd cells, these 
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cells display increased basal and induced ROS levels, as well as an increased m 
(Figure 2-7).  
Figure 2-7. Treatment of human fibroblasts with 10µM of MG-132 for 16h results in 
increased basal ROS levels, increased induced ROS levels and an increased m 
comparable to observations made on LMNAkd cells. Healthy human fibroblasts were 
treated with 10µM of MG-132, a known potent inhibitor of the proteasome, and analyzed 
with CM-H2DCFDA- and TMRM-based high content microscopy to check whether 
proteasomal dysfunction could give r ise to the same kind of observations made in the 
knockdown cells. Indeed, both a sustained knockdown of LMNA and a treatment with 
10µM of MG-132 give r ise to the same observations for basal and induced ROS (A & B), 
as well as for mitochondrial membrane potential (C). This adds to the hypothesis that 
proteasomal overload caused by LMNA knockdown might tr igger generation of 
intracellular ROS in the mitochondria. The experiments were performed in tr iplicate and 
a minimum of 100 cells were imaged per replicate. In the boxplots, the horizontal l ine 
indicates the median, boxes the 25th and 75th percentile, and whiske rs the 5th and 
95th percentile. For all f igures, signif icance was calculated with the Wilcoxon rank sum 
test; *** = p-value < 0.001.  
2.3. Discussion 
With this work, we set out to enhance our understanding of how PLA accumulation and 
LA deficiency affect cellular redox homeostasis and ROS levels at the cellular level. 
Since mature LA is firmly integrated within the nuclear lamina, it is characterized by 
low turnover rates.210 This makes studying LA biology by acute siRNA-mediated 
knockdown strategies unreliable. We therefore induced sustained knockdown in 
human fibroblasts by repetitive siRNA transfection. After the initial transfection, gene 
expression levels dropped relatively quickly to a minimum (within 72 h), but the actual 
protein levels progressively changed over a time span of 264 h (LA declined, PLA 
increased). In LMNAkd cells, and especially in ZMPSTE24kd cells, this was 
accompanied by overt changes in nuclear morphology in a large fraction (60-70%) of 
cells. Similar levels of nuclear dysmorphy were quantified in human mesenchymal 
stem cells (hMSCs) after siRNA-mediated knockdown of ZMPSTE24137 and the 
observed morphological changes were similar to those seen in Zmpste24 -/- mouse 
embryonic fibroblasts (MEF)211 and HGPS patient fibroblasts.212 As a rough validation, 
we extended our experiments with measurements of cells from LMNAY259X/Y259X and 
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LMNAG608G/+ patients, although it should be noted that the patient’s genetic background 
might play a role in the outcome of the experiments. In addition, knockdown of 
ZMPSTE24 causes accumulation of a farnesylated full-length PLA, whereas HGPS 
cells (LMNAG608G/+) produce a different farnesylated PLA variant lacking 50 amino 
acids. 
To measure ROS levels and mitochondrial function in a robust and reliable manner at 
the single cell level, we established and benchmarked a high-content microscopy 
workflow in which we measured both intracellular ROS levels and mitochondrial 
membrane potential (m). Using this approach, we observed that both accumulation 
of farnesylated PLA and reduction of mature LA increased intracellular ROS levels, 
albeit at different rates. Compared to ZMPSTE24kd, LMNAkd induced a progressive 
increase in basal ROS that was much more pronounced and started much earlier in 
the experimental time frame. And whereas ZMPSTE24kd cells showed no significant 
alteration in their response to the exogenous oxidant TBHP, LMNAkd cells proved to 
be hypersensitive. These observations correlate well with those obtained by Pekovic 
et al.213 and support the hypothesis that the nuclear lamina acts as an intracellular 
ROS-sink via conserved redox-reactive cysteine residues within the lamin tail.213 When 
A-type lamins (and their cysteine residues) are depleted, the ability of the lamina to act 
as a ROS buffering system is abrogated, rendering the cell more sensitive against 
(potentially dangerous) increases of the intracellular ROS levels. PLA accumulation 
however does not decrease the concentration of these cysteine residues, leaving the 
ROS-sink intact. If PLA concentrations rise above a certain threshold though, as 
observed in ZMPSTE24kd cells at 264h, ROS levels do increase. This was also 
recently reported by a study in fibroblasts of centenarians.214  
To determine whether elevated ROS levels correlated with mitochondrial dysfunction, 
we also quantified m. Our results revealed that LMNAkd induces m depolarization 
at early time points, followed by m hyperpolarization at 264 h. In contrast, 
ZMPSTE24kd induced a transient m depolarization. In accordance with the increase 
in m, we also observed a significant increase in mitochondrial •O2- levels in LMNAkd 
cells after 264h, as reported by the MitoSOX sensor dye. Indeed, it has been 
demonstrated before that mitochondria produce more ROS at high membrane 
potential.215,216  
Since mitochondria are the initial sites of oxidative damage and the instigators of 
oxidative stress in the cytosol upon proteasome dysfunction217, a possible connection 
with the knockdowns may lie in their potential to cause proteasome inhibition. Depletion 
of LA has been linked to accumulation of nuclear envelope proteins (SUN2, Emerin 
and Nesprin-1) in the endoplasmic reticulum and upregulation of various ubiquitin 
ligases, resulting in proteasome overload.114,218–220 Supporting this hypothesis, 
treatment of fibroblasts for 16h with 10µM of MG-132, a potent proteasome inhibitor, 
also resulted in a significant increase of basal and induced ROS levels, as well as 
increased m, as observed in LMNAkd cells at 264h. 
38 
 
In accordance with a defect in mitochondrial function, and consistent with observations 
in Zmpste24-/- mouse adult fibroblasts205, the basal mitochondrial respiration rate in 
both LMNAkd and ZMPSTE24kd cells as well as in LMNAY259X/Y259X and LMNAG608G/+ 
patient cells was lowered. 
Parallel to the increase in intracellular ROS, both knockdowns showed increased 
expression of ROS detoxifying enzymes. The greater induction of basal ROS in 
LMNAkd with respect to ZMPSTE24kd cells correlated with a larger number of 
upregulated genes. In both conditions, the general trend was preserved except a 
differential expression of GPX1 and SOD2. SOD2 is a mitochondrial superoxide 
converting enzyme, the expression of which is regulated by IL6, a senescence 
associated cytokine.221–223 We found that both IL6 and SOD2 were upregulated in 
ZMPSTE24kd and downregulated in LMNAkd cells. The same opposite expression 
was observed in LMNAG608G/+ and LMNAY259X/Y259X fibroblasts, respectively, even with 
a much stronger (~78 fold) downregulation of IL6 in LMNAY259X/Y259X cells. The 
upregulation of SOD2 in ZMPSTE24kd cells might explain why these cells display no 
significant increase in mitochondrial superoxide.217 When following this reasoning, 
downregulation of SOD2 should then trigger a rise in mitochondrial ROS levels, which 
we indeed observed in LMNAkd cells after 264h. Previously, we have shown that 
repetitive ruptures of the nuclear envelope in lamin A/C deficient cells temporarily 
relocate various transcription factors, several of which controlling oxidative stress 
response.62 In addition, we found that lamin A/C deficiency caused cytoplasmic 
translocation of nuclear PML bodies60, known sensors of oxidative stress and 
regulators of redox homeostasis.224,225 It is conceivable that these phenomena 
contribute to the oxidative stress phenotype witnessed in LMNAkd cells as well. 
Irrespective of the ROS source, we witnessed a decreased cell proliferation in both 
ZMPSTE24kd and LMNAkd cells. However, the actual cell fate between both 
knockdowns differed. Whereas ZMPSTE24kd cells resorted to a senescence pathway 
(shown by ß-galactosidase and p21 staining as well as upregulation of IL6), LMNAkd 
cells rather experienced increased apoptosis (evidenced by an increased number of 
cells with fragmented nuclei and m hyperpolarization, which is known to precede 
apoptosis226,227). These results align well with earlier findings. Indeed, premature 
senescence was observed in Zmpste24-/- MEFs, LmnaG609G/G609G MEFs, ZMPSTE24 
depleted hMSCs and HGPS fibroblasts136,221,228,229, and apoptosis was increased in 
Lmna-/- MEFs, especially when subjected to mechanical stress55,219, in myocytes from 
LmnaE82K/+ transgenic mice230 and in Lmna+/- atrioventricular nodal mouse myocytes.145 
This bifurcation in cell fate might be triggered by the extent of mature lamin A reduction, 
which translates into a ROS dosage effect. It has been shown that modestly increased 
levels of intracellular ROS induce and maintain cellular senescence, as observed in 
ZMPSTE24kd cells, while higher doses provoke apoptosis, i.e. LMNAkd cells.231–234  
In conclusion, we demonstrated that sustained knockdown of LMNA or ZMPSTE24 
resulted in increased basal ROS levels, which were accompanied by changes in 
mitochondrial function and altered gene expression of ROS detoxifying enzymes. 
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Reduction of LA caused a dramatic increase in basal and, especially, induced ROS 
levels ultimately leading to m hyperpolarization and apoptosis. Depletion of 
ZMPSTE24 on the other hand, triggered a senescence pathway, associated with 
moderately increased ROS levels and transient m depolarization. Thus, LA and PLA 
differentially regulate cell fate, in part via a redox-dependent pathway. Uncovering the 
pathways that lead to increased ROS production will help understanding laminopathy 
diversity and disease progression.  
 
2.4. Materials and methods 
Cell culture 
Normal human dermal fibroblasts (NHDF, LMNA+/+, Promocell, C-12300), fibroblasts 
from a patient with a lethal laminopathy phenotype due to a nonsense Y259X 
homozygous mutation in the LMNA gene (LMNAY259X/Y259X)207 and fibroblasts from a 
patient suffering from HGPS (LMNAG608G/+)208 were cultured in T25 or T75 culture 
flasks in DMEM High Glucose with L-Glutamine medium (Lonza, BE12-604F) 
supplemented with 10% fetal bovine serum (Gibco, 10500-064) and 1% 
penicillin/streptomycin/L-glutamine (Gibco, 10378-016), at 37°C and 5% CO2, 
according to standard procedures. All experiments were performed with cells in 
between passage 9 and 20.  In case of direct comparison, passage-matched cells were 
used. At set time points, viable cells were counted using Trypan blue and a Bürker 
chamber. Proliferative capacity was expressed in terms of population doubling level 
(PDL), the base 2 logarithm of the number of cells at the current time point divided by 
the number of cells that was seeded.    
siRNA-mediated knockdown 
Expression of ZMPSTE24 and LMNA was silenced with siGENOME Lamin A/C siRNA 
(Thermo Scientific, D-001050-01-20) and siGENOME Human ZMPSTE24 siRNA 
(Thermo Scientific, M-006104-02-0020), respectively. Stealth RNAi siRNA Negative 
Control, Med GC (Life Technologies, 12935-300) was used as a negative non-targeting 
control (NTkd). siRNA transfections were performed using Lipofectamine® RNAi-MAX 
Transfection Reagent (life technologies, 13778-075), according to manufacturer’s 
instructions following the scheme outlined in Figure 2-8. 
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Figure 2-8. A: Schematic overview of the maturation process of prelamin A to mature 
lamin A and interference by siRNA-mediated knockdown. B: Experimental design of the 
sustained siRNA-mediated knockdown by repetit ive transfections (TFs).  
Quantitative PCR 
RNA was extracted from cells using the RNAeasy mini kit (Qiagen, 74104), with on-
column DNAse digestion. Concentrations of purified RNA were measured with the 
NanoDrop 2000 (Thermoscientific). Per sample, 1µg of RNA was converted to cDNA 
using SuperScript® III Reverse Transcriptase (RT) (Life Technologies, 18080-044). All 
qPCR reactions were performed on a RotorGene 3000 (Qiagen/Corbett) using the 
SensiMix™ SYBR® No-ROX Kit (Bioline, QT650) according to the manufacturer’s 
instructions. Relative abundance of LMNA transcripts (forward: 
TGGACGAGTACCAGGAGCTT; reverse: ACTCCAGTTTGCGCTTTTTG), 
ZMPSTE24 transcripts (forward: CGAGAAGCGTATCTTCGGG; reverse: 
TGTGCTAGGAAGGTCTCCCA), SOD1 transcripts (forward: 
GACCTGCACTGGTACAGCCT; reverse: GCATCATCAATTTCGAGCAG), SOD2 
transcripts (forward: GGAGAAGTACCAGGAGGCGT; reverse: 
TAGGGCTGAGGTTTGTCCAG), SOD3 transcripts (forward: 
TCTCTTGGAGGAGCTGGAAA; reverse: CGAGTCAGAGTTGGGCTCC), IL6 
transcripts (forward: AGTGAGGAACAAGCCAGAGC; reverse: 
GTCAGGGGTGGTTATTGCAT), GSTT2 transcripts (forward: 
ACGCTCAAGGATGGTGATTT; reverse: AGGTACTCATGAACACGGGC), GPX1 
transcripts (forward: CCGAGAAGGCATACACCGAC; reverse: 
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GCCGGCCAGTTAAAAGGAGG), GPX5 transcripts (forward: 
ACAAGTCCCAAGCAGGAGAA; reverse: TGACGAAGAGGATGTGCTTG), PRDX1 
transcripts (forward: GCTGTTATGCCAGATGGTCAG; reverse: 
GGGCACACAAAGGTGAAGTC), PRDX2 transcripts (forward: 
GTCCTTCGCCAGATCACTGT; reverse: TGGGCTTAATCGTGTCACTG) and PRDX3 
transcripts (forward: CCACATGAACATCGCACTCT; reverse: 
TTGACGCTCAAATGCTTGAT) were measured relative to ACTB (forward: 
CCTTGCACATGCCGGAG ; reverse: GCACAGAGCCTCGCCTT) and GAPDH 
(forward: TGCACCACCAACTGCTTAGC; reverse: GGCATGGACTGTGGTCATGAG) 
reference transcripts. Ct-values were calculated using the ‘comparative quantification’ 
(CQ) method supplied as part of the Rotor Gene 3.0 software (Corbett Research). 
Analysis was done using the ΔΔCt-method.235  
Immunofluorescence staining 
NHDF cells were grown on glass coverslips and fixed in 4% paraformaldehyde for 15 
minutes at room temperature and washed (3x, 5 minutes) with PBS. Subsequently, 
cells were permeabilized with 0.5% Triton X-100 (5 minutes), after which they 
incubated with primary antibody diluted in 50% fetal bovine serum (FBS) for 60 
minutes. After minimally 3 PBS wash steps, slides were incubated with secondary 
antibody diluted in 50% FBS for 30 minutes, washed again, and mounted with 
VECTASHIELD™ Mounting Medium (VWR, 101098-042) containing 1 µg/ml 4′,6- 
diamino-2-phenylindole (DAPI). Primary antibodies were directed against lamin A 
(Abcam, ab26300) and prelamin A (Santa Cruz Biotechnology Inc., SC-6214). As 
secondary antibodies DyLight 488 conjugated donkey anti-rabbit (Jackson 
ImmunoResearch Laboratories Inc., JAC-705606147), and DyLight 649 conjugated 
donkey anti-goat (Jackson ImmunoResearch Laboratories Inc., JAC-705496147) were 
used. Immunofluorescent stained cells were visualized using a Nikon Ti Eclipse 
inverted widefield fluorescence microscope (Nikon Instruments) with 40x Plan Apo oil 
(NA = 1.3) and 60x Plan Apo VC (NA = 1.4) objectives. 
ß-galactosidase staining 
NHDF cells were grown on glass coverslips and fixed in 4% paraformaldehyde for 15 
minutes at room temperature and washed (2x, 5 minutes) with PBS. Fixed cells were 
incubated overnight at 37°C in 1 mg/ml X-Gal, 40 mM citric acid/phosphate buffer (pH 
6), 5 mM ferricyanide, 5 mM ferrocyanide, 2 mM MgCl2 and 150 mM NaCl. After 
incubation, the cells were washed (3x, 5 minutes) with PBS and permeabilized with 
0.5% Triton X-100 (5 minutes). The cells were washed (3x, 5 minutes) with PBS and 
mounted with VECTASHIELD™ Mounting Medium (VWR, Belgium, 101098-042) 
containing 1 µg/ml 4′,6- diamino-2-phenylindole (DAPI). Cells were visualized using a 
Nikon Ti Eclipse inverted widefield fluorescence microscope (Nikon Instruments) with 
a 40x Plan Apo oil (NA = 1.3) objective. 
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Western blot 
Cells were grown in T75 culture flasks and lysed using the whole-cell extraction 
protocol of the Nuclear Extract Kit (Active Motif, 40010). Protein concentration was 
measured with the Pierce 660 nm assay (Thermo Scientific, 22662). Cell lysates were 
subjected to SDS-PAGE (8% bis-tris with MOPS running buffer) and transferred to 
BioTrace PVDF membranes (Pall Corporation, 66542). Primary antibodies were 
directed against lamin A/C (Santa Cruz Biotechnology Inc., sc-56139) and nucleolin 
(control) (Novus Biologicals, NB600-241). HRP conjugated goat anti-mouse (Sigma-
Aldrich, A4416) and HRP conjugated goat anti-rabbit (Sigma-Aldrich, A6154) were 
used as secondary antibodies. Proteins were detected by chemiluminescence with 
Immobilon Western chemiluminescent HRP substrate (Millipore, WBKLS0100). 
High content live cell imaging of intracellular ROS and Δψm 
Intracellular ROS and mwere measured after dual staining with the fluorescent cell-
permeable probes 5-(and-6)-chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate 
(CM-H2DCFDA) (Life Technologies, C6827) and tetramethyl rhodamine methyl ester 
(TMRM, Invitrogen, T-668). Measurements were done 96 h, 168 h and 264 h after 
initiation of the knockdown (Figure 2-8B). 24 h before measurement, cells were 
transferred to 96-well plates at 2500 cells per well. Right before measurement they 
were washed in HBSS + Hepes (HH) (pH 7.2), incubated for 25 minutes in the dark at 
room temperature in HH-buffer containing 2 µM CM-H2DCFDA and 20nM TMRM, 
washed again in HH-buffer and then imaged (also in HH-buffer) on a Nikon Ti Eclipse 
inverted widefield fluorescence microscope with a 20x air Plan Apo objective (NA 0.75) 
using a 480/40 nm excitation, 520/35 nm emission filter combination for the CM-
H2DCFDA signal and a 540/25 nm excitation, 605/55 nm emission filter combination 
for the TMRM signal. Since fluorescence excitation induces the formation of ROS236, 
the CM-H2DCFDA signal increases during microscopic observation. To avoid 
excessive light exposure, the focal plane was searched with diffuse transmitted light. 
Subsequently an infrared-led based autofocus (Perfect Focus System, Nikon) was 
used, after which images were acquired automatically across the plate (4 images per 
well and per channel), the CM-H2DCFDA channel first. After the complete plate was 
imaged, 20 µM tert-butyl peroxide (Sigma-Aldrich, 458139-100mL) was added to all 
wells and after a 3-minute interval the acquisition was repeated. The workflow is 
depicted in Figure 2-9A. The method was benchmarked with different doses of TBPH 
(Figure 2-9B). TMRM reporter potential was validated with valinomycin (Sigma) (Figure 
2-9C) and oligomycin (Sigma) (Figure 2-9D), known inducers of m depolarization, 
respectively hyperpolarization.    
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Figure 2-9. A: Schematic overview of the high-content workflow to simultaneously 
measure intracellular ROS levels and m. B: Normalized levels of intracellular ROS 
measured by CM-H2DCFDA high content microscopy in human fibroblasts treated for 15 
minutes with increasing concentrations of TBHP. C: Normalized m  as measured by 
TMRM in human fibroblasts treated for 30 minutes with increasing concentrations of 
oligomycin. D: Live cell imaging of m in human fibroblasts loaded with TMRM and 
treated with 5 ng/mL valinomycin after 85s. The experiments were performed in 
triplicate and a minimum of 100 cells were imaged per replicate. In the boxplots, the 
horizontal l ine indicates the median, boxes the 25th and 75th percentile, and whiskers 
the 5th and 95th percentile.  
An analogous experimental setup was used for measuring mitochondrial superoxide 
levels with MitoSOX Red Reagent (Life technologies – M36008). This dye was 
combined with the pan-cellular, viability dye Calcein Green (Life Technologies – 
C34852) to simplify cell segmentation in downstream image analysis and exclude dead 
cells from the analysis.237 In brief, cells were grown in 96-well plates, washed in HH-
buffer, incubated in HH-buffer with 5 µM MitoSOX Red Reagent and 0.930 µM Calcein 
for 10 minutes at 37°C in the dark, washed again and imaged 1x with the same 4 
images/well acquisition protocol. The dynamic range of MitoSOX was determined via 
TBPH addition. All experiments were performed with at least 8 replicates per treatment 
per plate (depending on the experiment), on at least 3 different plates. 
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For MG132 treatment, 2000 cells were seeded in 96-well plates 2 days before 
measurement, 16h prior to staining, cells were treated with 10µM MG132 (Santa Cruz 
– SC-201270). 
Image analysis 
All image processing was performed in FIJI (http://fiji.sc), a packaged version of 
ImageJ freeware (W.S. Rasband, U.S.A. National Institutes of Health, Bethesda, 
Maryland, USA, http://rsb.info.nih.gov/ij/, 1997–2014). Quantification of nuclear signal 
intensities of immunostained cell cultures using INSCYDE.ijm, a script for high content 
analysis.56 Additionally, a new script was written for automated analysis of intracellular 
ROS and mitochondrial characteristics (RedoxMetrics.ijm). In brief, the image analysis 
pipeline consists of a flatfield correction to correct for illumination heterogeneity, noise 
reduction by Gaussian filtering and cell or mitochondrial segmentation and subsequent 
feature analysis of regions of interest. For CM-H2DCFDA or Calcein counterstained 
images, cells were segmented by autothresholding according to Huang’s algorithm and 
average intensities were measured within the segmented regions. For measurement 
of mitochondrial signals, mitochondria were first selectively enhanced by local contrast 
enhancement and multi-scale Laplacian filtering56 after which binarization was 
performed using Huang’s algorithm. The resulting mask was used for analyzing shape 
metrics of objects larger than a predefined size (> 3 pixels) on the original image. All 
scripts are available upon request. 
Respirometry 
The Seahorse Extracellular Flux XF24 analyzer (Seahorse Bioscience) was used to 
provide a comprehensive assessment of the relative state of aerobic metabolism in live 
cells in assessing mitochondrial function. Seeding density and concentration of 
Mitostress kit (Seahorse Bioscience, 101848-400) components were optimized 
according to the manufacturers guidelines. Fibroblasts were seeded at a concentration 
of 20000 cells per well the day prior to the experiment. OCR was measured before 
addition of any compound (basal OCR), after addition of oligomycin (0.5 µM final 
concentration), carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP, 0.5 µM) 
and rotenone/antimycin (0.5 and 0.05 µM). The OCR linked to coupled respiration was 
obtained by subtracting OCR after the addition of oligomycin from basal OCR. OCR 
after addition of the mitochondrial uncoupler FCCP reflected the maximal respiratory 
rate (spare respiratory capacity). Non-mitochondrial respiration was defined as the rate 
after rotenone/antimycin A application and was subtracted from the basal OCR to 
determine the mitochondrial OCR. 
Statistical analyses 
Data analysis and visualization was performed in R statistical freeware (http://www.r-
project.org). Standard statistical methods were employed, including the Shapiro-Wilk 
Normality Test to assess normality of the data, Levene’s test to assess 
homoscedasticity, student’s t-test, ANOVA and the Kruskal-Wallis rank sum test to 
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assess differences between the group means and Tukey (after ANOVA) and Dunnett 
type (After Kruskal-Wallis) post-hoc tests to assess significance for each group. We 
also used non-parametric contrast-based multiple comparison tests.238 Significance 
levels were indicated as follows: p<0.05 (*), p<0.01 (**), and p<0.001 (***). For graphics 
and annotation, the R program was expanded with the ggplot2 package.239  
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Abstract 
The nuclear lamina mechanically integrates the nucleus with the cytoskeleton and 
extracellular environment and regulates gene expression. These functions are exerted 
through direct and indirect interactions with the lamina’s constituent proteins, the A-
type lamins, which are encoded by the LMNA gene. Using quantitative stable isotope 
labeling-based shotgun proteomics we have analyzed the proteome of human dermal 
fibroblasts in which we have depleted A-type lamins by means of a sustained siRNA-
mediated LMNA knockdown. Gene ontology analysis revealed that the largest fraction 
of differentially produced proteins was involved in actin cytoskeleton organization, in 
particular proteins involved in focal adhesion dynamics, such as actin-related protein 
2 and 3 (ACTR2/3), subunits of the ARP2/3 complex, and fascin actin-bundling protein 
1 (FSCN1). Functional validation using quantitative immunofluorescence showed a 
significant reduction in the size of focal adhesion points in A-type lamin depleted cells, 
which correlated with a reduction in cell adhesion capacity after seeding on collagen, 
and an increased cell motility. At the same time, loss of A-type lamins led to more 
pronounced stress fibers and higher traction forces in cells undergoing enzymatic 
detachment. This phenotype could not be mimicked or reversed by experimental 
modulation of the STAT3-IL6 pathway, but it was partly recapitulated by chemical 
inhibition of the ARP2/3 complex. Thus, our data suggest that the loss of A-type lamins 
perturbs the balance between focal adhesions and cytoskeletal tension. This 
imbalance may contribute to mechano-sensing defects observed in certain 
laminopathies. 
 Introduction 
The nuclear lamina, a thin filamentous protein layer beneath the nuclear envelope, 
physically supports the cell nucleus and has a central role in nuclear organization and 
gene regulation.14 The major constituents of this meshwork are type V intermediate 
filament proteins, known as lamins. Mutations in the LMNA gene, which encodes A-
type lamins, cause a wide spectrum of tissue-specific and systemic diseases 
collectively called laminopathies. Disease manifestations include muscular 
dystrophies, lipodystrophies, dilated cardiomyopathies and the premature aging 
syndromes Hutchinson-Gilford progeria (HGPS) and restrictive dermopathy (RD).14 
Since the nuclear lamina is involved in gene regulation through chromatin organization 
and sequestration of transcription factors14,136,240–242, mutations in genes encoding 
nuclear lamins directly affect gene expression. Indeed, microarray analysis of HGPS 
fibroblasts136,243 and of Lmna deficient MEFs85 have revealed large-scale changes in 
the transcriptome with respect to their wild-type counterparts. However, the stability 
and function of the encoded proteins are regulated by post-translational modifications 
and interactions, precluding direct extrapolation of gene expression data to protein 
level changes. A limited number of pioneering studies has documented changes in 
global protein expression in laminopathy patient cells or mouse model cells.128,205,244,245 
However, the genetic variability between patients and the lower translational value of 
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animal model cells complicate extraction of causal effects.195–197 Therefore we have 
now analyzed proteome changes in a controlled, isogenic cell system, namely human 
dermal fibroblasts in which we depleted A-type lamins by means of sustained siRNA-
mediated knockdown246, with the underlying reasoning that this may have value for 
better understanding laminopathies that are characterized by reduction 
(haploinsufficiency) or loss of A-type lamins, among which certain 
cardiomyopathies.142,144 We identified several proteins with significantly altered 
abundance that were involved in focal adhesion (FA) kinetics: actin-related protein 2 
(ACTR2), actin-related protein 3 (ACTR3) and fascin actin-bundling protein 1 (FSCN1). 
We validated and complemented proteomics with functional studies, showing an 
unexpected uncoupling between cell adhesion and cytoskeletal tension.   
 Results 
SILAC-based quantitative analysis in A-type lamin depleted fibroblasts reveals 
changes in the cytoskeletal proteome  
To study the impact of A-type lamin depletion on global protein expression, we 
performed a SILAC-based quantitative proteomics experiment on human dermal 
fibroblasts after sustained knockdown of LMNA (LMNAkd). RT-qPCR revealed a ~16-
fold decrease of LMNA transcripts in LMNAkd cells. Lamins A and C were virtually 
absent on western blot and a ~2.8-fold decrease was observed via immunofluorescent 
staining of lamin A, essentially approximating background levels. LMNAkd cells also 
showed a significant increase of dysmorphic nuclei compared to control cells that were 
treated with a non-targeting control siRNA (NTkd) (3.0-fold increase). 
Using the SILAC based proteomics approach depicted in Figure 3-1A, we identified a 
total of 1,341 proteins, of which 75 showed significant differential expression (p<0.05). 
42 proteins were more abundantly and 33 were less abundantly present in LMNAkd 
cells than in NTkd cells. Gene ontology (GO) analysis of the protein class indicated 
that the largest group (23.7%) of the proteins were cytoskeletal or cytoskeleton-
associated. Gene ontology enrichment analysis (GOrilla) returned five GO terms that 
were significantly enriched for this protein set, namely 1) positive regulation of cellular 
component biogenesis, 2) regulation of cellular component biogenesis, 3) regulation of 
actin filament-based process, 4) ARP2/3 complex-mediated actin nucleation, and 5) 
regulation of actin filament polymerization (Figure 3-1B). A subset of 16 top hits that 
showed a relative fold change higher than 2 (CLIC4, DES, DLD, HSPB1, PLOD2, 
SAP18, SERPINB8, TGM2 and TPM1) or lower than 0.5 (ANXA4, ACTR2, ACTR3, 
ARPC4, EIF4G2, FSCN1 and LMOD1) was analyzed with RT-qPCR to assess 
transcript levels. Nine genes showed a clear positive correlation between transcript 
and SILAC ratio, whereas 7 did not (Figure 3-1C).  
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Sustained LMNA knockdown alters abundance of ACTR2, ACTR3, FSCN1 and 
CLIC4 
GO analysis revealed that the cytoskeletal proteome became strongly affected in 
LMNAkd cells. We therefore validated four of the most prominently altered cytoskeletal 
or cytoskeleton-associated proteins using western blot, namely actin-related protein 2 
(ACTR2) and actin-related protein 3 (ACTR3), subunits of the ARP2/3 complex, fascin 
actin-bundling protein 1 (FSCN1), a protein that organizes F-actin into parallel bundles 
and is involved FA disassembly and chloride intracellular channel protein 4 (CLIC4), 
which is involved in diverse processes such as cell migration and wound healing and 
may be important for regulating cytoskeletal organization during the cell cycle.247,248 
ACTR2, ACTR3 and FSCN1 proteins were found to be significantly less abundant in 
LMNAkd cells (ACTR2: 2.6-fold, ACTR3: 2.3-fold, and FSCN1: 2.8-fold decrease) in 
accordance with their SILAC ratio (ACTR2: 2.5-fold, ACTR3: 2.8-fold, and FSCN1: 3.0-
fold decrease), but only FSCN1 also showed lower mRNA levels (3.7-fold decrease). 
CLIC4 protein abundance and mRNA levels were both significantly increased (2.3-fold 
and 5.7-fold increase respectively) similar to the SILAC ratio (3.1-fold increase) (Figure 
3-1D & E). 
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Figure 3-1. SILAC based quantitative proteomics of human dermal f ibroblasts after 
sustained LMNAkd indicate that depletion of lamin A/C influences the levels of proteins 
involved in actin cytoskeleton organization. A: Schematic overview of t he SILAC 
experiment (see materials and methods for details). L = l ight medium, H = heavy 
medium, Int = intensity, m/z = mass/charge ratio. B: Proteins that showed signif icant 
differences (p<0.05) in the SILAC dataset were analyzed with Goril la, yielding a subset 
of signif icantly affected pathways (p-value for the respective GO term depicted next to 
the bars). C: Scatterplot between mRNA level, measured by RT -qPCR relative to non-
targeting control (NTkd), and SILAC ratio. Genes in green text color showed 
correlation, genes in black text color showed no correlation, and genes in red text color 
showed inverse correlation. D: Western blot analysis of ACTR2, ACTR3, FSCN1 and 
CLIC4. Nucleolin or actin was used as a loading control. E: Gene expression levels of 
ACTR2, ACTR3,  FSCN1 and CLIC4 measured by real-t ime qPCR relative to NTkd (in 
orange) and protein levels of ACTR2, ACTR3, FSCN1 and CLIC4 semi -quantif ied with 
western blot analysis ( in yellow). Error bars indicate the standard deviation on the 
mean value of three biological replicates; signif icance was calculated with a Student’s 
t-test; *** = p-value < 0.001. 
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A-type lamin depletion reduces focal adhesion area  
Since ARP2/3 and FSCN1 are directly involved in FA formation and disassembly, 
respectively, we quantified FAs by immunofluorescent staining of paxillin, vinculin and 
focal adhesion kinase (FAK) (Figure 3-2A) and quantitative image analysis (Figure 
3-2B-D).56 In contrast with paxillin and vinculin, the FAK antibody did not reliably stain 
FA. However, we did observe a significant decrease in nuclear FAK signal in LMNAkd 
cells (Figure 3-2I). Fluorescence intensity of paxillin foci was significantly decreased in 
LMNAkd cells compared to NTkd cells (-11.6%), as was the number of FAs per cell (-
46%), and the area per FA (-11.5%). In contrast, the number, shape (circularity) and 
fluorescence intensity of vinculin foci was not significantly altered; only the area 
showed a significant decrease in LMNAkd cells (-13.2%). Western blot analysis 
revealed a 2.4-fold decrease in paxillin protein abundance after LMNAkd, which was 
in line with the (non-significant) 1.6-fold decrease in the SILAC data. Vinculin and FAK 
protein levels were unaltered (Figure 3-2E). We also analyzed mRNA expression of 
paxillin with RT-qPCR and measured a 2.1-fold decrease of PXN expression. To 
assure that the effects on FA were specifically caused by A-type lamin depletion, we 
rescued LMNA expression in LMNAkd cells by prolonged culturing after a sustained 
knockdown in absence of siRNA. The number and area of paxillin foci restored when 
lamin A/C levels returned back to basal levels after 1 week in the absence of siRNA, 
suggesting a direct causal effect (Figure 3-2F-H).  
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Figure 3-2. A-type lamin depletion reduces focal adhesion and rescue of LMNA 
expression alleviates the de-adhesive phenotype. A: Representative images of NTkd 
and LMNAkd cells after immunofluorescence staining for paxil l in, vinculin or FAK 
(yellow) and counterstaining with DAPI (cyan). B: Normalized mean fluorescence (%) of 
FA points relative to the average of NTkd. C: Quantif ication of the number of FAs per 
cell. D: Area per FA (µm²). E: Western blot for Paxil l in, vinculin and FAK. Nucleolin or 
actin was used as a loading control. F: Number of FAs per cell relative to NTkd control 
1 week after LMNAkd was either arrested or continued. G: FA area relative to NTkd 
control cells. H: Lamin A level relative to NTkd control cells. I: Normalized mean 
fluorescence (%) of nuclear FAK relative to NTkd cells. Immunofluorescent staining was 
performed in triplicate and a minimum of 100 cells were imaged per replicate. In the 
boxplots, the horizontal l ine indicates the median, boxes the 25th and 75th percentile, 
and whiskers the 5th and 95th percentile. For all f igures, signif icance was calculated 
with the Wilcoxon rank sum test; *** = p-value < 0.001. 
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LMNAkd reduces adhesive capacity but increases contractile tension  
Since a reduction in FA number or size may reduce cell adhesion we analyzed the net 
adhesive capacity of the fibroblasts seeded onto collagen-coated wells using a 
colorimetric cell adhesion assay. We observed a 60% reduction in initial cell adhesion 
in LMNAkd cells (Figure 3-3A). Intuitively, a reduced number of FA points, would also 
suggest less contractile tension in those cells that are attached. Concurrent phalloidin 
staining however, revealed more pronounced stress fibers in lamin A/C depleted cells 
as evidenced by an increased fluorescence intensity for the fibers (Figure 3-3B). To 
analyze whether the more pronounced stress fibers also increased contractile tension 
we performed traction force microscopy (TFM) using trypsin-mediated detachment of 
micro-patterned cells. TFM measurements showed a significant 2.8-fold increase in 
traction force, suggesting that LMNAkd cells display higher contractility (Figure 3-3C).  
Figure 3-3. LMNAkd increases contractile tension, but reduces adhesive capacity. A: 
Schematic overview of the colorimetric cell adhesion assay. On the r ight site, the 
results of the assay are expressed relative to NTkd cells. Error bars indicate the 
standard deviation on the mean value of 10 replicates. B: Schematic overview of the 
rhodamine phalloidin staining used to characterize stress fibers of attached cells. On 
the r ight site, the normalized mean fluorescence intensity (relative to NTkd cells (%)) of 
stress fibers per cell is shown, isolated by fast Fourier transformation fi ltering on 
rhodamine phalloidin images. Staining was conducted in tr iplicate and a minimum of 
100 cells were imaged per replicate. In the boxplot, the horizontal l ine indicates the 
median, boxes the 25th and 75th percentile, and whiskers the 5th and 95th percentile. 
C: Schematic overview of the traction force microscopy experiment. On the r ight site, 
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maximum traction force in NTkd and LMNAkd cells is shown. Error bars indicate the 
standard deviation on the mean value of 8 NTkd cells and 10 LMNAkd cells. D: 
Representative images of NTkd and LMNAkd cells after immunofluorescence staining 
for paxil l in (yellow), rhodamine phalloidin staining for actin (cyan) and counterstaining 
with DAPI (grey). E: Representative DIC images, heat maps of the displacement and 
heat maps of the traction forces in NTkd and LMNAkd cells based on TFM 
measurements (see materials and methods for details). For the TFM experiment, 
signif icance was calculated with the Students t test ; *** = p-value < 0.001. For the other 
experiments signif icance was calculated with the Wilcoxon r ank sum test; *** = p-value 
< 0.001. 
A-type lamin depletion increases cell mobility but impairs directionality in 
wound healing  
Since FA size dictates cell migration rate we analyzed cell migration by means of a 
wound healing assay.249–251 In general, LMNAkd induced a significant decrease in 
wound healing performance: the wound healing rate, expressed as the decrease of 
wound area as a function of time (see materials and methods), was approximately 38% 
lower than the rate of NTkd cells (Figure 3-4A, C & D). The average displacement of 
individual NTkd fibroblasts was not significantly different from that of the entire field of 
view, but for LMNAkd, cells at the leading edge (i.e. the first row of cells) displayed a 
significant increase in motility as compared to NTkd cells. Despite this increased 
motility, LMNAkd fibroblast movement lacked direction: whereas 100% of the NTkd 
cells moved towards the wound, only 33% of the LMNAkd cells showed this 
directionality (Figure 3-4B & E).  
STAT3 knockdown does not reproduce the LMNAkd phenotype, nor does 
IL6/IL6R treatment alleviate the effects of LMNAkd 
Previous studies have shown that signal transducer and activator of transcription 3 
(STAT3) and interleukin 6 (IL6) induce FSCN1 expression in breast cancer cells and 
human glioblastoma multiforme cells.252,253 In addition, both STAT3 and IL6 can affect 
cell migration.254,255 Since LMNAkd reduced FSCN1 expression, we analyzed the gene 
expression of STAT3, IL6 and interleukin 6 receptor (IL6R) with RT-qPCR. A significant 
decrease in expression of STAT3 (7.1-fold) and IL6R (6.8-fold) was observed after 
LMNAkd. The protein level of STAT3 was also decreased 2.3-fold, as shown by 
western blot.   
To elucidate whether an LMNAkd-associated decrease in STAT3 expression caused 
the decreased expression of FSCN1, STAT3 gene expression was reduced by RNAi. 
Despite a 64-fold reduction in STAT3 expression, no significant change in FSCN1 
expression could be detected. IL6 expression was also unaffected by STAT3 
knockdown (STAT3kd), but the expression of IL6R was significantly decreased (10-
fold). Wound healing potential was slightly increased, but this was not significant 
(Figure 3-5A & B). Immunofluorescent staining of paxillin indicated that the number of 
FAs per cell and the area was unaltered after STAT3kd (Figure 3-5C & D).   
To check whether reduced IL6R expression contributed to the phenotype of LMNAkd 
cells, we treated LMNAkd cells with recombinant human IL6 and IL6 receptor (IL6R). 
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This however, did not restore FSCN1 expression, nor did it affect wound healing 
potential, the number of FAs per cell or FA area (Figure 3-5E-H).   
 
Figure 3-4. Lamin A/C depletion reduces wound healing potential, but increases single 
cell motility. A: Representative transmission images of the wound healing assay at two 
time points (0 and 21 h) of the experiment, the wound area is delineated in red. B: XY-
movement of individual cells over 28 h, relative to the init ial posit ion. C: Normalized 
wound area at different t ime points, relative to the initial wound area. The line is the 
mean value, the shaded region indicates the standard deviati on on the mean value of 8 
replicates. D: Cell migration rate (µm/h) of NTkd and LMNAkd cells. Error bars indicate 
the standard deviation on the mean value of 8 replicates. E: Average displacement 
(µm/h) of cells, measured by tracking individual cells in time-lapse images of a wound 
healing assay. The line is the mean value, the shaded region indicates the standard 
deviation on the mean value of 8 replicates.  In the boxplots, the horizontal l ine 
indicates the median, boxes the 25 t h and 75 t h percentile, and whiskers the 5 t h and 95 t h  
percentile.  Signif icance was calculated in D with the Student’s t-test and in E with the 
Wilcoxon rank sum test; * = p-value < 0.05; *** = p-value < 0.001. 
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Figure 3-5. Impaired wound healing and FA after LMNAkd is not attr ibuted to decreased 
STAT3 or decreased IL6/IL6R expression. A: Normalized wound area at different t ime 
points, relative to the init ial wound area, after STAT3kd compared to NTkd control. B: 
Cell migration rate (µm/h) of control and STAT3kd cells. C: Average number of FAs per 
cell after STAT3kd compared to NTkd control. D: Area per FA (µm²) after STAT3kd 
compared to NTkd control. E: Normalized wound area at different t ime points, relative 
to the init ial wound area, after LMNAkd compared to NTkd control in presence (blue) or 
absence of IL6/IL6R (grey). F: Cell migration rate (µm/h) of control and LMNAkd cells in 
presence (blue) or absence of IL6/IL6R (grey). G: Average number of FAs per cell after 
LMNAkd compared to NTkd control in presence (blue) or absence of IL6/IL6R (grey). H: 
Area per FA (µm²) after LMNAkd compared to NTkd control in presence (blue) or 
absence of IL6/IL6R (grey). The lines in A and E are the mean values, the shaded 
regions indicate the standard deviation on the mean value of 8 replicates. Error bars in 
B and F indicate the standard deviation on the mean value of 8 replicates. 
Immunofluorescent staining was conducted in triplicate and a minimum of 100 cells 
were imaged per replicate. In the boxplots, the horizontal l ine indicates the median, 
boxes the 25 t h and 75 t h percentile, and whiskers the 5 t h and 95 t h percentile. For all 
f igures, signif icance was calculated with either ANOVA or non -parametric contrast-
based multiple comparison tests; *** = p-value < 0.001. 
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A-type lamin depletion affects nuclear translocation of MKL1 
MKL1-SRF signaling is crucial for cytoskeletal organization and FA assembly and 
FSCN1 is a target gene of serum response factor (SRF).256–258 Previous studies have 
shown that megakaryoblastic leukemia 1 (MKL1) – serum response factor (SRF) 
signaling is impaired in lamin A/C deficient cells.105 We quantified MKL1 localization 
via immunofluorescence and observed a significant decrease in nuclear translocation 
of MKL1 in LMNAkd fibroblasts (Figure 3-6).  
 
Figure 3-6. A-type lamin depletion reduces nuclear translocation of MKL1. A: 
Representative images of NTkd and LMNAkd cells after immunofluorescence staining 
for paxil l in (yellow), MKL1 (red) and counterstaining with DAPI (cyan). Arrowheads 
show reduced nuclear MKL1 in LMNAkd cells. B: Normalized mean fluorescence (%) of 
nuclear MKL1 relative to NTkd cells. The immunofluorescent staining was conducted in 
triplicate and a minimum of 100 cells were imaged per replicate. In the boxplots, the 
horizontal l ine indicates the median, boxes the 25 t h and 75 t h percentile, and whiskers 
the 5 t h and 95 t h  percentile.  Signif icance was calculated with the Wilcoxon rank sum 
test; *** = p-value < 0.001.  
ARP2/3 inhibition causes FA attrition 
To investigate whether reduced protein levels of ACTR2 and ACTR3 impaired FA 
formation, we inhibited the ARP2/3 complex in normal fibroblasts with bardoxolone 
methyl (CDDO-me). Fibroblasts were treated for 2 hours with 5 µM or 10 µM CDDO-
me. Both concentrations reduced the number, the fluorescence, and the area of paxillin 
foci as compared to vehicle treated cells (Figure 3-7), suggesting that ARP2/3 complex 
contributes to lamin A/ C mediated FA formation. 
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Figure 3-7. Chemical inhibit ion of the ARP2/3 complex by CDDO-me reduces FA and 
causes cell detachment. A: Representative images of f ibroblasts treated with different 
concentrations of CDDO-me (0 µM, 5 µM and 10 µM) for two hours after rhodamine 
phalloidin staining for actin (cyan), immunofluorescence staining for paxil l in (yellow), 
and counterstaining with DAPI (grey). B: Area per paxil l in foci (µm²). C: Number of 
paxill in foci per cell. D: Normalized mean fluorescence (%) of paxil lin foci relative to 
vehicle treated cells. The immunofluorescent staining was conducted in tr iplicate and a 
minimum of 100 cells were imaged per replicate. In the boxplots, the horizontal l ine 
indicates the median, boxes the 25th and 75th percentile, and whiskers the 5th and 
95th percentile. For all f igures, signif icance was calculated with the Wilcoxon  rank sum 
test; * = p-value < 0.05; ** = p-value < 0.01; *** = p-value < 0.001.  
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 Discussion 
To highlight the molecular changes that appear in the context of loss of A-type lamins, 
we performed a SILAC based quantitative proteomics experiment on human dermal 
fibroblasts after LMNAkd. Using GO enrichment analysis we found that proteins 
involved in actin cytoskeleton organization were affected by LMNAkd, which is in line 
with previous observations in fibroblasts from patients carrying LMNA mutations.245 
What is novel in our data is a direct connection between the A-type lamins and FA 
formation. Specifically, proteins involved in FAs such as ACTR2, ACTR3, and FSCN1 
were significantly downregulated in LMNAkd cells. Since FSCN1 knockdown has been 
shown to increase FA surface and ARP2/3 has been shown to trigger FA formation, 
FA formation could be affected in both ways (up or down).259–261 Via 
immunofluorescent staining and image analysis we discovered a significant reduction 
in the average FA size per cell for vinculin and paxillin, and a significant reduction in 
paxillin positive foci in LMNAkd cells. This corresponds well with earlier results 
reporting smaller FAs in Lmna-/- MEFs, and a decrease in cell-matrix adhesion sites 
after mechanical challenge of LMNA-mutated (ΔK32-P1, R429W and L380S) 
myoblasts.262,263 Next to the effects on FA size, a remarkable decrease of nuclear FAK 
was observed in LMNAkd cells, which might be associated with decreased cell 
proliferation and increased inflammatory responses.264 Proliferation defects and 
increased apoptosis have been observed in LMNAkd and lamin A/C deficient 
cells.55,219,246 A reduction of FA size may suggest that LMNAkd cells are not as strongly 
attached to the substrate as NTkd cells, which was also indicated by an adhesion 
assay in which cells were allowed to attach for an hour before washing. However, such 
an assay only reflects the speed of attachment and not the actual adhesive potential 
or level of pre-stress in the attached cells. For those cells that were attached, we found 
more pronounced stress fibers and measured significantly higher traction forces during 
detachment, indicating increased cytoskeletal tension. More pronounced stress fibers 
might be attributed to a reduction in FSCN1 expression, since FSCN1 depletion has 
been shown to reorganize actin filaments into thicker, more contractile bundles, 
plausibly by slowing down actin polymerization at the stress fiber termini enabling the 
incorporation of a higher number of myosin II molecules.261 Counter intuitively, the actin 
stress fibers can still attach to and exert even stronger traction forces on smaller FAs. 
However it should be emphasized that stress fibers, which are not directly anchored at 
FAs, such as transverse arcs, will also cover a portion of the measured traction forces, 
albeit to a lesser extent.265 Moreover, whilst FA are considered to be the predominant 
mechanism by which cells exert traction forces on their extracellular matrix, it has also 
been noted that small FA at the leading edge of a migrating cell developed greater 
traction force than the larger FA further away from the front, suggesting that there is 
no one-to-one relationship between FA size and tensile force.266,267 Increased traction 
force may represent a compensatory mechanism that arises from the loss or reduction 
of mechanical coupling between the cytoskeleton and the nucleus. Supporting this 
notion, is the increased traction force observed  in Nesprin 1-depleted cells, aligning 
with their shared role in the LINC.268 However, in the latter cells a concomitant increase 
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in the number of focal adhesions was observed, whereas we have not detected a 
significant change in the absolute number of FA (as measured by vinculin).268 Our data 
thus revealed an apparent uncoupling between cell adhesive mechanisms and 
cytoskeletal tension. Similar uncoupling has previously also been documented for DAP 
kinase269, as it seems to promote disassembly of focal adhesions but not stress fibers 
in cells receiving serum factors269. Interestingly, DAP kinase enhances the formation 
of stress fibers in response to oxidative stress270, a hallmark of lamin A/C depleted 
cells.213,245,246 Loss of A-type lamins may thus activate a similar pathway. Since FA 
size dictates cell migration rate, we measured cell mobility by tracking individual cells 
at the leading edge in a wound healing assay. Whereas LMNAkd cells showed an 
overall lower wound healing potential quite similar to previous observations in Lmna-/- 
MEFs and after LMNAkd in SW480 colon cancer cells263,271,272 motility of individual 
cells was indeed increased. This may be a direct effect of reduced PXN expression, 
since low levels of paxillin have been shown to increase motility in lung cancer 
cells.273,274 Similar observation have been linked to a decrease in vinculin 
expression.275 The reduced wound healing potential is rather due to a loss of 
directionality, which may be caused by delayed reorientation of the nucleus and the 
microtubule-organizing center towards the wound, but may also be aggravated by 
impaired FA formation.271,276  
The reduced expression of FSCN1 after LMNAkd correlated with reduced IL6R and 
STAT3 expression. In contrast, IL6 showed a moderate increase in gene expression, 
possibly representing a compensatory mechanism STAT3 depletion could not 
reproduce the de-adhesive phenotype seen after LMNAkd nor did IL6/IL6R treatment 
alleviate the adhesive defects seen in LMNAkd cell. This might point to a cell-type 
specific regulation of FSCN1 expression by the IL6-STAT3 axis or cross-talk with other 
regulatory pathways.      
Since MKL1-SRF signaling regulates the expression of a large number of genes 
involved in actin cytoskeleton organization and FA, we analyzed the subcellular 
localization of MKL1.257 In line with studies in Lmna-/- MEFs and LMNA-mutated 
muscle precursors, we observed a decrease in nuclear MKL1 in LMNAkd cells.105,262 
Hence, as postulated by Ho et al.105 lamin A/C depletion might affect actin 
polymerization, through mislocalized emerin, which in turn blocks nuclear translocation 
of MKL1, subsequently disturbing expression of MKL1-SRF target genes.105 Indeed, 
knockdown experiments in human mesenchymal stem cells (hMSCs) have shown that 
LMNA expression correlates with expression of SRF and its cofactors and functional 
emerin-lamin A/C interactions are required for cell spreading and proliferation.32,106 
Interestingly, FSCN1 has been identified as a putative novel SRF target gene.256,258 
However, SRF-deficient cells show defective formation of stress fibers258, as opposed 
to LMNAkd cells. A possible explanation for this discrepancy might be elevated yes 
associated protein (YAP) signaling, which counteracts this effect, as observed in 
LMNA-mutated muscle precursors262, or the DAP kinase pathway mentioned earlier.  
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To elucidate whether decreased protein levels of ACTR2 and ACTR3 contribute to 
impaired FA formation in LMNAkd cells, we inhibited the ARP2/3 complex with CDDO-
me. ARP2/3 inhibition affected FA and induced cell detachment. This was also 
observed after knockdown of ACTR3 in HeLa cells.260 However, it should be stressed 
that the effects of chemical inhibition of ARP2/3 are exaggerated, since LMNAkd cells 
still express ACTR2 and ACTR3. Low levels of ACTR2 and ACTR3 proteins probably 
affect the number of the hybrid vinculin-ARP2/3 complexes which are involved in FA 
formation.260 Next to reduced protein levels of the APR2/3 subunits, reduced paxillin 
expression might also contribute to impaired FA formation in LMNAkd cells, as shown 
in pulmonary arterial muscle cells after paxillin knockdown and in paxillin null mouse 
embryonic stem cells.277,278 In contrast, FSCN1 knockdown has been associated with 
larger FAs and a higher number per cell261, so it is likely that decreased ACTR2, 
ACTR3 and paxillin protein levels overrule the effect of FSCN1 depletion on FA.  
In conclusion, our data suggest that reduced LMNA expression influences the levels 
of proteins involved in actin cytoskeleton organization, in particular those of FA 
formation/turnover. This altered protein expression perturbs the balance between focal 
adhesions and cytoskeletal tension as it is accompanied by decreased FA size, 
reduced initial cell attachment, but increased cell migration and cytoskeletal tension. 
Decreased protein levels of ACTR2, ACTR3 and paxillin likely contribute to the 
phenotype, whereas the STAT3-IL6 axis does not. Resolving the exact pathways 
underlying this uncoordinated regulation may help to better understand mechano-
signaling defects witnessed in certain laminopathies. Future studies should be 
complemented with 3D cell culture, since 3D cell migration can differ greatly from 2D 
cell migration, and 3D cell culture is a better approximation of an in vivo 
environment.279,280 
 Materials and Methods 
Cell culture 
Normal human dermal fibroblasts (NHDF, Promocell, C-12300) were cultured in T25 
or T75 culture flasks in DMEM High Glucose with L-Glutamine medium (Lonza, BE12-
604F) supplemented with 10% fetal bovine serum (Gibco, Life Technologies, 10500-
064) and 1% penicillin/streptomycin (Westburg, DE17-602E/12), at 37°C and 5% CO2, 
according to standard procedures. All experiments were performed with cells in 
between passages 9 and 20.  In case of direct comparison, passage-matched cells 
were used. Where indicated, fibroblasts were treated with 100 ng/ml human 
recombinant IL6 (Thermo Fisher Scientific, F10395-HNAE-25) and 200 ng/ml human 
recombinant IL6 receptor (IL6R) (Sigma-Aldrich, SRP3097-20UG) for 24 h. 
siRNA-mediated knockdown 
Expression of LMNA was silenced with siGENOME Lamin A/C siRNA (Dharmacon, D-
001050-01-20). STAT3 expression was silenced with ON-TARGETplus STAT3 siRNA 
(Dharmacon, L-003544-00-0005). Stealth RNAi siRNA Negative Control, Med GC (Life 
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Technologies, 12935-300) was used as a negative non-targeting control (NTkd). 
siRNA transfections were performed using Lipofectamine RNAi-MAX Transfection 
Reagent (Life technologies, 13778-075) according to the manufacturer’s instructions. 
A sustained knockdown was induced by two transfection rounds separated by 72 h. All 
measurements were carried out 168 h (1 week) after the initial transfection.     
Stable isotope labeling and mass spectrometry 
NHDF cells were grown in SILAC DMEM (lacking L-arginine and L-lysine, Cambridge 
Isotope Laboratories, DMEM-500) supplemented with 1% penicillin/streptomycin/L-
glutamine (Gibco, 10378–016) and 10% dialyzed FBS (Cambridge Isotope 
Laboratories, FBS-50). Before knockdown, LMNAkd fibroblasts were grown in medium 
supplemented with [13C6]-L-arginine (Cambridge Isotope Laboratories, CLM-2265-H-
0.1) and [13C6]-L-lysine (Cambridge Isotope Laboratories, CLM-2247-H-0.05) and 
control (NTkd) fibroblasts in medium supplemented with 0.47 mM L-arginine 
(Cambridge Isotope Laboratories, ULM-8347-0.1) and 0.46 mM L-lysine (Cambridge 
Isotope Laboratories, ULM-8766-0.05) for at least five passages. A labeling efficiency 
of 99.2% was obtained with no significant arginine to proline conversion (Suppl. Doc. 
S2). NTkd and LMNAkd fibroblasts (passage 17) were lysed by applying three freeze-
thaw cycles and digested using trypsin. A fraction of the samples was mixed and 
analyzed by the Orbitrap Velos mass spectrometer, based on the results, the mixing 
was changed to obtain a 1:1 ratio. The peptide mixture was analyzed by a LC−MS/MS 
system using an Ultimate 3000 RSLC nano liquid chromatograph (Thermo Fisher 
Scientific, Bremen, Germany) in-line connected to a Q Exactive mass spectrometer 
(Thermo Fisher Scientific). Peptides were identified and quantified with MaxQuant281, 
which used Mascot282 as search engine. Reversed sequences and commonly 
observed contaminants were removed and the relative quantification ratios were 
normalized and log transformed using Perseus software (Computation Systems 
Biochemistry, Max Planck Institute of Biochemistry, München, Germany). An outlier 
significance score for log protein ratios (significance A) was calculated, a p-value of 
0.05 was used as threshold value.281 The SILAC experiment was conducted in 
triplicate, but one replicate was omitted since no significant depletion of A-type lamins 
was observed in that replicate. The complete dataset is provided as supplementary 
material (Suppl. Doc. S1), in which SILAC ratio’s (log2 fold change), posterior error 
probability (PEP), intensity, significance A levels, sequence coverage, peptide counts 
(razor and unique peptides), molecular weight (kDa), protein IDs, protein names and 
gene names are presented. Gene ontology of identified proteins was analyzed for 
protein class with the online resource PANTHER (Protein ANalysis THrough 
Evolutionary Relationships)283 and gene ontology enrichment analysis was performed 
with GOrilla (Gene Ontology enRIchment AnaLysis and VisuaLizAtion tool).284 
Quantitative PCR 
RNA was extracted from cells using the RNAeasy mini kit (Qiagen, 74104), with on-
column DNase digestion. Concentrations of purified RNA were measured with the 
NanoDrop 2000 (Thermoscientific). Per sample, 1 µg of RNA was converted to cDNA 
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using SuperScript® III Reverse Transcriptase (RT) (Life Technologies, 18080-044). All 
qPCR reactions were performed on a RotorGene 3000 (Qiagen/Corbett) using the 
SensiMix™ SYBR® No-ROX Kit (Bioline, QT650) according to the manufacturer’s 
instructions. Relative abundance of LMNA transcripts (forward: 
TGGACGAGTACCAGGAGCTT; reverse: ACTCCAGTTTGCGCTTTTTG), IL6 
transcripts (forward: AGTGAGGAACAAGCCAGAGC; reverse: 
GTCAGGGGTGGTTATTGCAT), IL6R transcripts (forward: 
GGCACGCCTTGGACAGAATC; reverse: AAGAATCTTGCACTGGGAGGC), STAT3 
transcripts (forward: CAGGAGCATCCTGAAGCTGAC; reverse: 
GGTGAGGGACTCAAACTGCC), ACTR2 transcripts (forward: 
GTAGCCATCCAGGCAGTTCT; reverse: AAGGCGTATCCTCGCAACAG), ACTR3 
transcripts (forward: CTGTGTGGTGGACTGTGGCA; reverse: 
TCAACACCTTTCATCACCCTCC), FSCN1 transcripts (forward: 
CCAACCGCTCCAGCTATGAC; reverse: CTGCCCACCGTCCAGTATTT), CLIC4 
transcripts (forward: GAGGACAAAGAGCCCCTCATC; reverse: 
GGGGCAGTTTCCTATGCTTTC) and PXN transcripts (forward: 
GGAAAAGTTGCGGGGCATAG; reverse: GTGGTAGACTCCAAGTCCGC), were 
measured relative to ACTB (forward: CCTTGCACATGCCGGAG; reverse: 
GCACAGAGCCTCGCCTT) and GAPDH (forward: TGCACCACCAACTGCTTAGC; 
reverse: GGCATGGACTGTGGTCATGAG) reference transcripts. Analysis was done 
using the ΔΔCt-method.235 
Immunofluorescence staining 
Cells were grown on glass coverslips and fixed in 4% paraformaldehyde for 15 min at 
room temperature and washed (3 x 5 min) with PBS. Subsequently, cells were 
permeabilized with 0.5% Triton X-100 (5 min), and incubated with primary antibody 
diluted in 50% fetal bovine serum (FBS) for 60 min. After minimally 3 PBS washing 
steps, slides were incubated with secondary antibody diluted in 50% FBS for 30 min 
and, where indicated, with rhodamine phalloidin (ThermoFisher Scientific, R415) for 
the labeling of F-actin. After the incubation, the slides were washed again, and 
mounted with VECTASHIELD™ Mounting Medium (Vector Labs, VWR, 101098-042) 
containing 1 µg/ml 4′,6- diamino-2-phenylindole (DAPI, ThermoFisher Scientific, 
D1306). Primary antibodies used were directed against lamin A (Rabbit, Abcam, 
ab26300), paxillin (Mouse, Merck Millipore, 05-417), vinculin (Mouse, Sigma-Aldrich, 
V9131), FAK (Rabbit, Santa Cruz Biotechnology Inc., sc-932) and MKL1 (Rabbit, 
Abcam, ab49311). Secondary antibodies were DyLight 488 conjugated donkey anti-
rabbit (Jackson ImmunoResearch Laboratories Inc., JAC-705606147) and DyLight 488 
conjugated donkey anti-mouse (Jackson ImmunoResearch Laboratories Inc., JAC-
715486150). Immunofluorescent stained cells were visualized using a Nikon Ti Eclipse 
inverted widefield fluorescence microscope (Nikon Instruments) with 40x Plan Apo oil 
(NA = 1.3) or 60x Plan Apo VC (NA = 1.4) objectives. Immunofluorescent staining was 
performed in triplicate, and per microscope slide a minimum of 9 regions was imaged. 
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Western blot 
Cells were grown in T75 culture flasks and lysed using the whole-cell extraction 
protocol of the Nuclear Extract Kit (Active Motif, 40010). Protein concentration was 
measured with the Pierce 660 nm assay (Thermo Scientific, 22662). Cell lysates were 
subjected to SDS-PAGE (8% or 12% bis-tris with MOPS running buffer) and 
transferred to BioTrace PVDF membranes (Pall Corporation, 66542). Primary 
antibodies were directed against lamin A/C (Mouse, Santa Cruz Biotechnology Inc., 
sc-56139), ARP2 (Rabbit, Abcam, ab47654), ARP3 (Mouse, Abcam, ab49671), Fascin 
(Mouse, Abcam, ab78487), STAT3 (Cell Signaling, #9139), paxillin (Mouse, Merck 
Millipore, 05-417), vinculin (Mouse, Sigma-Aldrich, V9131), FAK (Rabbit, Santa Cruz 
Biotechnology Inc., sc-932), beta actin (Mouse, Abcam, ab8226) and nucleolin 
(control) (Rabbit, Novus Biologicals, NB600-241). HRP conjugated goat anti-mouse 
(Sigma-Aldrich, A4416) and HRP conjugated goat anti-rabbit (Sigma-Aldrich, A6154) 
were used as secondary antibodies. Proteins were detected by chemiluminescence 
with Immobilon Western chemiluminescent HRP substrate (Millipore, WBKLS0100). 
Wound healing assay and cell tracking 
Cells were seeded into a 24 well plate and grown up to 100% confluency. A scratch 
was applied using a pipette tip. The cells were washed twice with PBS to remove 
floating debris. To inhibit cell division, DMEM without FBS was used. Cell migration 
was monitored by transmission microscopy with a Nikon Ti Eclipse inverted widefield 
fluorescence microscope (Nikon Instruments), and cell migration rate was determined 
by plotting the scratch area as a function of time. By fitting a linear trend line to this 
plot, the slope of the curve can be estimated, and by dividing the slope by two times 
the length (l) of the wound (as cells are migrating of both edges of the wound towards 
each other) the cell migration rate was calculated.285 
 𝑣𝑚𝑖𝑔𝑟𝑎𝑡𝑖𝑜𝑛 =
|𝑠𝑙𝑜𝑝𝑒|
2×𝑙
 
The wound healing assay was complemented with individual cell tracking; therefore, 
nuclei were stained with Hoechst 33342 (ThermoFisher Scientific, H3570) and time-
lapse images, with a temporal resolution of 10 min, were acquired. Image analysis is 
described below.    
Cell adhesion assay 
A 96 well plate was coated with bovine collagen type I (10µg/ml in PBS) (VWR, 392-
2502) and stored overnight at 4°C, and rinsed. Remaining protein binding sites were 
blocked with BSA (1% in PBS) and incubated for 30 min at room temperature and 
rinsed. In the meantime, cells were detached with 2 mM EDTA (in PBS) and counted. 
20,000 cells per 96 well plate were seeded and incubated for 60 min at 37°C and 5% 
CO2 humidified atmosphere. Coated wells without cells were used as background 
control. The wells were 5 times thoroughly washed with PBS and fixed with 96% 
ethanol for 10 min at room temperature. The cells were stained with crystal violet (0.1% 
in 10% ethanol) and incubated for 30 min at room temperature. The wells were 
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thoroughly washed with demineralized water to remove excess stain, and acetic acid 
(10% in demineralized water) was added and incubated for 20 min at room temperature 
on a shaker. Absorbance was measured at 595 nm with a spectrophotometer (Tecan 
Infinite 200 Pro, Männedorf, Switzerland). Cell adhesion was registered as absorbance 
corrected for background.   
Traction force microscopy 
Traction force microscopy is based on measuring the displacement of fluorescent 
beads embedded in polyacrylamide gels, which is triggered by cell detachment. By 
tracking the movement of the fluorescent beads, the displacement can be calculated, 
which correlates with cellular traction force.  
Polyacrylamide gels (0.1% bis and 5% acrylamide; 70 µm thick) containing 1:50 
volume of carboxylate-modified fluorescence latex beads (0.2 µm Fluospheres, 
Molecular Probes, Eugene, OR) were fabricated on 25-mm diameter glass 
coverslips.286 The Young’s modulus of the gel was estimated to be 15 kPa using 
Dynamic Mechanical Analysis (Mettler Toledo, Switzerland). Collagen-coated PDMS 
stamps were allowed to react with the activated gel for 1 h at 37°C to create collagen-
coated adhesive islands. After removal of the excess of collagen by washing with PBS, 
unprinted areas of the gels were passivated with a bovine serum albumin solution 
overnight. Cells (5000/ml) were seeded on the gel and incubated till they were 
completely spread. Fluorescence images of the gel containing fluorescent beads 
immediately beneath the patterned cells were taken during cell detachment with 
trypsin. The change of the position of the fluorescence beads were measured in 
MATLAB software using an algorithm described previously.287 This yielded the 
discretized displacement field between two consecutive frames. The calculated 
displacements were summed up to determine the overall two-dimensional 
displacement field. The traction field was then calculated from the displacement field 
by solving the inverse of the Boussinesq solution from the displacement field on the 
surface of an elastic half space to obtain the traction field when the mechanical 
properties of the gel are known. The Poisson ratio of the gel was assumed to be close 
to 0.5. The interior of the cell was subdivided into 64 µm2 squares to approximate the 
discretized localization of contractile forces.  
Image analysis 
Image processing was performed in Fiji (http:// fiji.sc), a packaged version of ImageJ 
freeware (W.S. Rasband, U.S.A. National Institutes of Health, Bethesda, Maryland, 
USA, http://rsb. info.nih.gov/ij/, 1997−2014).  
The focal adhesion points were quantified by means of a custom-designed image 
processing pipeline288, which is essentially based on a high-content analysis workflow 
described before56 and is available upon request. In brief, the analysis consists of a 
few image preprocessing steps, followed by hierarchical segmentation of nuclei, cells, 
and focal adhesion points (FAs) to allow region-specific analysis of objects. Nuclear 
regions of interest (ROIs) are segmented in the DAPI channel after filtering with a 
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Gaussian kernel of small radius (Σ = 3), automatic thresholding according to Otsu’s 
algorithm and watershed-based separation. Cellular boundaries are then delineated 
by conditional region growing from the nuclear seeds restricted by a Voronoi 
tessellation. Finally, FAs are specifically enhanced in the FA channel by means of a 
Laplacian operator and binarized using the Triangle autothresholding algorithm. The 
Triangle algorithm was selected since this is a geometric method, resulting in a better 
coverage of the complete FA size. The resulting ROIs were used for analyzing shape 
(area and circularity) and intensity metrics of objects larger than a predefined size (>5 
pixels) on the original image.   
Stress fiber thickness was quantified in microscopic images of phalloidin-stained cells 
by applying a fast Fourier transformation, low frequency filtering, inverse 
transformation and Isodata autothresholding, after which fluorescence intensity and 
area per stress fiber was calculated per cell.  
Cell mobility was determined by tracking nuclei from Hoechst 33342 counterstained 
individual cells through time using a dedicated script (trackRuptures.ijm; available upon 
request).61 In this analysis, nuclei are detected using a Laplacian of Gaussian blob 
detector, binarized using an automatic threshold algorithm and touching nuclei are 
separated using a conditional watershed algorithm. Once nuclei have been detected 
in all time points, they are connected through time based on a nearest neighbor 
algorithm, which is confined by a maximum displacement. If for a given nucleus, no 
corresponding neighbor is found in the next time point, potential candidates are sought 
in the closest subsequent time point. After, this automatic procedure, the operator can 
manually check and correct tracks. 
Statistical analyses 
Data analysis and visualization was performed in R statistical freeware (http://www.r-
project.org). Standard statistical methods were employed, including the Shapiro-Wilk 
Normality Test to assess normality of the data; Levene’s test to assess 
homoscedasticity; Student’s t-test, ANOVA, and the Kruskal-Wallis rank sum test to 
assess differences between the group means; and Tukey (after ANOVA) and Dunnett 
type (After Kruskal-Wallis) post-hoc tests to assess significance for each group. We 
also used non-parametric contrast-based multiple comparison tests and Wilcoxon 
tests.289 Significance levels were indicated as follows: p<0.05 (*), p<0.01 (**), and 
p<0.001 (***). For graphics and annotation, the R program was expanded with the 
ggplot2 package.239 
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Abstract 
The metalloprotease ZMPSTE24 catalyzes maturation of lamin A, a key component of 
the nuclear lamina. Loss of ZMPSTE24 leads to premature aging disorders and severe 
metabolic alterations, including lipoatrophy. However, as yet, the molecular changes 
that accompany ZMPSTE24 deficiency at the cellular level are not completely 
understood. Here, we explore the potential of label-free confocal Raman 
microspectroscopy (RMS) to discriminate genome-edited ZMPSTE24 knockout (ZKO) 
cells from non-targeting controls. Hyperspectral image data sets were collected from 
individual living cells at 785 nm excitation. Unsupervised classification of average 
cellular spectra allowed separating both cell types with high fidelity. Subsequent 
analysis of spectral differences revealed that ZKO cells had a decreased lipid content. 
Cross-correlation with fluorescent labeling revealed that this decrease was associated 
with a significant reduction in lipid droplet (LD) number and size in ZKO cells. 
Counterintuitively, this was accompanied with increased expression of several LD 
biogenesis genes (GPAM, PEMT, and PGC1α). Thus, our data suggest that loss of 
ZMPSTE24 impairs intracellular lipid storage and proves that RMS is a powerful tool 
for label-free interrogation of pathological cells.  
4.1. Introduction 
Laminopathies are diseases of the nuclear lamina. They are caused by mutations in 
genes encoding nuclear lamins, such as the LMNA gene (producing lamin A/C), or in 
genes involved in lamin processing, such as ZMPSTE24. The latter encodes the zinc 
metalloprotease ZMPSTE24, which is crucial for proper maturation of lamin A. Lamin 
A is produced as a precursor protein, prelamin A, and undergoes a sequence of 
posttranslational modifications at its C-terminus, including carboxymethylation, 
farnesylation and proteolytic cleavage. This final step is solely catalyzed by 
ZMPSTE24.14 Consequently, loss of ZMPSTE24 results in the accumulation of 
farnesylated prelamin A. Diseases that are caused by ZMPSTE24 deficiency include 
mandibuloacral dysplasia type B (MADB) and restrictive dermopathy (RD).2–5 MADB 
is caused by partial loss of ZMPSTE24 activity, while RD is associated with complete 
loss.129 MADB is characterized by skeletal abnormalities and generalized 
lipodystrophy, and some patients have features of premature aging.117,126 On the other 
hand, RD is a lethal neonatal genodermatosis. RD patients usually die within several 
hours or days of birth.126,127 
A vast array of omics tools has become available to study pathologies at the cellular 
level. However, these methods only highlight changes in selected subsets of molecules 
(e.g., gene and protein expression) and offer no cellular context. Raman 
microspectroscopy or Raman microscopy (RMS) offers an interesting tool for obtaining 
insight into the true molecular markup (lipids, proteins, carbohydrates …) of the 
intracellular environment. By probing molecular vibrations with a laser, RMS is able to 
assess the chemical microenvironment of the biological sample at a submicron 
scale.290 This technique can be used to characterize and image cells in absence of 
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fluorescent stains.290,291 Since molecular changes in cells, tissues or biofluids can 
either cause or be the effect of diseases, RMS can be applied for medical 
diagnostics.188–191 Here we used RMS to study HeLa cells in which the ZMPSTE24 
gene was stably knocked out using CRISPR/Cas9-mediated genome editing.  
4.2. Results 
Stable ZKO cells accumulate prelamin A 
To avoid the heterogeneity and bypass the limited availability of patient cells, we 
established a set of isogenic model cell lines with a stable ZMPSTE24 knockout using 
targeted CRISPR/Cas9 genome editing. We further refer to these cells as HeLa-ZKO. 
Multiple clones were isolated and compared with control-treated, wild type HeLa cells 
(HeLa-WT), which underwent identical operational procedures but without the specific 
guide RNA. All HeLa-ZKO clones demonstrated a significant reduction of ZMPSTE24 
transcripts, as measured by qPCR analysis (Figure 4-1C), albeit with high interclonal 
variability. In contrast, all HeLa-ZKO clones showed a strong and comparable > 2-fold 
prelamin A (PLA) accumulation as compared to HeLa-WT clones, as measured by 
quantitative microscopy after immunofluorescence staining for PLA (Figure 4-1B & D). 
Western blotting confirmed a specific accumulation of PLA, and complete absence of 
mature lamin A in HeLa-ZKO clones, as shown by the upward shift of the lamin A band 
as compared to the HeLa-WT control cells (Figure 4-1A). The accumulation also 
affected the nuclear phenotype as evidenced by quantitative image analysis. Despite 
some variability between clones, knockout of ZMPSTE24 resulted in a slightly 
increased nuclear area, except for clone Z6 (Figure 4-1F). The effect on nuclear 
dysmorphy was less pronounced, presumably because of the high basal nuclear 
morphology aberrations (Figure 4-1G). However, nuclear herniations and nuclear 
blebs were more frequently observed in HeLa-ZKO cells compared to HeLa-WT control 
cells (Figure 4-1D).  
Unsupervised clustering of Raman spectra discriminates HeLa-ZKO cells from 
HeLa-WT cells 
Fixed HeLa-ZKO (clone Z6) and HeLa-WT cells (clone C1) were subsequently 
subjected to confocal RMS. Raman spectra were collected by raster-scanning 
individual cells (n >=50 per cell type) with a 785 nm laser. The resulting hyperspectral 
image data sets were processed according to the workflow depicted in Figure 4-2 (cfr. 
also M&M). 
First, spectral information from all cellular pixels was pooled into average cellular 
spectra. Hierarchical cluster analysis (HCA) of average spectra allowed separating 
HeLa-ZKO cells from HeLa-WT cells with an accuracy of 91.96%, a sensitivity (true 
positive rate) of 90.74%, and a selectivity (true negative rate) of 93.10%, with a false 
discovery rate (FDR) of 7.54% (Figure 4-3A). Unsupervised clustering through 
principal component analysis (PCA) performed worse compared to HCA. The biplot of 
the first two principal components (PCs) showed strong overlap between the 98% 
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confidence interval of the HeLa-WT cells and the 98% confidence interval of HeLa-
ZKO cells (Figure 4-3B). In addition, PCA was used to reduce the data prior to the 
former mentioned HCA by selecting the first 3 PCs. However, this resulted in a 
decreased sensitivity and selectivity (data not shown).  
 
Figure 4-1. ZMPSTE24 knockout induces prelamin A accumulation in HeLa cells. A: 
Western blot analysis of lamin A, lamin C and prelamin A in HeLa -WT (C1) and HeLa-
ZKO clones (Z5, Z6, Z8, and Z9). Nucleolin was used as a loading c ontrol. B: 
Normalized mean fluorescence (fold change) of prelamin A in different HeLa -ZKO 
clones (Z5, Z6, Z8, and Z9) relative to HeLa-WT cells (C1). Error bars indicate the 
standard deviation on the mean value of three biological replicates; signif icance was 
calculated with a Student’s t-test; *** = p-value < 0.001. C: Gene expression level of 
ZMPSTE24 measured by real-time qPCR in HeLa-ZKO clones relative to HeLa-WT cells 
(C1). Error bars indicate the standard deviation on the mean value of three technica l 
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replicates. Signif icance was calculated with a Student’s t-test; *** = p-value < 0.001. D: 
Representative images of HeLa-WT (C1) and HeLa-ZKO (Z6 and Z8) cells after 
immunofluorescence staining for prelamin A (yellow), lamin B1 (red) and 
counterstaining with DAPI (blue). Arrowheads indicate nuclear blebs. E-G: Nuclear 
circularity (E), nuclear area (relative C1) (F), and the number of dysmorphic nuclei (G) 
were measured through analysis of microscopic images from all HeLa -WT (C1) and 
HeLa-ZKO clones (Z5, Z6, Z8, and Z9), untreated HeLa cells were included as an extra 
control (-). Error bars indicate the standard deviation on the mean value of four 
biological replicates; signif icance was calculated with ANOVA or non -parametric 
contrast-based multiple comparison tests; * = p-value < 0.05, *** = p-value < 0.001.  
 
Figure 4-2. Raman spectra were collected by raster -scanning individual cells with a 785 
nm laser. The spectra were preprocessed in R using the hyperSpec package.292 Init ial 
preprocessing involved cosmic ray removal and smoothing and interpolation. Cellular 
pixels were selected by HCA after fast polynomial baseline removal and outlier removal 
with PCA. The average spectrum of the cellular pixels was calculated the background 
was accurately removed with baselineWavelet correction.  Finally, the average spectra 
were min-max normalized. The preprocessing is described in more detail in the M&M 
section.  
Difference spectrum highlights changes in lipid content of HeLa-ZKO cells 
To determine which spectral components contributed the most to the discriminatory 
power, we compared the average spectra of HeLa-ZKO and HeLa-WT cells, and 
generated a difference spectrum (Figure 4-3C & D). This revealed that 4 bands 
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deviated strongly in HeLa-ZKO cells: namely a Raman peak at 876 cm-1, in close 
vicinity to a peak at 856 cm-1, which might be attributed to hydroxyproline, a major 
component of collagen293; chain C-C stretching vibration at 1065 cm-1; CH2 twisting at 
1301 cm-1; and CH2 deformation at 1439 cm-1.291,294 The last three are typical bands 
for lipids. Hydroxyproline is also associated with a Raman band at 957 cm-1 and 1207 
cm-1, however no significant differences were observed at these regions. Furthermore, 
dermal fibroblast from patients with LMNA mutations show normal synthesis and 
mobility of type I collagen.295 Therefore this Raman peak was not further investigated 
and we focused our work on the lipid specific Raman peaks. We calculated the area of 
these peaks, by integrating a fitted spline, and observed a significant decrease for all 
three bands in HeLa-ZKO cells (Figure 4-3E-G), suggesting a significant reduction in 
lipid content. 
 
Figure 4-3. Raman spectra of HeLa-ZKO show signif icant changes compared to control 
cells. A: Heatmap of the average spectra of HeLa-ZKO (red) and HeLa-WT cells (gray), 
clustered by HCA. B: Biplot of the first two principal components (PCs) of HeLa -ZKO 
(red) and HeLa-WT cells (gray). The ell ipse represents the 98% coincidence interval. C: 
Mean Raman spectrum of HeLa-ZKO (red) and HeLa-WT cells (gray). D: Mean 
difference spectrum of HeLa-ZKO (red) cells relative to HeLa-WT cells (gray). The 
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shaded region in C and D indicates the standard deviation on the mean value. Arrows 
indicate signif icant differences in the Raman spectra. E: Integrated area of the Raman 
spectra at 1065 cm -1 relative to HeLa-WT cells. F: Integrated area of the Raman 
spectra at 1301 cm -1 relative to HeLa-WT cells. G: Integrated area of the Raman 
spectra at 1439 cm -1 relative to HeLa-WT cells. In the boxplots, the horizontal l ine 
indicates the median, boxes the 25th and 75th percentile, and whiskers the 5th and 
95th percentile. For all f igures, signif icance was calculated with the Wilcoxon rank sum 
test; *** = p-value < 0.001.   
HeLa-ZKO cells have less lipid droplets and lipid droplet size is decreased 
We next asked whether the reduction in specific bands could also be assigned to 
specific regions within the cells. We found that the three major bands were strongly 
enriched in micron-sized cytoplasmic regions that resembled lipid droplets (LDs). 
Supporting this idea, the average Raman spectrum of these regions showed high 
similarity with the reference spectrum of triolein, a symmetrical triglyceride derived from 
glycerol and oleic acid (Figure 4-4B).294 To ascertain these regions were LDs, we 
performed a correlative confocal RMS-confocal fluorescence microscopy experiment 
in which we revisited identical cells before and after counterstaining for LDs using the 
fluorescent marker bodipy 493/503. To promote LD formation, cells were treated with 
cycloheximide prior to the recordings. Quantitative colocalization analysis between 
RMS images after Vertex Component Analysis (VCA) and confocal fluorescence 
images confirmed colocalization, thus proving that indeed these bands were 
characteristic for LDs (Figure 4-4A). An average Pearson correlation coefficient of 
0.72±0.06 was calculated for three biological replicates. More importantly, quantitative 
analysis of LDs in fluorescence microscopy images revealed a significant reduction in 
the number of LDs in HeLa-ZKO clones compared to HeLa-WT. In addition, LD size 
was in most clones, except clone 6 (p-value = 0.052), significantly reduced in HeLa-
ZKO cells compared to HeLa-WT cells (Figure 4-4C-E). 
HeLa-ZKO cells show increased expression of LD biogenesis genes 
To elucidate the potential cause of the reduction in LD size in HeLa-ZKO cells, we 
analyzed the expression of genes involved in LD biogenesis using qPCR: 
acylglycerolphosphate acyltransferase (AGPAT); seipin (BSCL2); diacylglycerol O-
acyltransferase 1 (DGAT1); fat storage inducing transmembrane protein 2 (FITM2); 
mitochondrial glycerol-3-phosphate acyltransferase (GPAM); 
phosphatidylethanolamine N-methyltransferase (PEMT); and peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC1-α). Transcript levels of GPAM, 
PEMT and PGC1-α were significantly increased in HeLa-ZKO cells compared to HeLa-
WT cells (1.77-fold, 2.06-fold and 2.07-fold increase respectively, Figure 4-4F). 
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Figure 4-4. HeLa-ZKO cells have less LDs, decreased LD size and altered expression 
of genes involved in LD biogenesis. A: Correlation between bodipy 493/503 image 
(green) and VCA image (red) of a cycloheximide treated HeLa cell. On the left side, the 
reflection image of the cell is depicted. B: Average Raman spectrum of LDs (gray) and 
the reference spectrum of tr iolein (green). C: Representative images of HeLa -WT and 
HeLa-ZKO cells after bodipy 493/503 staining (yellow) and counterstaining with Hoechst 
33342 (cyan). D: Number of LDs in different HeLa-ZKO clones relative to HeLa-WT 
cells (C1). E: Size of LDs in different HeLa-ZKO clones relative to HeLa-WT cells (C1). 
HeLa cells were included as an extra control ( -). Error bars in D and E indicate the 
standard deviation on the mean value of four biological replicates. Signif icance was 
calculated with ANOVA; * = p-value < 0.05; ** = p-value < 0.01; *** = p-value < 0.001. 
F: Gene expression levels of AGPAT, BSCL2, DGAT, FITM, GPAM ,  PEMT, and PGC1α  
measured by real-t ime qPCR in HeLa-ZKO cells (Z6) relative to HeLa-WT cells (C1). 
Error bars indicate the standard deviation on the mean value of three technical 
replicates. Signif icance was calculated with a Student’s t-test; ** = p-value < 0.01.  
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4.3. Discussion 
Previous studies have shown that RMS can be used to study a wide variety of 
diseases, but most studies focused on cancer.188–191 Here we used this technique to 
study the molecular changes in HeLa-ZKO cells, which were acquired through targeted 
CRISPR/Cas9 genome editing. CRISPR/Cas9 promotes genome editing by 
stimulating a double stranded break (DSB) at the target genomic locus which is re-
ligated by error-prone nonhomologous end joining (NHEJ), leading to insertion/deletion 
(indel) mutations, which in turn result in frameshift mutations and premature stop 
codons.296,297 All HeLa-ZKO clones showed prelamin A accumulation, but ZMPSTE24 
expression was highly variable among the clones. Interestingly, one HeLa-ZKO clone 
produced a shorter lamin C isoform, as demonstrated by western blotting, this clone 
was excluded from the results. This might be caused by off-target effects during 
CRISPR/Cas9 genome editing.298 Several approaches have been proposed to reduce 
off-target effects, such as the use of a D10 mutant nickase version of Cas9 paired with 
two guide RNAs that each cleave only one strand, or fusion of catalytically inactive 
Cas9 with a Fok I nuclease domain (fCas9).298 Next to CRISPR/Cas9-associated off-
target effects, the unstable genome of HeLa cells, which shows a remarkably high level 
of aneuploidy, can also contributes to high interclonal variability.299 The latter can be 
resolved by using primary cells, since these have a more stable genome. However, 
genome editing in primary cells is less straightforward, due to the necessity of cellular 
expansion after clonal selection. Therefore, iPSCs or hTERT-immortalized primary 
cells are the best option. 
We were able to discriminate most of the HeLa-ZKO cells from HeLa-WT cells with 
HCA, however the FDR was higher than 5%.  By increasing the sample size in future 
experiments, discrimination performance can be enhanced and, in parallel, supervised 
clustering can be used to classify the data. In the difference spectrum, we noticed four 
Raman bands which were significantly reduced in HeLa-ZKO cells, three bands were 
typical for lipids and one band was related to hydroxyproline. The lipid specific Raman 
bands were enriched in LDs, which was confirmed by bodipy 493/503 staining. The 
average Raman spectrum of LDs showed good resemblance with the reference 
spectrum of triolein. This triglyceride likely constitutes the neutral lipid ester core of the 
LDs, which is encapsulated by a surface phospholipid monolayer.300–302 The main 
function of LDs is storing lipid esters, originating from lipid synthesis or membrane 
lipids, in doing so they form an important defense mechanism against 
lipotoxicity.301,303–305 HeLa-ZKO cells had fewer LDs and their size was reduced 
compared with HeLa-WT cells. To explain this phenomenon, we analyzed the 
expression of a number of genes involved in LD biogenesis. GPAM, PEMT and PGC1α 
showed increased expression. The first gene encodes a mitochondrial isoform of 
glycerol-3-phosphate acyltransferase (GPAT), which is involved in the synthesis of 
glycerolipids. GPAM specifically directs the incorporation of exogenous fatty acids into 
triacylglycerol.306 Overexpression of GPAM in rat hepatocytes resulted in decreased 
fatty acid oxidation and increased glycerolipid biosynthesis.307 Interestingly, in 
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Drosophila cells this was accompanied by the formation of many small LDs.308 The 
second gene PEMT is involved in the conversion of phosphatidylethanolamine (PE) to 
phosphatidylcholine (PC). Increased expression of PEMT can induce accumulation of 
PC, which in turn stabilizes the LD surface, resulting in smaller LDs.309 The third gene, 
PGC1α, is a key regulator of mitochondrial biogenesis.310 Similar to GPAT and PEMT, 
overexpression of PGC1α is accompanied by the formation of smaller LDs in oleate-
induced human skeletal muscle cells.311 Interestingly, both increased PEMT activity 
and increased PGC1α expression has been linked to prelamin A accumulation.312,313 
More specific, increased PEMT activity has been observed in prelamin A accumulating 
hMSC-derived adipocytes and increased expression of PGC1α has been documented 
in the liver from Zmpste24-deficient mice.312,313 Furthermore, increased Pgc1α 
expression has also been observed in HGPS mice.314 Taken together the altered 
expression of these genes can partly explain the reduced size of LDs we observed, 
however in contrast to our observations increased expression of these genes normally 
increases lipid content. A possible explanation for this is that the overexpression of the 
aforementioned genes is a compensatory mechanism for accelerated lipolysis induced 
by prelamin A accumulation, which has been linked to loss of adipose tissue and 
reduced lipid storage.128,312,315–318 Moreover experiments in Zmpste24-/- mice showed 
increased partitioning of fatty acid towards β-oxidation.128 A possible mechanism by 
which prelamin A accumulation impairs lipid storage might be through interaction with 
the Sp1 transcription factor, perturbing adipogenesis, or sequestration of sterol 
regulatory element-binding protein 1 (SREBP1) which lowers PPARγ expression, 
causing impairment of pre-adipocyte differentiation.100,242,317,319 
In conclusion, our work indicates that ZMPSTE24-deficiency in HeLa cells impairs lipid 
storage by reducing the number and size of LDs. Altered gene expression can 
contribute to the reduced LD size. RMS enabled us to identify molecular changes in 
HeLa-ZKO cells, which indicates that RMS can be a reliable technique for cell 
biologists. In future experiments, a larger number of cells should be included and other 
cell types, including patient cells, should be analyzed. In addition, nonlinear Raman 
technologies, such as coherent anti-Stokes-shifted Raman scattering (CARS) 
microscopy and stimulated Raman (SRS) microscopy, can be used instead of 
spontaneous RMS to reduce acquisition times and increase spatial resolution. 
However, a major drawback of the latter techniques is that they are often only limited 
to a discrete number of wavelengths. In a recent study this issue was solved by the 
introduction of an electronically-tunable acousto-optical filter as a wavelength selector, 
allowing broadband nonlinear RMS.320 
4.4. Materials and Methods 
Cell culture 
HeLa cells were cultured in T10 or T25 culture flasks in DMEM High Glucose with L-
Glutamine medium (Lonza, BE12-604F) supplemented with 10% fetal bovine serum 
(Gibco, Life Technologies, 10500-064) and 1% penicillin/streptomycin (Westburg, 
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DE17-602E/12), at 37°C and 5% CO2, according to standard procedures. To stimulate 
the number of LDs we treated the cells with 10 µg/ml cycloheximide (CHX) for 24 h. 
CRISPR/Cas9 mediated genome editing 
To generate stable knockout HeLa cell lines for ZMPSTE24 and controls, we used 
CRISPR/Cas9 genome editing. The gRNA and Cas9 protein were delivered to cells by 
plasmid transfection. The plasmids were constructed starting from pSpCas9(BB)-2A-
Puro (PX459) (from Feng Zhang, Addgene # 48138 and 48139). The gRNA sequence 
which targets the first exon of ZMPSTE24 was 5′-
GGCCGAGAAGCGTATCTTCGGGG-3′. They were designed with the CRISPR oligo 
design tool (Feng Zhang). The constructs were made based on the protocol of Ran et 
al. 296. 48 h after transfection (Lipofectamin 2000, Life Technologies, 11668027, 
according to manufacturer’s instructions), cells were selected by culturing cells in the 
presence of puromycin (1 µg/ml). Control cells underwent the same treatment 
mentioned above but with a construct containing no gRNA. Individually selected cells 
were grown to colonies and screened by quantitative immunofluorescence for 
accumulation of prelamin A. Targeting efficiency was validated by high-resolution melt 
(HRM) analysis around the cut position of the Cas9 protein using the following primers 
for ZMPSTE24: forward: 5′-CTGGACGCTTTGTGGGAGAT -3′, reverse: 5′-
CGCTGTGCTAGGAAGGTCTC -3′.  
Raman acquisition and analysis 
HeLa cells were seeded onto CaF2 slides and cultured for 24 h. The cells were fixed 
in 4% paraformaldehyde for 15 min at room temperature and washed (3 x 5 min) with 
PBS. The Raman measurements were performed in Hanks balanced salt solution 
(HBSS) to avoid cell detachment. Raman spectra were collected by raster-scanning 
the fixed cells under a confocal Raman microscope (alpha300 R, WITec, GmbH, Ulm, 
Germany) at 785 nm excitation with 2 µm step size and 1 s integration time per 
spectrum with a grating of 600 g mm-1 grating and a 63X water immersion (NA = 0.95) 
objective. At least 50 cells per condition were measured. After data acquisition the 
hyperspectral datasets were preprocessed in the WITec Project Four software and in 
R using the hyperSpec package.292 In a first step pixels containing cosmic rays were 
removed and replaced by the mean spectrum of four adjacent pixels, this was 
performed with a standard tool in the Project Four software. The corrected spectra 
were exported and subsequent preprocessing was carried out in R. The wavelength 
axis was calibrated towards the Raman signal of CaF2 at 322 cm-1, to cope with small 
shifts in the excitation wavelength. Next, signal-to-noise ratio (SNR) was increased by 
smoothing and interpolation. The spectra were smoothed by local polynomial 
regression fitting and in parallel interpolated on a new wavelength axis with equidistant 
spacing, since the unequal data point spacing can influence data analysis. The 
background was initially removed by fitting a polynome of the 4th order to the spectral 
region between 500 and 1400 cm-1 and a polynome of the 3rd order to the region 
between 500 and 2000 cm-1, since both regions could not be fitted by the same 
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polynome at once. The two polynomes were combined and subtracted from the 
spectra. After baseline correction, the data distribution was studied with principal 
component analysis (PCA) and outliers were removed and replaced by the average 
spectrum of eight adjacent pixels with an in-house written algorithm. Next, cellular 
pixels were detected by hierarchical cluster analysis (HCA) and the average Raman 
spectrum of these pixels was calculated from the original Raman spectra obtained after 
smoothing and interpolation. The average spectra of the cells were pooled and the 
background was more precisely permanently removed using the time-consuming 
baselineWavelet package (Zhang et al., http://code.google.com/p/baselinewavelet, 
2009). To estimate the baseline, peak position was accurately detected by continuous 
wavelet transformation (CWT), peak-width was estimated by SNR enhancing 
derivative calculation based on CWT, and finally the baseline was fitted using 
penalized least squares with binary masks. Finally, the average spectra were min-max 
normalized to minimize the influence of the focal volume on the signal. The minimum 
of each spectrum was scaled to 0 and the maximum to 1. The normalization also 
minimized variance between measurements. The complete preprocessing protocol is 
depicted in Figure 4-2.   
The average cellular spectra were analyzed with HCA and PCA. A difference spectrum 
was generated to highlight changes by subtracting the mean Raman spectrum of 
control cells from the Raman spectra of ZMPSTE24-/- cells.  
LDs were isolated in Raman images by using VCA. The Raman images were 
preprocessed as mentioned before, but instead of polynomial baseline correction, 
baseline wavelet correction was applied on the whole image. Next the Raman spectra 
were min-max normalized and analyzed with VCA.     
Immunofluorescence staining 
HeLa cells were grown on glass coverslips or polystyrene 96 well plates (Greiner Bio-
One, 655090) and fixed in 4% paraformaldehyde for 15 min at room temperature and 
washed (3 x 5 min) with PBS. Subsequently, cells were permeabilized with 0.5% Triton 
X-100 (5 min), and incubated with primary antibody diluted in 50% fetal bovine serum 
(FBS) for 60 min. After minimally 3 PBS washing steps, slides were incubated with 
secondary antibody diluted in 50% FBS for 30 min. After the incubation, the slides were 
washed again, and mounted with VECTASHIELD™ Mounting Medium (Vector Labs, 
VWR, 101098-042) containing 1 µg/ml 4′,6- diamino-2-phenylindole (DAPI, 
ThermoFisher Scientific, D1306). Primary antibodies used were directed against lamin 
A (Rabbit, Abcam, ab26300, 1/200), lamin B1 (Abcam, ab16048, 1/1000) and prelamin 
A (Goat, Santa Cruz Biotechnology Inc., sc-6214, 1/150). Secondary antibodies were 
Alexa Fluor 488 conjugated donkey anti-rabbit (Jackson ImmunoResearch 
Laboratories Inc., JAC-711546152) and DyLight 649 conjugated donkey anti-goat 
(Jackson ImmunoResearch Laboratories Inc., JAC-705606147). Immunofluorescent 
stained cells were visualized using a Nikon Ti Eclipse inverted widefield fluorescence 
microscope (Nikon Instruments) with 40x Plan Apo oil (NA = 1.3) or 60x Plan Apo VC 
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(NA = 1.4) objectives. Immunofluorescent staining was performed in triplicate, and per 
microscope slide a minimum of 9 regions was imaged. 
Bodipy 493/503 staining 
HeLa cells were grown on glass, CaF2 coverslips, or polystyrene 96 well plates and 
fixed in 4% paraformaldehyde for 15 min at room temperature and washed (3x, 5 min) 
with PBS. The cells were stained with bodipy 493/503 (1 µg/ml in PBS, ThermoFisher 
Scientific, D3922) and Hoechst 33342 (5 µg/ml in PBS, ThermoFisher Scientific, 
H3570) for 20 min at room temperature. After staining the cells were washed (3X, 5 
min) and stored in PBS. Cells were visualized using a Nikon A1R confocal microscope 
(Nikon Instruments) or Nikon Ti Eclipse inverted widefield fluorescence microscope 
(Nikon Instruments) with a 60x Plan Apo VC oil (NA = 1.4) objective or a 40x Plan Fluor 
dry (NA = 0.75) objective.   
Western blot 
Cells were grown in T75 culture flasks and lysed using the Nucleospin Triprep Kit 
(Macherey-Nagel, 740966.50). Protein concentration was measured with the Pierce™ 
BCA Protein Assay Kit (Thermo Scientific, 23227). Cell lysates were subjected to SDS-
PAGE (NuPAGE™ Novex™ 4–12% Bis-Tris Protein Gels with MOPS running buffer, 
Thermo Scientific, J00047) and transferred to BioTrace PVDF membranes (Pall 
Corporation, 66542). Primary antibodies were directed against lamin A/C (Mouse, 
Santa Cruz Biotechnology Inc., sc-56139) and nucleolin (Rabbit, Novus Biologicals, 
NB600-241). HRP conjugated goat anti-mouse (Sigma-Aldrich, A4416) and HRP 
conjugated goat anti-rabbit (Sigma-Aldrich, A6154) were used as secondary 
antibodies. Proteins were detected by chemiluminescence with Immobilon Western 
chemiluminescent HRP substrate (Millipore, WBKLS0100). 
Quantitative PCR 
RNA was extracted using the Nucleospin Triprep kit (Macherey-Nagel). After quality 
control with the Bioanalyser (Agilent), cDNA synthesis was executed (Tetro cDNA 
synthesis kit, Bioline) followed by qPCR (Sensimix, Bioline, CFX connect Biorad). 
Primers were used for AGPAT: forward:5’-CAGAGCTGGGACGTCATCTG-3’, reverse: 
5’-TACTGCAAGAAGGAGCGTCG-3’; BSCL2: forward: 5’-
CCTATGAAGGCGCAGGTCAT-3’, reverse: 5’-CGACCACTGGAGCGATCATT-3’; 
DGAT1: forward: 5’-TGCTGAAGCCACTGTCAGAG-3’, reverse: 5’-
CCCCAACAAGGACGGAGAC-3’; FITM2: forward: 5’-
GGCAGAAGGAGACAGAACGT-3’, reverse: 5’-TCAAGGAGTTGTCCCCGTTG-3’; 
GPAM: forward: 5’-ACAAAGATGGCAGCAGAGCT-3’, reverse: 5’-
TGACTTTGGGGAGGAACAGC-3’; PEMT: forward: 5’-
GCCACTATGTAGGTGAGGGC-3’, reverse: 5’-ATGTACTGGGGAAGCACAGC-3’; 
PGC1-α:  forward: 5’-GGTGGAAGCAGGGTCAAAGT-3’, reverse: 5’-
CTTTGCGCAGGTCAAACGAA-3’; ZMPSTE24: forward: 5’-
CGAGAAGCGTATCTTCGGGG-3’, reverse: 5’-TGTGCTAGGAAGGTCTCCCA-3’; 
ACTB: forward: 5’-CCTTGCACATGCCGGAG-3’, reverse: 5’-
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GCACAGAGCCTCGCCTT-3’; GAPDH: forward: 5’-TGCACCACCAACTGCTTAGC-
3’, reverse: 5’-GGCATGGACTGTGGTCATGAG-3’. 
Image analysis 
Image Processing. Image processing was performed in Fiji (http:// fiji.sc), a packaged 
version of ImageJ freeware (W.S. Rasband, U.S.A. National Institutes of Health, 
Bethesda, Maryland, USA, http://rsb. info.nih.gov/ij/, 1997−2014).  
The LDs were quantified by means of a custom-designed image processing pipeline288, 
which is essentially based on a high-content analysis workflow described before56 and 
is available upon request. In brief, the analysis consists of a few image preprocessing 
steps, followed by hierarchical segmentation of nuclei, cells, and LDs to allow region-
specific analysis of objects. Nuclear regions of interest (ROIs) are segmented in the 
DAPI channel after filtering with a Gaussian kernel of small radius (Σ = 3), automatic 
thresholding according to Otsu’s algorithm and watershed-based separation. Cellular 
boundaries are then delineated by conditional region growing from the nuclear seeds 
restricted by a Voronoi tessellation. Finally, LDs are specifically enhanced in the LD 
channel by means of a Laplacian operator and binarized using the Triangle 
autothresholding algorithm. The resulting ROIs were used for analyzing shape (area 
and circularity) and intensity metrics of objects larger than a predefined size (>5 pixels) 
on the original image.  
Statistical analyses 
Data analysis and visualization was performed in R statistical freeware (http://www.r-
project.org). Standard statistical methods were employed, including the Shapiro-Wilk 
Normality Test to assess normality of the data; Levene’s test to assess 
homoscedasticity; Student’s t-test, ANOVA, and the Kruskal-Wallis rank sum test to 
assess differences between the group means; and Tukey (after ANOVA) and Dunnett 
type (After Kruskal-Wallis) post-hoc tests to assess significance for each group. We 
also used non-parametric contrast-based multiple comparison tests and Wilcoxon 
tests.289 Significance levels were indicated as follows: p<0.05 (*), p<0.01 (**), and 
p<0.001 (***). For graphics and annotation, the R program was expanded with the 
ggplot2 package.239 
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Mimicking lamin dysfunction in cells 
During the course of this PhD, we have identified different cellular pathways that are 
regulated by A-type lamins. To do so, we have optimized experimental perturbations 
that enable studying lamin A/C maturation defects in an isogenic context: namely 
through sustained siRNA-mediated knockdown (Ch. 2 and Ch.3) or CRISPR-Cas9-
mediated knockout (Ch. 4) of LMNA or ZMPSTE24. The rationale for developing 
human model cells was given shape by the fact that animal model cells are more 
difficult to translate.196,197 For example, the average rate of successful translation from 
animal models to clinical cancer trials is less than 8%.197 However, it should be noted 
that animal models are essential as a bridge between in vitro and clinical studies. 
Furthermore, patient cells are scarce, and have a heterogeneous genetic 
background.195 In contrast, isogenic cell lines only differ (by definition) in the expression 
of the target gene (i.e. LMNA or ZMPSTE24). This facilitates interpretation of 
experimental data. However, patient cells remain indispensable as reference, and 
were therefore used during our experiments to validate our models. Ideally three 
different isogenic cell lines should be developed. This would strengthen our findings 
even further and improve their credibility.     
In contrast with CRISPR/Cas9-mediated knockout, siRNA-mediated knockdown is 
transient. We prolonged the effect through repetitive transfection rounds, resulting in a 
sustained knockdown. Indeed, knockdown efficiency was strongly time-dependent, 
especially at the protein level. This is most likely caused by the slow turnover of lamin 
A.210 Despite this lag time, siRNA transfections bear the advantage that they are easily 
applicable, effective and can be used on a wide range of cell types, including primary 
cells. CRISPR/Cas9-mediated genome editing enables the generation of stable 
knockout cells, but also allows the introduction of point mutations.321 Unlike siRNA 
transfections, genome editing is more laborious and time-consuming. Especially clonal 
selection is a bottleneck and clonal expansion requires numerous cell divisions. 
Therefore CRISPR/Cas9 is difficult to apply to primary (mortal) cells. A way to 
circumvent this problem is by using (conditionally) immortalized primary cells, e.g. 
through ectopic hTERT expression, or by using iPSCs. In addition, iPSCs can be 
differentiated into multiple cell types, favouring their use. These cells have been 
generated from HGPS fibroblasts and were nearly indistinguishable from control cells, 
while differentiation into the affected cell lineages recapitulated the disease 
phenotype.322,323     
Sustained knockdowns induced overt changes in nuclear morphology of fibroblasts, 
which resembled the changes of laminopathy patient fibroblast nuclei. Nuclei from 
genome-edited HeLa cells showed less pronounced morphological alterations, 
although ZMPSTE24 knockout cells did more frequently present nuclear herniations 
and blebs. This may be explained by the sheer fact that HeLa cells display a high basal 
nuclear morphology by default, making these cells less reliable for morphological 
analysis.  
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Both siRNA-mediated knockdown and CRISPR/Cas9-mediated genome engineering 
hold the risk to induced off-target effects. Off-target effects linked to siRNA 
transfections include non-specific induction of inflammatory cytokines and type I 
interferon by cellular sensors of foreign RNA (e.g. MDA5, RIG-I, PKR, OAS1-3, TLR3, 
TLR7 and TLR8) which can obscure on-target effects.324,325 Altered IL6 expression for 
example can be a sequence-independent off-target effect through activation of TLR3, 
TLR7, and TLR8.326 Hence, the altered IL6 expression in LMNAkd and ZMPSTE24kd 
cells, might be caused by off-target effects. CRISPR-Cas9-associated off-target effects 
are caused by mismatches between the guide RNA and the DNA, resulting in off-target 
cleavage activity.298 In line with this, one HeLa-ZKO clone showed a dramatic deviation 
in phenotype, as compared to the other colonies, although this can also be caused by 
genome instability in HeLa cells. Several modifications of this technique have been 
proposed to decrease the probability of these off-target effects, as discussed in chapter 
4. Such as the paired nicking strategy, or fusion of catalytically inactive Cas9 with a 
Fok I nuclease domain (fCas9), which has a much higher specificity than wild-type 
Cas9.298 Next to these suggestions, the use of inducible CRISPR/Cas9 could 
dramatically decrease off-target effects with a pulse exposure of the genome to the 
Cas9/sgRNA complex.327  
Lamins are important regulators of cellular redox biology 
As described in chapter 2, LMNA deficiency caused elevated basal ROS levels and 
hypersensitivity to exogenous TBHP (induced ROS). ZMPSTE24 deficiency on the 
other hand was associated with moderately increased basal ROS levels. Both 
knockdowns were accompanied by an upregulation of several ROS detoxifying 
enzymes. The hypersensitivity towards exogenous ROS in LMNAkd cells, supports the 
hypothesis that the nuclear lamina acts as an intracellular ROS-sink by virtue of their 
conserved cysteine residues within the lamin tail.213 This ROS buffering capacity has 
also been documented in R439C skin fibroblasts, which express lamin A with an 
additional cysteine residue.328 Hence, loss of A-type lamins (and their cysteine 
residues), abrogates the ability of the lamina to act as a ROS buffering system, 
rendering the cell more sensitive against increases of the intracellular ROS levels. Next 
to loss of this ROS buffering system, LMNA deficient cells present repetitive nuclear 
ruptures, which can temporarily relocate various transcription factors, several of which 
controlling oxidative stress response62, and result in cytoplasmic translocation of 
nuclear PML bodies60, known sensors of oxidative stress and regulators of redox 
homeostasis.224,225 In contrast to LMNAkd cells, ZMSPTE24kd cells are not 
hypersensitive to exogenous TBPH, in part due to the ROS buffering capacities of 
prelamin A.  
Mitochondria are the instigators of oxidative stress   
Loss of ROS buffering can aggravate the release of intracellular ROS and thereby 
boost basal ROS levels. However, this is only the case in presence of ROS build up in 
the cell. As dysfunctional mitochondria can trigger intracellular ROS release, we 
analyzed m, mitochondrial •O2- levels, and basal mitochondrial respiration rate. In 
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LMNAkd cells we noticed that elevated ROS levels were preceded by m 
depolarization, eventually followed by m hyperpolarization, which was accompanied 
by increased mitochondrial •O2- levels. Furthermore, we measured a lowered basal 
mitochondrial respiration rate. In contrast, ZMPSTE24kd cells showed a transient m 
depolarization and no increased mitochondrial •O2- levels were measured, which was 
likely due to upregulation of SOD2. Although, basal mitochondrial respiration was also 
lowered. Of note, we have also performed a SILAC-based differential proteome 
analysis on ZMPSTE24kd cells (unpublished data). GO analysis of these data 
indicated altered levels of proteins involved in ion transmembrane transport and 
mitochondrial membrane components. More specifically, TOMM70A, a translocase of 
the outer mitochondrial membrane, showed reduced protein levels and STOML2, a 
protein involved in mitochondrial biogenesis and function329, showed decreased gene 
expression (unpublished results). In line with this, proteomic profiling of adipose tissue 
of Zmpste24-/- mice highlighted major changes in mitochondrial function.128 This further 
supports the notion that ZMPSTE24kd impairs mitochondrial function.  
Proteasome overload can trigger mitochondrial dysfunction   
In LMNAkd cells mitochondrial dysfunction preceded elevated ROS levels, indicating 
that mitochondria are likely the initial sites of oxidative damage and the instigators of 
oxidative stress in the cytosol. Maharjan et al. (2014) showed that mitochondrial 
dysfunction can be triggered by proteasome overload, as demonstrated by 
accumulation of polyubiquitinated proteins in mitochondria upon proteasome inhibition, 
resulting in loss of m and the generation of ROS from the electron transport chain 
(ETC).217 Loss of A-type lamins can cause proteasome overload by the accumulation 
of nuclear envelope proteins (SUN2, Emerin and Nesprin-1) in the ER.114,218,219 In 
addition, loss of A-type lamins can trigger an upregulation of various ubiquitin 
ligases.220 The proteasome hypothesis is supported by the fact that MG132 treatment, 
a potent proteasome inhibitor, also resulted in a significant increase of basal and 
induced ROS levels, as well as increased m. In line with this, our research group 
recently measured reduced activity of the 20S proteasome in LMNAkd cells, as well as 
a significant decrease in the number of autophagosomes in these cells (Sieprath, T. 
(2017). Exploring the role of lamins as mediators of oxidative stress (Unpublished 
doctoral dissertation)). Supporting this, LmnaH222P/H222P mice (a mouse model for LMNA 
cardiomyopathy) responded well to Temsirolimus, a rapamycin analogue, that 
activates autophagy.330 ZMPSTE24kd also impaired 20S proteasome activity, likely 
triggered by prelamin A accumulation, but did not significantly affect autophagy 
(Sieprath, T. (2017). Exploring the role of lamins as mediators of oxidative stress 
(Unpublished doctoral dissertation)). So, in ZMPSTE24kd cells, accumulation of 
polyubiquitinated proteins in mitochondria can be avoided by autophagy, or 
dysfunctional mitochondria can be cleared through mitophagy, explaining the 
moderately increased basal ROS levels. Moreover, our research group tested 
sulforaphane, a plant-derived isothiocyanate (1-isothiocyanato-4-
methylsulfinylbutane), which has been shown to enhance progerin clearance in HGPS 
88 
 
fibroblast, via proteasome and autophagy activation.159 Indeed, 20S proteasomal 
activity and the number of autophagosomes increased in LMNAkd and ZMPSTE24kd 
cells, and this was accompanied by decreased basal ROS levels (Sieprath, T. (2017). 
Exploring the role of lamins as mediators of oxidative stress (Unpublished doctoral 
dissertation)).  
ROS dosage induces different cell fates 
In contrast to LMNAkd, which induced apoptosis, reduced expression of ZMPSTE24 
triggered a senescence pathway. We hypothesize that a ROS dosage effect dictates 
the dichotomy in cellular outcomes. Modestly increased levels of intracellular ROS 
induce and maintain cellular senescence, as observed in ZMPSTE24kd cells, while 
higher doses provoke apoptosis, as seen in LMNAkd cells.231–234 However, LMNAkd 
cells also present decreased protein levels of paxillin and a decrease in nuclear FAK, 
which can also contribute to the onset of apoptosis264,277,331,332. Next to their direct 
contribution to the onset of apoptosis, they can also impair adhesion-dependent cell 
cycle progression.333 Nevertheless, decreasing the basal ROS level might postpone 
senescence and apoptosis in LMNAkd and ZMPSTE24kd cells or trigger senescence 
instead of apoptosis in LMNAkd cells.  
ROS levels can be reduced by the ROS scavenger N-acetyl cysteine as shown by 
Pekovic et al. (2011) in HGPS fibroblasts and LMNA deficient fibroblasts213, or by 
sulforaphane treatment, as mentioned earlier. Alternatively, ROS levels can be 
reduced through restoring or boosting mitochondrial function. One way to do this, might 
be by targeting the phosphorylation of Rac1b by rho-associated protein kinase 
(ROCK): ROCK inhibitors have been found to block the interaction of Rac1b and 
cytochrome c in mitochondria, and thereby reduce ROS levels and recover 
mitochondrial function in HGPS fibroblasts.334 Next to ROCK inhibitors the 
mitochondrial-targeting antioxidant methylene blue (MB) is also very promising. MB 
alleviated the mitochondrial defects and rescued nuclear abnormalities in HGPS 
fibroblasts.335 Figure 5-1 depicts the mechanisms contributing to the cell fate of 
LMNAkd and ZMPSTE24kd cells.  
Loss of lamins uncouples intracellular mechanical wiring 
A differential proteomics analysis, revealed that sustained depletion of A-type lamins 
also affected the production of proteins involved in FA formation. Since nuclear 
translocation of MKL1 was significantly reduced, we hypothesized that impaired MKL1-
SRF signaling, which regulates the expression of a large number of genes involved in 
actin cytoskeleton organization and FA257, was responsible for smaller FA size in 
LMNAkd cells. Emerin stimulates MKL1-SRF-dependent gene activity in a substrate-
stiffness-dependent matter336, and ectopic expression of emerin can restore nuclear 
translocation of MKL1 in Lmna-/- MEFs.105 Hence, since correct localization of emerin 
depends on lamin A, impaired MKL1-SRF signaling in LMNAkd cells could likely be a 
result of mislocalized emerin.337 In future experiments the impact of impaired MKL1-
89 
 
SRF signalling on production of FA proteins should be studied through knockdown 
experiments. Furthermore, activation of SRF should recover FA size in LMNAkd cells.  
Interestingly, LMNAkd cells presented more pronounced stress fibers and significantly 
higher traction forces during cell detachment. Counterintuitively, the actin stress fibers 
still attached to and exerted even stronger traction forces on smaller FAs. Thus, LMNA 
knockdown appeared to uncouple cell adhesive mechanisms and cytoskeletal tension. 
A similar observation was made previously for DAP kinase, which stabilizes and 
enhances the formation of stress fibers through phosphorylation of TPM1, independent 
of FA formation, before the onset of apoptosis.269 Intriguingly, DAP kinase becomes 
activated in response to oxidative stress.270 This may imply that there is a direct 
connection between redox biology and cytoskeletal function, which is regulated by A-
type lamins. To establish the involvement of DAP kinase, future experiments should 
focus on studying the abundance and activity of DAP kinase in LMNAkd cells vs WT 
controls. If DAP kinase were a downstream target of elevated ROS levels, treatment 
with antioxidants or knockdown of DAP kinase in LMNAkd cells should counteract the 
uncoupling and might prevent the onset of apoptosis.269 Cytoskeletal tension can also 
be decreased in LMNAkd cells by the aforementioned ROCK inhibition, since ROCK 
is involved in actomyosin contraction. Indeed treatment of immortalized human 
trabecular meshwork cells with ROCK inhibitors showed a loss of stress fibers.338 Thus 
ROCK inhibitors might not only alleviate mitochondrial dysfunction in LMNAkd cells, 
but also decrease cytoskeletal tension. 
Taken together, we hypothesize that pathogenesis in LMNAkd cells is caused by 
proteasome overload (as shown by decreased 20S proteasome activity), which causes 
mitochondrial dysfunction, resulting in elevated ROS levels. In parallel, FA size is 
reduced by impaired MKL1-SRF signaling. Elevated ROS levels might activate DAP 
kinase, resulting in increased cytoskeletal tension independent of FA size, as shown 
in previous studies.269,270 The aforementioned events eventually result in the onset of 
apoptosis. So, we can distinguish two key pathways in LMNAkd cells, namely impaired 
MKL1-SRF signalling and elevated ROS levels, probably as a result of proteasome 
overload. The proposed mechanism is displayed in Figure 5-1.  
Loss of ZMPSTE24 alters lipid metabolism 
Loss of ZMPSTE24 expression in HeLa cells was associated with reduced lipid storage 
in HeLa cells, as demonstrated by reduced LD number and size. Furthermore, 
increased expression of three LD-associated genes was observed, namely GPAM, 
PEMT and PGC1α. In line with our observations, increased expression of these genes 
induce reduced LD size.308,309,311 On the other hand, these genes are involved in 
processes which can increase lipid storage. In addition, SILAC results of ZMPSTEkd 
fibroblasts showed an upregulation of ATP citrate lyase (ACLY), which is a lipogenic 
gene. We proposed that the overexpression of the aforementioned genes is a 
compensatory mechanism against the accelerated lipolysis induced by prelamin A 
accumulation, as was hypothesized by Sánchez et al. (2015) for increased PEMT 
activity in prelamin A accumulating hMSC-derived adipocytes.312 Indeed, experiments 
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in Zmpste24-/- mice showed increased partitioning of fatty acids towards β-oxidation 
and away from storage128, and LDs supply fatty acids for mitochondrial β-oxidation.339 
This hypothesis can be tested by coupling stimulated Raman scattering (SRS) 
microscopy with isotope labeled glucose.340 Using this approach de novo lipogenesis 
can be visualized in real time, and the turnover of newly synthesized lipids can be 
assessed. Furthermore, SRS microscopy has much faster acquisition times than RMS, 
enabling the generation of Raman images with a high resolution. 
Next to increased β-oxidation, interaction of prelamin A with Sp1 has been shown to 
perturb adipogenesis and sequestration of SREBP1 by prelamin A impairs pre-
adipocyte differentiation.100,242,317,319 Since these processes implicate activation of LD 
biogenesis, interaction/sequestration of these transcription factors can impair lipid 
storage.  
 
Figure 5-1. Scheme showing how loss of lamin A/C and accumulation of prelamin A 
eventually result in apoptosis and senescence, respectively.   
Towards physiologically relevant model systems 
The primary function of nuclear lamins is to regulate nuclear mechanics. However, by 
organizing chromatin and sequestering transcription factors, lamins also regulate a 
plethora of signaling pathways. Yet, knowledge about the pathogenic mechanisms that 
underlie laminopathies is incomplete. Using a variety of cytomics approaches, we have 
identified a set of additional pathways that are regulated by A-type lamins. In short, we 
have discovered that A-type lamins are essential for cellular redox balance, focal 
adhesion formation and cytoskeletal tension, and lipid droplet formation. This 
underlines the pleiotropic nature of lamin function and may also provide a novel basis 
for better understanding disease development.  
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For all our experiments, we either used human dermal fibroblasts or HeLa cells. 
However, in the context of laminopathies more relevant cell lineages should be 
selected. Results obtained from LMNAkd fibroblasts should be validated in 
cardiomyocytes or myoblasts.107,262,341 Results obtained from ZMPSTE24kd fibroblasts 
and HeLa-ZKO cells should be validated in preadipocytes and adipocytes.128 However, 
these cell lineages have different genetic background. This can be bypassed through 
the use of hMSCs or generation of iPSCs. These stem cells can be differentiated into 
multiple cell lineages with the same genetic background. 
A significant drawback of working with cells is the fact that they do not completely mimic 
the functions of living tissues. Cells within a tissue establish a 3D communication 
network through cell-cell and cell-extracellular matrix (ECM) interactions.342 This 3D 
communication network can be approximated with 3D cell culture models such as 
organotypic explant culture, which can be retrieved from surgeries343, cellular 
spheroids, polarized epithelial cell cultures, artificial skin, and microcarrier culture.342 
When studying cell migration and cell adhesion, as discussed in chapter 3, 3D cell 
culture is a better reflection of the in vivo situation and eventually can give different 
outcomes compared to 2D cell culture. This has been demonstrated for lmna-deficient 
MEFs, which showed a significantly reduced migration rate in a 3D matrix, while no 
significant changes were observed on a 2D substrate.279 Similarly, cell adhesion is 
remarkably different in a 3D matrix than on a 2D substrate. FA proteins do not form 
aggregates in a 3D matrix. However they do modulate cell motility, but rather by 
affecting protrusion activity and matrix deformation.344 To even better approximate 
tissue biology, 3D culture models should comprise different cell types. Besides 
organotypic explant culture, iPSCs can be used to engineer organoids with mixed cell 
types.  
Novel therapeutic and diagnostic strategies 
Our findings can pave the way to novel therapeutic strategies for laminopathies. 
Especially the proteasome hypothesis is very promising, exemplified by the positive 
effect of sulforaphane treatment on our model cells and HGPS fibroblasts. Future 
studies should validate these results, prior to animal and clinical studies. Besides 
sulforaphane, treatments restoring mitochondrial dysfunction might also be successful. 
To this end, ROCK inhibitors and methylene blue can be used. Finally, antioxidants, 
such as N-acetyl cysteine, can also show some effect by reducing ROS levels. 
However, these will probably lack effectivity as monotherapy, and are therefore 
preferred in combination with one of the former drugs. Despite the potential of these 
therapeutic strategies, a lifelong administration is required, in contrast to gene 
therapies.  
Restoring the cytoskeletal tension and FA formation is less straightforward than the 
preceding therapeutic strategies, and our findings should first be validated in animal 
studies. Instead of a novel therapeutic strategy, these observations might be relevant 
for early diagnosis of LMNA DCM, which manifests at a later age. Cytoskeletal 
alterations or impaired FA formation might already be present before the first 
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symptoms appear. However, DNA sequencing has become the most obvious and 
preferred diagnostic platform for genetic diseases, making it very hard to compete with. 
In line with this, implementation of RMS as a novel diagnostic strategy for 
laminopathies is also not very likely in the near future.   
 
Main results and perspectives 
1. Sustained knockdown and CRISPR/CAS9-mediated genome editing are complementary 
tools to modulate lamin levels 
2. Lamins are important regulators of cellular redox biology. 
3. Sustained lamin A/C depletion and to a lower extent prelamin A accumulation trigger 
oxidative stress and mitochondrial dysfunction.   
4. ROS dosage contributes to the different cell fates of lamin A/C and ZMPSTE24 depleted 
cells. 
5. SILAC-based proteomics offers a holistic insight in differentially modulated proteins 
between cells.   
6. Loss of lamin A/C uncouples FA formation and cytoskeletal tension. 
7. Loss of ZMPSTE24 decreases lipid storage. 
8. Raman microscopy allows molecular fingerprinting of model cells, but with limited 
resolution and sensitivity 
93 
 
  
94 
 
REFERENCES  
1.  Hetzer MW. The nuclear envelope. Cold Spring Harb Perspect Biol 2010; 2:1–
16.  
2.  Wolfner MF, Wilson KL. The nuclear envelope: emerging roles in development 
and disease. Cell Mol Life Sci C 2001; 58:1737–40.  
3.  Pavelka M, Roth J. Nuclear Envelope and Rough Endoplasmic Reticulum 
[Internet]. In: Functional Ultrastructure: Atlas of Tissue Biology and Pathology. 
Vienna: Springer Vienna; 2010. page 30–1. 
4.  Sosa BA, Rothballer A, Kutay U, Schwartz TU. LINC complexes form by binding 
of three KASH peptides to domain interfaces of trimeric SUN proteins. Cell 2012; 
149:1035–47.  
5.  Lim RYH, Fahrenkrog B. The nuclear pore complex up close. Curr Opin Cell Biol 
2006; 18:342–7.  
6.  Alber F, Dokudovskaya S, Veenhoff LM, Zhang W, Kipper J, Devos D, Suprapto 
A, Karni-Schmidt O, Williams R, Chait BT, et al. The molecular architecture of 
the nuclear pore complex. Nature 2007; 450:695–701.  
7.  Gerace L, Huber MD. Nuclear lamina at the crossroads of the cytoplasm and 
nucleus. J Struct Biol 2012; 177:24–31.  
8.  Zwerger M, Medalia O. From lamins to lamina: a structural perspective. 
Histochem Cell Biol 2013; 140:3–12.  
9.  Shumaker DK, Kuczmarski ER, Goldman RD. The nucleoskeleton: Lamins and 
actin are major players in essential nuclear functions. Curr Opin Cell Biol 2003; 
15:358–66.  
10.  Turgay Y, Eibauer M, Goldman AE, Shimi T, Khayat M, Ben-Harush K, 
Dubrovsky-Gaupp A, Sapra KT, Goldman RD, Medalia O. The molecular 
architecture of lamins in somatic cells. Nature 2017; 543:261–4.  
11.  Höger TH, Grund C, Franke WW, Krohne G. Immunolocalization of lamins in the 
thick nuclear lamina of human synovial cells. Eur J Cell Biol 1991; 54:150—156.  
12.  Goldman AE, Maul G, Steinert PM, Yang HY, Goldman RD. Keratin-like proteins 
that coisolate with intermediate filaments of BHK-21 cells are nuclear lamins. 
Proc Natl Acad Sci  1986; 83:3839–43.  
13.  Gruenbaum Y, Medalia O. Lamins: the structure and protein complexes. Curr 
Opin Cell Biol 2015; 32:7–12.  
14.  Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: 
laminopathies and their role in premature ageing. Physiol Rev 2006; 86:967–
1008.  
15.  Malhas A, Goulbourne C, Vaux DJ. The nucleoplasmic reticulum: Form and 
function. Trends Cell Biol 2011; 21:362–73.  
16.  Naetar N, Ferraioli S, Foisner R. Lamins in the nuclear interior − life outside the 
lamina. J Cell Sci 2017; :2087–96.  
95 
 
17.  Wilson KL, Foisner R. Lamin-binding Proteins. Cold Spring Harb Perspect Biol 
2009; :1–17.  
18.  Stewart CL, Roux KJ, Burke B. Blurring the boundary: the nuclear envelope 
extends its reach. [Internet]. Science2007; 318:1408–12.  
19.  Dechat T, Adam SA, Taimen P, Shimi T, Goldman RD. Nuclear lamins. Cold 
Spring Harb. Perspect. Biol.2010; 2.  
20.  Stuurman N, Heins S, Aebi U. Nuclear lamins: their structure, assembly, and 
interactions. [Internet]. J. Struct. Biol.1998; 122:42–66.  
21.  Nakajima N, Abe K. Genomic structure of the mouse A-type lamin gene locus 
encoding somatic and germ cell-specific lamins. FEBS Lett 1995; 365:108–14.  
22.  Furukawa K, Hotta Y. cDNA cloning of a germ cell specific lamin B3 from mouse 
spermatocytes and analysis of its function by ectopic expression in somatic cells. 
EMBO J 1993; 12:97–106.  
23.  Gerace L, Blobel G. The nuclear envelope lamina is reversibly depolymerized 
during mitosis. Cell 1980; 19:277–87.  
24.  Benavente R, Krohne G, Franke WW. Cell type-specific expression of nuclear 
lamina proteins during development of Xenopus laevis. Cell 1985; 41:177–90.  
25.  Lehner CF, Stick R, Eppenberger HM, Migg EA. Differential expression of 
nuclear lamin proteins during chicken development. J Cell Biol 1987; 105:577–
87.  
26.  Schatten G, Maul GG, Schatten H, Chaly N, Simerly C, Balczon R, Brown DL. 
Nuclear lamins and peripheral nuclear antigens during fertilization and 
embryogenesis in mice and sea urchins. Proc Natl Acad Sci U S A 1985; 
82:4727–31.  
27.  Constantinescu D, Gray HL, Sammak PJ, Schatten GP, Csoka AB. Lamin A/C 
expression is a marker of mouse and human embryonic stem cell differentiation. 
Stem Cells 2006; 24:177–85.  
28.  Rober R-A, Weber K, Osborn M. Differential timing of nuclear lamin A/C 
expression in the various organs of the mouse embryo and the young animal: a 
developmental study. Development 1989; 105:365–78.  
29.  Prokocimer M, Margalit A, Gruenbaum Y. The nuclear lamina and its proposed 
roles in tumorigenesis: Projection on the hematologic malignancies and future 
targeted therapy. J Struct Biol 2006; 155:351–60.  
30.  Machiels BM, Zorenc AHG, Endert JM, Kuijpers HJH, Van Eys GJJM, 
Ramaekers FCS, Broers JL V. An alternative splicing product of the lamin A/C 
gene lacks exon 10. J Biol Chem 1996; 271:9249–53.  
31.  Verstraeten VLRM, Broers JL V, Ramaekers FCS, van Steensel M a M. The 
nuclear envelope, a key structure in cellular integrity and gene expression. 
[Internet]. Curr. Med. Chem.2007; 14:1231–48.  
32.  Swift J, Ivanovska IL, Buxboim A, Harada T, Dave PC, Dingal P, Pinter J, 
Pajerowski JD, Spinler KR, Shin J-W, et al. Nuclear Lamin-A Scales with Tissue 
Stiffness and Enhances Matrix-Directed Differentiation. 2013; 341.  
96 
 
33.  Parry DAD, Conway JF, Steinertt PM. Structural studies on lamin Similarities and 
differences between lamin and intermediate-filament proteins. Biochem J 1986; 
238:305–8.  
34.  Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE. Structure of the globular tail 
of nuclear lamin. J Biol Chem 2002; 277:17381–4.  
35.  Loewinger L, McKeon F. Mutations in the nuclear lamin proteins resulting in their 
aberrant assembly in the cytoplasm. EMBO J 1988; 7:2301–9.  
36.  Shimi T, Kittisopikul M, Tran J, Goldman AE, Adam SA, Zheng Y, Jaqaman K, 
Goldman RD. Structural organization of nuclear lamins A, C, B1, and B2 
revealed by superresolution microscopy. Mol Biol Cell 2015; 26:4075–86.  
37.  Davies BSJ, Fong LG, Yang SH, Coffinier C, Young SG. The posttranslational 
processing of prelamin A and disease. Annu Rev Genomics Hum Genet 2009; 
10:153–74.  
38.  Rusiñol AE, Sinensky MS. Farnesylated lamins, progeroid syndromes and 
farnesyl transferase inhibitors. [Internet]. J. Cell Sci.2006; 119:3265–72.  
39.  Corrigan DP, Kuszczak D, Rusinol AE, Thewke DP, Hrycyna CA, Michaelis S, 
Sinensky MS. Prelamin A endoproteolytic processing in vitro by recombinant 
Zmpste24. Biochem J 2005; 387:129–38.  
40.  Winter-Vann AM, Casey PJ. Post-prenylation-processing enzymes as new 
targets in oncogenesis. Nat Rev Cancer 2005; 5:405–12.  
41.  Davies BS, Coffinier C, Yang SH, Barnes RH, Jung H-J, Young SG, Fong LG. 
Investigating the purpose of prelamin A processing. Nucleus 2010; 2:4–9.  
42.  Barrowman J, Hamblet C, Kane MS, Michaelis S. Requirements for efficient 
proteolytic cleavage of prelamin A by ZMPSTE24. PLoS One 2012; 7:e32120.  
43.  Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton M. The processing 
pathway of prelamin A. J Cell Sci 1994; 107 ( Pt 1:61–7.  
44.  Jung H-J, Nobumori C, Goulbourne CN, Tu Y, Lee JM, Tatar A, Wu D, Yoshinaga 
Y, de Jong PJ, Coffinier C, et al. Farnesylation of lamin B1 is important for 
retention of nuclear chromatin during neuronal migration. Proc Natl Acad Sci U 
S A 2013; 110:E1923-32.  
45.  Davies BSJ, Barnes RH, Tu Y, Ren S, Andres DA, Peter Spielmann H, 
Lammerding J, Wang Y, Young SG, Fong LG. An accumulation of non-
farnesylated prelamin A causes cardiomyopathy but not progeria. Hum Mol 
Genet 2010; 19:2682–94.  
46.  Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Coté N, Gavino B, Qiao 
X, Chang SY, Young SR, et al. Prelamin A and lamin A appear to be dispensable 
in the nuclear lamina. J Clin Invest 2006; 116:743–52.  
47.  Coffinier C, Jung HJ, Li Z, Nobumori C, Yun UJ, Farber EA, Davies BS, 
Weinstein MM, Yang SH, Lammerding J, et al. Direct synthesis of lamin A, 
bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no 
detectable pathology in mice. J Biol Chem 2010; 285:20818–26.  
48.  González-Granado JM, Navarro-Puche A, Molina-Sanchez P, Blanco-Berrocal 
97 
 
M, Viana R, Font de Mora J, Andrés V. Sorting nexin 6 enhances lamin a 
synthesis and incorporation into the nuclear envelope. PLoS One 2014; 
9:e115571.  
49.  Dessev G, Iovcheva C, Tasheva B, Goldman R. Protein kinase activity 
associated with the nuclear lamina. [Internet]. Proc. Natl. Acad. Sci. U. S. 
A.1988; 85:2994–8.  
50.  Goss VL, Hocevar BA, Thompson LJ, Stratton CA, Burns DJ, Fields AP. 
Identification of nuclear beta II protein kinase C as a mitotic lamin kinase. J Biol 
Chem  1994; 269:19074–80.  
51.  Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear 
lamina comes of age. Nat Rev Mol Cell Biol 2005; 6:21–31.  
52.  Sieprath T, Darwiche R, De Vos WH. Lamins as mediators of oxidative stress. 
Biochem Biophys Res Commun 2012; 421:635–9.  
53.  Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT. Lamins 
a and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 2006; 
281:25768–80.  
54.  De Vos WH, Houben F, Hoebe RA, Hennekam R, van Engelen B, Manders 
EMM, Ramaekers FCS, Broers JL V, Van Oostveldt P. Increased plasticity of the 
nuclear envelope and hypermobility of telomeres due to the loss of A–type 
lamins. Biochim Biophys Acta - Gen Subj 2010; 1800:448–58.  
55.  Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, 
Stewart CL, Lee RT. Lamin A/C deficiency causes defective nuclear mechanics 
and mechanotransduction. J. Clin. Invest.2004; 113:370–8.  
56.  De Vos WH, Van Neste L, Dieriks B, Joss GH, Van Oostveldt P. High content 
image cytometry in the context of subnuclear organization. Cytometry A 2010; 
77:64–75.  
57.  Broers JL V, Peeters E a G, Kuijpers HJH, Endert J, Bouten CVC, Oomens CWJ, 
Baaijens FPT, Ramaekers FCS. Decreased mechanical stiffness in LMNA-/- 
cells is caused by defective nucleo-cytoskeletal integrity: implications for the 
development of laminopathies. Hum Mol Genet 2004; 13:2567–80.  
58.  Pajerowski JD, Dahl KN, Zhong FL, Sammak PJ, Discher DE. Physical plasticity 
of the nucleus in stem cell differentiation. Proc Natl Acad Sci U S A 2007; 
104:15619–24.  
59.  Verstraeten VLRM, Peckham L a, Olive M, Capell BC, Collins FS, Nabel EG, 
Young SG, Fong LG, Lammerding J. Protein farnesylation inhibitors cause 
donut-shaped cell nuclei attributable to a centrosome separation defect. Proc 
Natl Acad Sci U S A 2011; 108:4997–5002.  
60.  Houben F, De Vos WH, Krapels IPC, Coorens M, Kierkels GJJ, Kamps M a F, 
Verstraeten VLRM, Marcelis CLM, Van Den Wijngaard  a., Ramaekers FCS, et 
al. Cytoplasmic localization of PML particles in laminopathies. Histochem Cell 
Biol 2013; 139:119–34.  
61.  Robijns J, Molenberghs F, Sieprath T, Corne TDJ, Verschuuren M, De Vos WH. 
In silico synchronization reveals regulators of nuclear ruptures in lamin A/C 
98 
 
deficient model cells. Sci Rep 2016; 6:30325.  
62.  De vos WH, Houben F, Kamps M, Malhas A, Verheyen F, Cox J, Manders EMM, 
Verstraeten VLRM, van Steensel MAM, Marcelis CLM, et al. Repetitive 
disruptions of the nuclear envelope invoke temporary loss of cellular 
compartmentalization in laminopathies. Hum Mol Genet 2011; 20:4175–86.  
63.  Lu W, Gotzmann J, Sironi L, Jaeger VM, Schneider M, Lüke Y, Uhlén M, 
Szigyarto CAK, Brachner A, Ellenberg J, et al. Sun1 forms immobile 
macromolecular assemblies at the nuclear envelope. Biochim Biophys Acta - Mol 
Cell Res 2008; 1783:2415–26.  
64.  Simon DN, Zastrow MS, Wilson KL. Direct actin binding to A- and B-type lamin 
tails and actin filament bundling by the lamin A tail. Nucleus 2010; 1:264–72.  
65.  Starr DA, Fridolfsson HN. Interactions Between Nuclei and the Cytoskeleton Are 
Mediated by SUN-KASH Nuclear-Envelope Bridges. Annu Rev Cell Dev Biol 
2010; 26:421–44.  
66.  Andrés V, González JM. Role of A-type lamins in signaling, transcription, and 
chromatin organization. [Internet]. J. Cell Biol.2009; 187:945–57.  
67.  Cremer T, Cremer M, Dietzel S, Müller S, Solovei I, Fakan S. Chromosome 
territories--a functional nuclear landscape. [Internet]. Curr. Opin. Cell Biol.2006; 
18:307–16.  
68.  Solovei I, Wang AS, Thanisch K, Schmidt CS, Krebs S, Zwerger M, Cohen T V., 
Devys D, Foisner R, Peichl L, et al. LBR and lamin A/C sequentially tether 
peripheral heterochromatin and inversely regulate differentiation. Cell 2013; 
152:584–98.  
69.  Ludérus ME, den Blaauwen JL, de Smit OJ, Compton D a, van Driel R. Binding 
of matrix attachment regions to lamin polymers involves single-stranded regions 
and the minor groove. Mol Cell Biol 1994; 14:6297–305.  
70.  Zhao K, Harel A, Stuurman N, Guedalia D, Gruenbaum Y. Binding of matrix 
attachment regions to nuclear lamin is mediated by the rod domain and depends 
on the lamin polymerization state. FEBS Lett 1996; 380:161–4.  
71.  Lee KK, Haraguchi T, Lee RS, Koujin T, Hiraoka Y, Wilson KL. Distinct functional 
domains in emerin bind lamin A and DNA-bridging protein BAF. [Internet]. J. Cell 
Sci.2001; 114:4567–73.  
72.  Mattout A, Goldberg M, Tzur Y, Margalit A, Gruenbaum Y. Specific and 
conserved sequences in D. melanogaster and C. elegans lamins and histone 
H2A mediate the attachment of lamins to chromosomes. J Cell Sci 2007; 
120:77–85.  
73.  Goldberg M, Harel  a, Brandeis M, Rechsteiner T, Richmond TJ, Weiss  a M, 
Gruenbaum Y. The tail domain of lamin Dm0 binds histones H2A and H2B. Proc 
Natl Acad Sci U S A 1999; 96:2852–7.  
74.  Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, 
de Klein A, Wessels L, de Laat W, et al. Domain organization of human 
chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008; 
453:948–51.  
99 
 
75.  Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SWM, Solovei I, Brugman 
W, Gr??f S, Flicek P, Kerkhoven RM, van Lohuizen M, et al. Molecular Maps of 
the Reorganization of Genome-Nuclear Lamina Interactions during 
Differentiation. Mol Cell 2010; 38:603–13.  
76.  Shah PP, Donahue G, Otte GL, Capell BC, Nelson DM, Cao K, Aggarwala V, 
Cruickshanks H a., Rai TS, McBryan T, et al. Lamin B1 depletion in senescent 
cells triggers large-scale changes in gene expression and the chromatin 
landscape. Genes Dev 2013; 27:1787–99.  
77.  Shimi T, Pfleghaar K, Kojima SI, Pack CG, Solovei I, Goldman AE, Adam SA, 
Shumaker DK, Kinjo M, Cremer T, et al. The A- and B-type nuclear lamin 
networks: Microdomains involved in chromatin organization and transcription. 
Genes Dev 2008; 22:3409–21.  
78.  Galiová G, Bártová E, Raška I, Krejčí J, Kozubek S, Raska I, Krejcí J, Kozubek 
S. Chromatin changes induced by lamin A/C deficiency and the histone 
deacetylase inhibitor trichostatin A. Eur J Cell Biol 2008; 87:291–303.  
79.  Bronshtein I, Kepten E, Kanter I, Berezin S, Lindner M, Redwood AB, Mai S, 
Gonzalo S, Foisner R, Shav-Tal Y, et al. Loss of lamin A function increases 
chromatin dynamics in the nuclear interior. Nat Commun 2015; 6:8044.  
80.  Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, Erdos MR, 
Eriksson M, Goldman AE, Khuon S, Collins FS, et al. Mutant nuclear lamin A 
leads to progressive alterations of epigenetic control in premature aging. Proc 
Natl Acad Sci U S A 2006; 103:8703–8.  
81.  Mattioli E, Columbaro M, Capanni C, Santi S, Maraldi NM, D’Apice MR, Novelli 
G, Riccio M, Squarzoni S, Foisner R, et al. Drugs affecting prelamin A 
processing: effects on heterochromatin organization. Exp Cell Res 2008; 
314:453–62.  
82.  Kennedy BK, Barbie DA, Classon M, Dyson N, Harlow E. Nuclear organization 
of DNA replication in primary mammalian cells. Genes Dev 2000; 14:2855–68.  
83.  Moir RD, Montag-Lowy M, Goldman RD. Dynamic properties of nuclear lamins: 
Lamin B is associated with sites of DNA replication. J Cell Biol 1994; 125:1201–
12.  
84.  Shumaker DK, Solimando L, Sengupta K, Shimi T, Adam SA, Grunwald A, 
Strelkov S V., Aebi U, Cardoso MC, Goldman RD. The highly conserved nuclear 
lamin Ig-fold binds to PCNA: Its role in DNA replication. J Cell Biol 2008; 
181:269–80.  
85.  Singh M, Hunt CR, Pandita RK, Kumar R, Yang C-R, Horikoshi N, Bachoo R, 
Serag S, Story MD, Shay JW, et al. Lamin A/C depletion enhances DNA 
damage-induced stalled replication fork arrest. Mol Cell Biol 2013; 33:1210–22.  
86.  Meier J, Georgatos SD. Type B lamins remain associated with the integral 
nuclear envelope protein p58 during mitosis: implications for nuclear 
reassembly. EMBO J 1994; 13:1888–98.  
87.  Gonzalez-Suarez I, Redwood AB, Perkins SM, Vermolen B, Lichtensztejin D, 
Grotsky D a, Morgado-Palacin L, Gapud EJ, Sleckman BP, Sullivan T, et al. 
100 
 
Novel roles for A-type lamins in telomere biology and the DNA damage response 
pathway. EMBO J 2009; 28:2414–27.  
88.  Raab M, Gentili M, Belly H De, Thiam H, Vargas P, Jimenez AJ, Lautenschlaeger 
F, Voituriez R, Manel N, Piel M. ESCRT III repairs nuclear envelope ruptures 
during cell migration to limit DNA damage and cell death. 2016; 352:359–63.  
89.  Denais CM, Gilbert RM, Isermann P, Mcgregor AL, Lindert M, Weigelin B, 
Davidson PM, Friedl P, Wolf K, Lammerding J. Nuclear envelope rupture and 
repair during cancer cell migration. 2016; 352.  
90.  Redwood AB, Perkins SM, Vanderwaal RP, Feng Z, Biehl KJ, Gonzalez-Suarez 
I, Morgado-Palacin L, Shi W, Sage J, Roti-Roti JL, et al. A dual role for A-type 
lamins in DNA double-strand break repair. Cell Cycle 2011; 10:2549–60.  
91.  Redwood AB, Gonzalez-Suarez I, Gonzalo S. Regulating the levels of key 
factors in cell cycle and DNA repair: New pathways revealed by lamins. Cell 
Cycle 2011; 10:3652–7.  
92.  Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang J, Li KM, Chau PY, 
Chen DJ, et al. Genomic instability in laminopathy-based premature aging. Nat 
Med 2005; 11:780–5.  
93.  Manju K, Muralikrishna B, Parnaik VK. Expression of disease-causing lamin A 
mutants impairs the formation of DNA repair foci. J Cell Sci 2006; 119:2704–14.  
94.  Varela I, Cadinanos J, Pendas AM, Gutierrez-Fernandez A, Folgueras AR, 
Sanchez LM, Zhou Z, Rodriguez FJ, Stewart CL, Vega JA, et al. Accelerated 
ageing in mice deficient in Zmpste24 protease is linked to p53 signalling 
activation. Nature 2005; 437:564–8.  
95.  Heessen S, Fornerod M. The inner nuclear envelope as a transcription factor 
resting place. EMBO Rep 2007; 8:914–9.  
96.  Ivorra C, Kubicek M, González JM, Sanz-González SM, Álvarez-Barrientos A, 
O’Connor J-EE, Burke B, Andrés V, Alvarez-Barrientos A, O’Connor J-EE, et al. 
A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. 
Genes Dev 2006; 20:307–20.  
97.  Gonzàlez JM, Navarro-Puche A, Casar B, Crespo P, Andrès V. Fast regulation 
of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the 
nuclear envelope. J Cell Biol 2008; 183:653–66.  
98.  Dreuillet C. In vivo and in vitro interaction between human transcription factor 
MOK2 and nuclear lamin A/C. Nucleic Acids Res 2002; 30:4634–42.  
99.  Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and 
SREBP1: implications for partial lipodystrophy and other laminopathies. Hum 
Mol Genet 2002; 11:769–77.  
100.  Capanni C, Mattioli E, Columbaro M, Lucarelli E, Parnaik VK, Novelli G, Wehnert 
M, Cenni V, Maraldi NM, Squarzoni S, et al. Altered pre-lamin A processing is a 
common mechanism leading to lipodystrophy. Hum Mol Genet 2005; 14:1489–
502.  
101.  Malhas AN, Lee CF, Vaux DJ. Lamin B1 controls oxidative stress responses via 
101 
 
Oct-1. J Cell Biol 2009; 184:45–55.  
102.  Markiewicz E, Tilgner K, Barker N, van de Wetering M, Clevers H, Dorobek M, 
Hausmanowa-Petrusewicz I, Ramaekers FCS, Broers JL V, Blankesteijn WM, et 
al. The inner nuclear membrane protein emerin regulates beta-catenin activity 
by restricting its accumulation in the nucleus. EMBO J 2006; 25:3275–85.  
103.  Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PCM, Costa T, 
Janssens K, Menten B, Van Roy N, Vermeulen SJT, et al. Loss-of-function 
mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and 
melorheostosis. Nat Genet 2004; 36:1213–8.  
104.  Martineau LC, Gardiner PF. Insight into skeletal muscle mechanotransduction: 
MAPK activation is quantitatively related to tension. J Appl Physiol 2001; 
91:693–702.  
105.  Ho CY, Jaalouk DE, Vartiainen MK, Lammerding J. Lamin A/C and emerin 
regulate MKL1-SRF activity by modulating actin dynamics. Nature 2013; 
497:507–11.  
106.  Emerson LJ, Holt MR, Wheeler MA, Wehnert M, Parsons M, Ellis JA. Defects in 
cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations. 
Biochim Biophys Acta - Mol Basis Dis 2009; 1792:810–21.  
107.  Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ. 
Activation of MAPK pathways links LMNA mutations to cardiomyopathy in 
Emery-Dreifuss muscular dystrophy . J Clin Invest 2007; 117:1282–93.  
108.  Muchir A, Wu W, Sera F, Homma S, Worman HJ. Mitogen-activated protein 
kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with 
cardiomyopathy caused by lamin A/C gene mutation. Biochem Biophys Res 
Commun 2014; 452:958–61.  
109.  Roskoski R. ERK1/2 MAP kinases: Structure, function, and regulation. 
Pharmacol Res 2012; 66:105–43.  
110.  Yang SH, Jung H-J, Coffinier C, Fong LG, Young SG. Are B-type lamins 
essential in all mammalian cells? Nucleus 2011; 2:562–9.  
111.  Coffinier C, Chang SY, Nobumori C, Tu Y, Farber EA, Toth JI, Fong LG, Young 
SG. Abnormal development of the cerebral cortex and cerebellum in the setting 
of lamin B2 deficiency. Proc Natl Acad Sci U S A 2010; 107:5076–81.  
112.  Szeverenyi I, Cassidy AJ, Cheuk WC, Lee BTK, Common JEA, Ogg SC, Chen 
H, Shu YS, Goh WLP, Kee WN, et al. The human intermediate filament 
database: Comprehensive information on a gene family involved in many human 
diseases. Hum Mutat 2008; 29:351–60.  
113.  Dittmer TA, Misteli T, Aaronson R, Blobel G, Gerace L, Blum A, Blobel G, 
McKeon F, Kirschner M, Caput D, et al. The lamin protein family. Genome Biol 
2011; 12:222.  
114.  Parnaik VK, Chaturvedi P, Muralikrishna B. Lamins, laminopathies and disease 
mechanisms: Possible role for proteasomal degradation of key regulatory 
proteins. J Biosci 2011; 36:471–9.  
102 
 
115.  Raffaele Di Barletta M, Ricci E, Galluzzi G, Tonali P, Mora M, Morandi L, 
Romorini A, Voit T, Orstavik KH, Merlini L, et al. Different mutations in the LMNA 
gene cause autosomal dominant and autosomal recessive Emery-Dreifuss 
muscular dystrophy. Am J Hum Genet 2000; 66:1407–12.  
116.  Muchir  a, Bonne G, van der Kooi  a J, van Meegen M, Baas F, Bolhuis P a, de 
Visser M, Schwartz K. Identification of mutations in the gene encoding lamins 
A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular 
conduction disturbances (LGMD1B). Hum Mol Genet 2000; 9:1453–9.  
117.  Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D’Apice MR, Massart C, 
Capon F, Sbraccia P, Federici M, Lauro R, et al. Mandibuloacral Dysplasia Is 
Caused by a Mutation in LMNA-Encoding Lamin A/C. Am J Hum Genet 2002; 
71:426–31.  
118.  Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, 
Schmidt H, Brabant G, Kumar S, Durrington PN, et al. LMNA, encoding lamin 
A/C, is mutated in partial lipodystrophy. Nat Genet 2000; 24:153–6.  
119.  Navarro CL, De Sandre-Giovannoli A, Bernard R, Boccaccio I, Boyer A, 
Geneviève D, Hadj-Rabia S, Gaudy-Marqueste C, Smitt HS, Vabres P, et al. 
Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and 
identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 
2004; 13:2493–503.  
120.  Renard D, Fourcade G, Milhaud D, Bessis D, Esteves-Vieira V, Boyer A, Roll P, 
Bourgeois P, Levy N, De Sandre-Giovannoli A. Novel LMNA mutation in atypical 
Werner syndrome presenting with ischemic disease. Stroke 2009; 40:e11-4.  
121.  Lopez-Mejia IC, Vautrot V, De Toledo M, Behm-Ansmant I, Bourgeois CF, 
Navarro CL, Osorio FG, Freije JMP, Stévenin J, De Sandre-Giovannoli A, et al. 
A conserved splicing mechanism of the LMNA gene controls premature aging. 
Hum Mol Genet 2011; 20:4540–55.  
122.  Garg A, Subramanyam L, Agarwal AK, Simha V, Levine B, D’Apice MR, Novelli 
G, Crow Y. Atypical Progeroid Syndrome due to Heterozygous Missense LMNA 
Mutations. J Clin Endocrinol Metab 2009; 94:4971–83.  
123.  Luo D-Q, Wang X-Z, Meng Y, He D-Y, Chen Y-M, Ke Z-Y, Yan M, Huang Y, 
Chen D-F. Mandibuloacral dysplasia type A-associated progeria caused by 
homozygous LMNA mutation in a family from Southern China. BMC Pediatr 
2014; 14:256.  
124.  Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y, Botha 
EG, Garg A, Hanson NB, Martin GM, et al. LMNA mutations in atypical Werner’s 
syndrome. Lancet 2003; 362:440–5.  
125.  Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, 
Robbins CM, Moses TY, Berglund P, et al. Recurrent de novo point mutations in 
lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003; 423:293–8.  
126.  Ben Yaou R, Navarro C, Quijano-Roy S, Bertrand AT, Massart C, De Sandre-
Giovannoli A, Cadiñanos J, Mamchaoui K, Butler-Browne G, Estournet B, et al. 
Type B mandibuloacral dysplasia with congenital myopathy due to homozygous 
ZMPSTE24 missense mutation. Eur J Hum Genet 2011; 19:647–54.  
103 
 
127.  Moulson CL, Go G, Gardner JM, van der Wal AC, Smitt JHS, van Hagen JM, 
Miner JH. Homozygous and compound heterozygous mutations in ZMPSTE24 
cause the laminopathy restrictive dermopathy. J Invest Dermatol 2005; 125:913–
9.  
128.  Peinado JR, Quirós PM, Pulido MR, Mariño G, Martínez-Chantar ML, Vázquez-
Martínez R, Freije JMP, López-Otín C, Malagón MM. Proteomic profiling of 
adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature 
aging, reveals major changes in mitochondrial function and vimentin processing. 
Mol Cell Proteomics 2011; 10:M111.008094.  
129.  Barrowman J, Wiley PA, Hudon-Miller SE, Hrycyna CA, Michaelis S. Human 
ZMPSTE24 disease mutations: Residual proteolytic activity correlates with 
disease severity. Hum Mol Genet 2012; 21:4084–93.  
130.  Denecke J, Brune T, Feldhaus T, Robenek H, Kranz C, Auchus RJ, Agarwal AK, 
Marquardt T. A homozygous ZMPSTE24 null mutation in combination with a 
heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria 
syndrome (HGPS): insights into the pathophysiology of HGPS. Hum Mutat 2006; 
27:524–31.  
131.  Simha V, Garg A. Body fat distribution and metabolic derangements in patients 
with familial partial lipodystrophy associated with mandibuloacral dysplasia. J 
Clin Endocrinol Metab 2002; 87:776–85.  
132.  Azibani F, Muchir A, Vignier N, Bonne G, Bertrand AT. Striated muscle 
laminopathies. Semin Cell Dev Biol 2014; 29:107–15.  
133.  Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, 
Zhavoronkov A. Signaling pathway activation drift during aging: Hutchinson-
Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and 
old-age cells. Aging (Albany NY) 2015; 7:26–37.  
134.  Carrero D, Soria-valles C, Lo C. Hallmarks of progeroid syndromes : lessons 
from mice and reprogrammed cells. 2016; :719–35.  
135.  Favreau C, Higuet D, Courvalin J-C, Buendia B. Expression of a Mutant Lamin 
A That Causes Emery-Dreifuss Muscular Dystrophy Inhibits In Vitro 
Differentiation of C2C12 Myoblasts. Mol Cell Biol 2004; 24:1481–92.  
136.  Plasilova M, Chattopadhyay C, Ghosh A, Wenzel F, Demougin P, Noppen C, 
Schaub N, Szinnai G, Terracciano L, Heinimann K. Discordant gene expression 
signatures and related phenotypic differences in lamin A- and A/C-related 
Hutchinson-Gilford progeria syndrome (HGPS). PLoS One 2011; 6:e21433.  
137.  Yu K-R, Lee S, Jung J-W, Hong I-S, Kim H-S, Seo Y, Shin T-H, Kang K-S. 
MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by 
directly targeting ZMPSTE24. J Cell Sci 2013;  
138.  Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS. 
Rapamycin reverses cellular phenotypes and enhances mutant protein 
clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 2011; 
3:89ra58.  
139.  Taylor MRG, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di 
104 
 
Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, et al. Natural history of 
dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 
2003; 41:771–80.  
140.  Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated 
and hypertrophic cardiomyopathy. A population-based study in Olmsted County, 
Minnesota, 1975-1984. Circulation 1989; 80:564–72.  
141.  Diane F, Calum M, Takeshi S, R. WM, Maurizio P, Michael F, John A, Jr. VHJ, 
Serena S, Umberto DG, et al. Missense Mutations in the Rod Domain of the 
Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System 
Disease. N Engl J Med 1999; 341:1715–24.  
142.  Lu JT, Muchir A, Nagy PL, Worman HJ. LMNA cardiomyopathy: cell biology and 
genetics meet clinical medicine. Dis Model Mech 2011; 4:562–8.  
143.  van Engelen BGM, Muchir  a, Hutchison CJ, van der Kooi  a J, Bonne G, 
Lammens M. The lethal phenotype of a homozygous nonsense mutation in the 
lamin A/C gene. Neurology 2005; 64:374–6.  
144.  Sullivan T, Escalante-Alcalde D, Bhatt H, Anver M, Bhat N, Nagashima K, 
Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear 
envelope integrity leading to muscular dystrophy. J Cell Biol 1999; 147:913–9.  
145.  Wolf CM, Wang L, Alcalai R, Pizard A, Burgon PG, Ahmad F, Sherwood M, 
Branco DM, Wakimoto H, Fishman GI, et al. Lamin A/C haploinsufficiency 
causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction 
system disease. J Mol Cell Cardiol 2008; 44:293–303.  
146.  Krimm I, Östlund C, Gilquin B, Couprie J, Hossenlopp P, Mornon JP, Bonne G, 
Courvalin JC, Worman HJ, Zinn-Justin S. The Ig-like structure of the C-terminal 
domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and 
partial lipodystrophy. Structure 2002; 10:811–23.  
147.  Camozzi D, D’Apice MR, Schena E, Cenni V, Columbaro M, Capanni C, Maraldi 
NM, Squarzoni S, Ortolani M, Novelli G, et al. Altered chromatin organization 
and SUN2 localization in mandibuloacral dysplasia are rescued by drug 
treatment. Histochem Cell Biol 2012; 138:643–51.  
148.  Tu Y, Sánchez-iglesias S, Araújo-vilar D, Fong LG, Young SG, Tu Y, Sánchez-
iglesias S, Araújo-vilar D, Loren G. LMNA missense mutations causing familial 
partial lipodystrophy do not lead to an accumulation of prelamin A. Nucleus 2016; 
7:512–21.  
149.  Cao K, Capell BC, Erdos MR, Djabali K, Collins FS. A lamin A protein isoform 
overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis 
in progeria and normal cells. Proc Natl Acad Sci 2007; 104:4949–54.  
150.  Pierard-Franchimont C, Pierard GE, Hermanns-Le T, Arrese Estrada J, Verloes 
A, Mulliez N. Dermatopathological aspects of restrictive dermopathy. J Pathol 
1992; 167:223–8.  
151.  Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, Meta M, Bendale P, 
Gelb MH, Young SG, et al. Blocking protein farnesyltransferase improves 
nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford 
105 
 
progeria syndrome mutation. Proc Natl Acad Sci U S A 2005; 102:10291–6.  
152.  Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. 
[Internet]. Science2006; 312:1059–63.  
153.  Cao K, Blair CD, Faddah DA, Kieckhaefer JE, Olive M, Erdos MR, Nabel EG, 
Collins FS. Progerin and telomere dysfunction collaborate to trigger cellular 
senescence in normal human fibroblasts. J Clin Invest 2011; 121:2833–44.  
154.  Yu K-R, Lee S, Jung J-W, Hong I-S, Kim H-S, Seo Y, Shin T -h., Kang K-S. 
MicroRNA-141-3p plays a role in human mesenchymal stem cell aging by 
directly targeting ZMPSTE24. J Cell Sci 2014; 127:475–475.  
155.  Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-
Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD, et al. Clinical trial 
of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria 
syndrome. Proc Natl Acad Sci U S A 2012; 109:16666–71.  
156.  Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, Cadiñanos J, 
Osorio FG, Foray N, Cobo J, et al. Combined treatment with statins and 
aminobisphosphonates extends longevity in a mouse model of human premature 
aging. Nat Med 2008; 14:767–72.  
157.  Konstantinopoulos PA, Papavassiliou AG. Multilevel modulation of the 
mevalonate and protein-prenylation circuitries as a novel strategy for anticancer 
therapy. Trends Pharmacol Sci 2007; 28:6–13.  
158.  Cenni V, Capanni C, Mattioli E, Columbaro M, Wehnert M, Ortolani M, Fini M, 
Novelli G, Bertacchini J, Maraldi NM, et al. Rapamycin treatment of 
Mandibuloacral Dysplasia cells rescues localization of chromatin-associated 
proteins and cell cycle dynamics. Aging (Albany NY) 2014; 6:755–70.  
159.  Gabriel D, Roedl D, Gordon LB, Djabali K. Sulforaphane enhances progerin 
clearance in Hutchinson-Gilford progeria fibroblasts. Aging Cell 2015; 14:78–91.  
160.  Egesipe A-L, Blondel S, Cicero A Lo, Jaskowiak A-L, Navarro C, Sandre-
Giovannoli A De, Levy N, Peschanski M, Nissan X. Metformin decreases 
progerin expression and alleviates pathological defects of Hutchinson–Gilford 
progeria syndrome cells. npj Aging Mech Dis 2016; 2:16026.  
161.  Liu B, Ghosh S, Yang X, Zheng H, Liu X, Wang Z, Jin G, Zheng B, Kennedy BK, 
Suh Y, et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and 
alleviates progeroid features in laminopathy-based progeria. Cell Metab 2012; 
16:738–50.  
162.  Ghosh S, Liu B, Zhou Z. Resveratrol activates SIRT1 in a Lamin A-dependent 
manner. Cell Cycle 2013; 12:872–6.  
163.  Hutchison CA. DNA sequencing: Bench to bedside and beyond. Nucleic Acids 
Res 2007; 35:6227–37.  
164.  Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008; 
26:1135–45.  
165.  Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet 
2010; 11:31–46.  
106 
 
166.  Lee H, Gurtowski J, Yoo S, Nattestad M, Marcus S, Goodwin S, McCombie WR, 
Schatz M. Third-generation sequencing and the future of genomics. bioRxiv 
2016; :48603.  
167.  Abdallah C, Dumas-Gaudot E, Renaut J, Sergeant K. Gel-based and gel-free 
quantitative proteomics approaches at a glance. Int J Plant Genomics 2012; 
2012:494572.  
168.  Chandramouli K, Qian P-Y. Proteomics: challenges, techniques and possibilities 
to overcome biological sample complexity. Hum Genomics Proteomics 2009; 
2009:22.  
169.  Li Z, Adams RM, Chourey K, Hurst GB, Hettich RL, Pan C. Systematic 
comparison of label-free, metabolic labeling, and isobaric chemical labeling for 
quantitative proteomics on LTQ orbitrap velos. J Proteome Res 2012; 11:1582–
90.  
170.  Jensen ON. Modification-specific proteomics: characterization of post-
translational modifications by mass spectrometry. Curr Opin Chem Biol 2004; 
8:33–41.  
171.  Boisvert F-M, Lam YW, Lamont D, Lamond AI. A quantitative proteomics 
analysis of subcellular proteome localization and changes induced by DNA 
damage. Mol Cell Proteomics 2010; 9:457–70.  
172.  Boisvert F-M, Ahmad Y, Gierliński M, Charrière F, Lamont D, Scott M, Barton G, 
Lamond AI. A quantitative spatial proteomics analysis of proteome turnover in 
human cells. Mol Cell Proteomics 2012; 11:M111.011429.  
173.  Lodish H, Berk A, Kaiser CA, Krieger M, Bretscher A, Ploegh H, Amon A, Scott 
MP, Martin K. Molecular cell biology [Internet]. 2016.  
174.  Thorn K. A quick guide to light microscopy in cell biology. Mol Biol Cell 2016; 
27:219–22.  
175.  Fernández-Suárez M, Ting AY. Fluorescent probes for super-resolution imaging 
in living cells. Nat Rev Mol Cell Biol 2008; 9:929–43.  
176.  Renz M. Fluorescence microscopy-A historical and technical perspective. Cytom 
Part A 2013; 83:767–79.  
177.  Wang E, Babbey CM, Dunn KW. Performance comparison between the high-
speed Yokogawa spinning disc confocal system and single-point scanning 
confocal systems. J Microsc 2005; 218:148–59.  
178.  Wollman R, Stuurman N. High throughput microscopy: from raw images to 
discoveries. J Cell Sci 2007; 120:3715–22.  
179.  Pepperkok R, Ellenberg J. High-throughput fluorescence microscopy for 
systems biology. Nat Rev Mol Cell Biol 2006; 7:690–6.  
180.  Rimon N, Schuldiner M. Getting the whole picture: combining throughput with 
content in microscopy. J Cell Sci 2011; 124:3743–51.  
181.  Roukos V, Misteli T. Deep Imaging: The next frontier in microscopy. Histochem 
Cell Biol 2014; 142:125–31.  
107 
 
182.  Klein K, Gigler AM, Aschenbrenner T, Monetti R, Bunk W, Jamitzky F, Morfill G, 
Stark RW, Schlegel J. Label-free live-cell imaging with confocal Raman 
microscopy. Biophys J 2012; 102:360–8.  
183.  Wegner KD, Hildebrandt N. Quantum dots: bright and versatile in vitro and in 
vivo fluorescence imaging biosensors. Chem Soc Rev 2015; 44:4792–834.  
184.  Schie IWW, Huser T. Methods and Applications of Raman Microspectroscopy to 
Single-Cell Analysis. Appl Spectrosc  2013; 67:813–28.  
185.  Raman C V., Krishnan KS. A new class of spectra due to secundary radiation. 
Indian J Phys 1928; 2:399–419.  
186.  Kano H, Segawa H, Leproux P, Couderc V. Linear and nonlinear Raman 
microspectroscopy: History, instrumentation, and applications. Opt Rev 2014; 
21:752–61.  
187.  Hedegaard M, Matthäus C, Hassing S, Krafft C, Popp J. Spectral unmixing and 
clustering algorithms for assessment of single cells by Raman microscopic 
imaging. 2011; 130:1249–60.  
188.  Kong K, Kendall C, Stone N, Notingher I. Raman spectroscopy for medical 
diagnostics - From in-vitro biofluid assays to in-vivo cancer detection. Adv Drug 
Deliv Rev 2015; 89:121–34.  
189.  Marro M, Nieva C, Sanz-Pamplona R, Sierra  a. Molecular monitoring of 
epithelial-to-mesenchymal transition in breast cancer cells by means of Raman 
spectroscopy. Biochim Biophys Acta - Mol Cell Res 2014; 1843:1785–95.  
190.  Neugebauer U, Bocklitz T, Clement JH, Krafft C, Popp J. Towards detection and 
identification of circulating tumour cells using Raman spectroscopy. Analyst 
2010; 135:3178–82.  
191.  Tolstik T, Marquardt C, Matthäus C, Bergner N, Bielecki C, Krafft C, Stallmach  
a., Popp J. Discrimination and classification of liver cancer cells and proliferation 
states by Raman spectroscopic imaging. Analyst 2014; 139:6036–43.  
192.  Beleites C, Neugebauer U, Bocklitz T, Krafft C, Popp J. Sample size planning for 
classification models. Anal Chim Acta 2013; 760:25–33.  
193.  Konorov SO, Jardon M a, Piret JM, Blades MW, Turner RFB. Raman 
microspectroscopy of live cells under autophagy-inducing conditions. Analyst 
2012; 137:4662–8.  
194.  Czamara K, Majzner K, Selmi A, Baranska M, Ozaki Y, Kaczor A. Unsaturated 
lipid bodies as a hallmark of inflammation studied by Raman 2D and 3D 
microscopy. Sci Rep 2017; 7:40889.  
195.  Liu P-Q, Tan S, Mendel MC, Murrills RJ, Bhat BM, Schlag B, Samuel R, Matteo 
JJ, de la Rosa R, Howes K, et al. Isogenic Human Cell Lines for Drug Discovery: 
Regulation of Target Gene Expression by Engineered Zinc-Finger Protein 
Transcription Factors. J Biomol Screen 2005; 10:304–13.  
196.  Burkhardt AM, Zlotnik A. Translating translational research: mouse models of 
human disease. Cell Mol Immunol 2013; 10:373–4.  
197.  Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials 
108 
 
in cancer treatment. Am J Transl Res 2014; 6:114–8.  
198.  Candelario J, Borrego S, Reddy S, Comai L. Accumulation of distinct prelamin A 
variants in human diploid fibroblasts differentially affects cell homeostasis. Exp 
Cell Res 2011; 317:319–29.  
199.  Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, 
Gruenbaum Y, Khuon S, Mendez M, Varga R, et al. Accumulation of mutant 
lamin A causes progressive changes in nuclear architecture in Hutchinson–
Gilford progeria syndrome. Proc Natl Acad Sci U S A 2004; 101:8963–8.  
200.  Navarro CL, Cadiñanos J, Sandre-Giovannoli A De, Bernard R, Courrier S, 
Boccaccio I, Boyer A, Kleijer WJ, Wagner A, Giuliano F, et al. Loss of ZMPSTE24 
(FACE-1) causes autosomal recessive restrictive dermopathy and accumulation 
of Lamin A precursors. Hum Mol Genet 2005; 14:1503–13.  
201.  Malhas AN, Vaux DJ. The nuclear envelope and its involvement in cellular stress 
responses. Biochem Soc Trans 2011; 39:1795–8.  
202.  Barascu A, Le Chalony C, Pennarun G, Genet D, Zaarour N, Bertrand P. 
Oxydative stress alters nuclear shape through lamins dysregulation: a route to 
senescence. Nucleus 2012; 3:411–7.  
203.  Lattanzi G, Marmiroli S, Facchini A, Maraldi NM. Nuclear damages and oxidative 
stress: new perspectives for laminopathies. Eur J Histochem 2012; 56:e45.  
204.  Caron M, Auclair M, Donadille B, Béréziat V, Guerci B, Laville M, Narbonne H, 
Bodemer C, Lascols O, Capeau J, et al. Human lipodystrophies linked to 
mutations in A-type lamins and to HIV protease inhibitor therapy are both 
associated with prelamin A accumulation, oxidative stress and premature cellular 
senescence. Cell Death Differ 2007; 14:1759–67.  
205.  Rivera-Torres J, Acín-Perez R, Cabezas-Sánchez P, Osorio FG, Gonzalez-
Gómez C, Megias D, Cámara C, López-Otín C, Enríquez JA, Luque-García JL, 
et al. Identification of Mitochondrial Dysfunction in Hutchinson-Gilford Progeria 
Syndrome Through Use of Stable Isotope Labelling with Amino Acids in Cell 
Culture. J Proteomics 2013;  
206.  Lawless C, Wang C, Jurk D, Merz A, Zglinicki T Von, Passos JF. Quantitative 
assessment of markers for cell senescence. Exp Gerontol 2010; 45:772–8.  
207.  Muchir A, Van Engelen BG, Lammens M, Mislow JM, McNally E, Schwartz K, 
Bonne G. Nuclear envelope alterations in fibroblasts from LGMD1B patients 
carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C 
gene. Exp Cell Res 2003; 291:352–62.  
208.  Verstraeten VLRM, Broers JL V, van Steensel MAM, Zinn-Justin S, Ramaekers 
FCS, Steijlen PM, Kamps M, Kuijpers HJH, Merckx D, Smeets HJM, et al. 
Compound heterozygosity for mutations in LMNA causes a progeria syndrome 
without prelamin A accumulation. Hum Mol Genet 2006; 15:2509–22.  
209.  Zhang D, Cui Y, Niu L, Xu X, Tian K, Young CYF, Lou H, Yuan H. Regulation of 
SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R 
expression in docetaxel resistant prostate cancer cells. Eur J Cell Biol 2014; 
93:289–98.  
109 
 
210.  Broers JL, Machiels BM, van Eys GJ, Kuijpers HJ, Manders EM, van Driel R, 
Ramaekers FC. Dynamics of the nuclear lamina as monitored by GFP-tagged 
A-type lamins. [Internet]. J. Cell Sci.1999; 112 ( Pt 2:3463–75.  
211.  Goulbourne CN, Malhas AN, Vaux DJ. The induction of a nucleoplasmic 
reticulum by prelamin A accumulation requires CTP:phosphocholine 
cytidylyltransferase-α. J Cell Sci 2011; 124:4253–66.  
212.  Richards S a, Muter J, Ritchie P, Lattanzi G, Hutchison CJ. The accumulation of 
un-repairable DNA damage in laminopathy progeria fibroblasts is caused by 
ROS generation and is prevented by treatment with N-acetyl cysteine. Hum Mol 
Genet 2011; 20:3997–4004.  
213.  Pekovic V, Gibbs-Seymour I, Markiewicz E, Alzoghaibi F, Benham AM, Edwards 
R, Wenhert M, von Zglinicki T, Hutchison CJ. Conserved cysteine residues in 
the mammalian lamin A tail are essential for cellular responses to ROS 
generation. Aging Cell 2011; 10:1067–79.  
214.  Lattanzi G, Ortolani M, Columbaro M, Prencipe S, Mattioli E, Lanzarini C, Maraldi 
NM, Cenni V, Garagnani P, Salvioli S, et al. Lamins are rapamycin targets that 
impact human longevity: a study in centenarians. J Cell Sci 2014; 127:147–57.  
215.  Korshunov SS, Skulachev VP, Starkov A a. High protonic potential actuates a 
mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 
1997; 416:15–8.  
216.  Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 
552:335–44.  
217.  Maharjan S, Oku M, Tsuda M, Hoseki J, Sakai Y. Mitochondrial impairment 
triggers cytosolic oxidative stress and cell death following proteasome inhibition. 
Sci Rep 2014; 4:5896.  
218.  Muchir A, Massart C, van Engelen BG, Lammens M, Bonne G, Worman HJ. 
Proteasome-mediated degradation of integral inner nuclear membrane protein 
emerin in fibroblasts lacking A-type lamins. Biochem Biophys Res Commun 
2006; 351:1011–7.  
219.  Chen C-Y, Chi Y-H, Mutalif RA, Starost MF, Myers TG, Anderson SA, Stewart 
CL, Jeang K-T. Accumulation of the inner nuclear envelope protein Sun1 is 
pathogenic in progeric and dystrophic laminopathies. Cell 2012; 149:565–77.  
220.  Muralikrishna B, Chaturvedi P, Sinha K, Parnaik VK. Lamin misexpression 
upregulates three distinct ubiquitin ligase systems that degrade ATR kinase in 
HeLa cells. Mol Cell Biochem 2012; :1–10.  
221.  Osorio FG, Bárcena C, Soria-Valles C, Ramsay AJ, de Carlos F, Cobo J, Fueyo 
A, Freije JMP, López-Otín C. Nuclear lamina defects cause ATM-dependent NF-
κB activation and link accelerated aging to a systemic inflammatory response. 
Genes Dev 2012; 26:2311–24.  
222.  Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo 
W, Chicas A, Lee CS, et al. Control of the senescence-associated secretory 
phenotype by NF-κB promotes senescence and enhances chemosensitivity. 
Genes Dev 2011; 25:2125–36.  
110 
 
223.  Kojima H, Kunimoto H, Inoue T, Nakajima K. The STAT3-IGFBP5 axis is critical 
for IL-6/gp130-induced premature senescence in human fibroblasts. Cell Cycle 
2012; 11:730–9.  
224.  Sahin Umut U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, Niwa-
Kawakita M, Faklaris O, Setterblad N, de Thé H, et al. Oxidative stress-induced 
assembly of PML nuclear bodies controls sumoylation of partner proteins. J Cell 
Biol 2014; 204:931–45.  
225.  Guo S, Cheng X, Lim J-H, Liu Y, Kao H-Y. Control of antioxidative response by 
the tumor suppressor protein PML through regulating Nrf2 activity. Mol Biol Cell 
2014; 25:2485–98.  
226.  Giovannini C, Matarrese P, Scazzocchio B, Sanchez M, Masella R, Malorni W. 
Mitochondria hyperpolarization is an early event in oxidized low-density 
lipoprotein-induced apoptosis in Caco-2 intestinal cells. FEBS Lett 2002; 
523:200–6.  
227.  Nagy G, Koncz A, Perl A. T Cell Activation-Induced Mitochondrial 
Hyperpolarization Is Mediated by Ca(2+)- and Redox-Dependent Production of 
Nitric Oxide(). J Immunol 2003; 171:5188–97.  
228.  Liu J, Yin X, Liu B, Zheng H, Zhou G, Gong L, Li M, Li X, Wang Y, Hu J, et al. 
HP1α mediates defective heterochromatin repair and accelerates senescence in 
Zmpste24-deficient cells. Cell Cycle 2014; 13:1237–47.  
229.  Liu Y, Drozdov I, Shroff R, Beltran LE, Shanahan CM. Prelamin A accelerates 
vascular calcification via activation of the DNA damage response and 
senescence-associated secretory phenotype in vascular smooth muscle cells. 
Circ Res 2013; 112:e99-109.  
230.  Lu D, Lian H, Zhang X, Shao H, Huang L, Qin C, Zhang L. LMNA E82K Mutation 
Activates FAS and Mitochondrial Pathways of Apoptosis in Heart Tissue Specific 
Transgenic Mice. PLoS One 2010; 5:e15167.  
231.  Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and 
apoptosis: dueling or complementary cell fates? EMBO Rep 2014; 15:1139–53.  
232.  Chen QM, Liu J, Merrett JB. Apoptosis or senescence-like growth arrest: 
influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal 
human fibroblasts. Biochem J 2000; 347:543–51.  
233.  Bladier C, Wolvetang EJ. Response of a Primary Human Fibroblast Cell Line to 
H202 : Growth Arrest or Apoptosis ? Cell Growth Differ 1997; 8:589–98.  
234.  Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson S a. Influence of 
Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions 
Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate 
Decisions. Society 2003; 23:8576–85.  
235.  Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-
time quantitative PCR and the 2-ddCT method. Methods 2001; 25:402–8.  
236.  Dixit R, Cyr R. Cell damage and reactive oxygen species production induced by 
fluorescence microscopy: effect on mitosis and guidelines for non-invasive 
fluorescence microscopy. Plant J 2003; 36:280–90.  
111 
 
237.  Mukhopadhyay P, Rajesh M, Haskó G, Hawkins BJ, Madesh M, Pacher P. 
Simultaneous detection of apoptosis and mitochondrial superoxide production in 
live cells by flow cytometry and confocal microscopy. Nat Protoc 2007; 2:2295–
301.  
238.  Konietschke F, Hothorn LA, Brunner E. Rank-based multiple test procedures and 
simultaneous confidence intervals. Electron J Stat 2012; 6:738–59.  
239.  Wickham H. ggplot2: Elegant Graphics for Data Analysis. 1st ed. New York, NY: 
Springer New York; 2009.  
240.  Nitta RT, Jameson S a, Kudlow B a, Conlan L a, Kennedy BK. Stabilization of 
the retinoblastoma protein by A-type nuclear lamins is required for INK4A-
mediated cell cycle arrest. Mol Cell Biol 2006; 26:5360–72.  
241.  McCord RP, Nazario-Toole A, Zhang H, Chines PS, Zhan Y, Erdos MR, Collins 
FS, Dekker J, Cao K. Correlated alterations in genome organization, histone 
methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria 
syndrome. Genome Res 2013; 23:260–9.  
242.  Maraldi NM, Capanni C, Lattanzi G, Camozzi D, Facchini A, Manzoli FA. 
SREBP1 interaction with prelamin A forms: a pathogenic mechanism for 
lipodystrophic laminopathies. Adv Enzyme Regul 2008; 48:209–23.  
243.  Wang J, Robinson JF, O’Neil CH, Edwards JY, Williams CM, Huff MW, Pickering 
JG, Hegele RA. Ankyrin G overexpression in Hutchinson-Gilford progeria 
syndrome fibroblasts identified through biological filtering of expression profiles. 
J Hum Genet 2006; 51:934–42.  
244.  Mateos J, Landeira-Abia A, Fafián-Labora JA, Fernández-Pernas P, Lesende-
Rodríguez I, Fernández-Puente P, Fernández-Moreno M, Delmiro A, Martín MA, 
Blanco FJ, et al. iTRAQ-based analysis of progerin expression reveals 
mitochondrial dysfunction, reactive oxygen species accumulation and altered 
proteostasis. Stem Cell Res Ther 2015; 6:119.  
245.  Magagnotti C, Bachi A, Zerbini G, Fattore E, Fermo I, Riba M, Previtali SC, 
Ferrari M, Andolfo A, Benedetti S. Protein profiling reveals energy metabolism 
and cytoskeletal protein alterations in LMNA mutation carriers. Biochim Biophys 
Acta 2012; 1822:970–9.  
246.  Sieprath T, Corne TD, Nooteboom M, Grootaert C, Rajkovic A, Buysschaert B, 
Robijns J, Broers JL, Ramaekers FC, Koopman WJ, et al. Sustained 
accumulation of prelamin a and depletion of lamin A/C both cause oxidative 
stress and mitochondrial dysfunction but induce different cell fates. Nucleus 
2015; :1–11.  
247.  Argenzio E, Margadant C, Leyton-Puig D, Janssen H, Jalink K, Sonnenberg A, 
Moolenaar WH. CLIC4 regulates cell adhesion and beta1 integrin trafficking. J 
Cell Sci 2014; 127:5189–203.  
248.  Berryman MA, Goldenring JR. CLIC4 Is Enriched at Cell-Cell Junctions and 
Colocalizes With AKAP350 at the Centrosome and Midbody of Cultured 
Mammalian Cells. Cell Motil Cytoskeleton 2003; 56:159–72.  
249.  Dang I, Gorelik R, Sousa-Blin C, Derivery E, Guérin C, Linkner J, Nemethova M, 
112 
 
Dumortier JG, Giger FA, Chipysheva TA, et al. Inhibitory signalling to the Arp2/3 
complex steers cell migration. Nature 2013;  
250.  Hwang JH, Smith C a, Salhia B, Rutka JT. The role of fascin in the migration and 
invasiveness of malignant glioma cells. Neoplasia 2008; 10:149–59.  
251.  Kim DH, Wirtz D. Focal adhesion size uniquely predicts cell migration. FASEB J 
2013; 27:1351–61.  
252.  Snyder M, Huang XY, Zhang JJ. Signal Transducers and Activators of 
Transcription 3 (STAT3) directly regulates cytokine-induced fascin expression 
and is required for breast cancer cell migration. J Biol Chem 2011; 286:38886–
93.  
253.  Snyder M, Huang J, Huang X, Zhang JJ. A STAT3/NFkB Complex is Necessary 
for the Expression of Fascin in Metastatic Breast Cancer Cells in Response to 
IL-6 and TNF-a. 2014;  
254.  Debidda M, Wang L, Zang H, Poli V, Zheng Y. A role of STAT3 in Rho GTPase-
regulated cell migration and proliferation. J Biol Chem 2005; 280:17275–85.  
255.  Lin Z-Q, Kondo T, Ishida Y, Takayasu T, Mukaida N. Essential involvement of 
IL-6 in the skin wound-healing process as evidenced by delayed wound healing 
in IL-6-deficient mice. J Leukoc Biol 2003; 73:713–21.  
256.  Schratt G, Philippar U, Berger J, Schwarz H, Heidenreich O, Nordheim A. Serum 
response factor is crucial for actin cytoskeletal organization and focal adhesion 
assembly in embryonic stem cells. J Cell Biol 2002; 156:737–50.  
257.  Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a 
subset of SRF target genes that are MKL dependent. BMC Mol Biol 2004; 5:13.  
258.  Schwartz B, Marks M, Wittler L, Werber M, Währisch S, Nordheim A, Herrmann 
BG, Grote P. SRF is essential for mesodermal cell migration during elongation 
of the embryonic body axis. Mech Dev 2014; 133:23–35.  
259.  Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: 
nucleation, high affinity pointed end capping, and formation of branching 
networks of filaments. Proc Natl Acad Sci U S A 1998; 95:6181–6.  
260.  Chorev DS, Moscovitz O, Geiger B, Sharon M. Regulation of focal adhesion 
formation by a vinculin-Arp2/3 hybrid complex. Nat Commun 2014; 5:3758.  
261.  Elkhatib N, Neu MB, Zensen C, Schmoller KM, Louvard D, Bausch AR, Betz T, 
Vignjevic DM. Fascin plays a role in stress fiber organization and focal adhesion 
disassembly. Curr Biol 2014; 24:1492–9.  
262.  Bertrand AT, Ziaei S, Ehret C, Duchemin H, Mamchaoui K, Bigot A, Mayer M, 
Quijano-Roy S, Desguerre I, Lainé J, et al. Cellular microenvironments reveal 
defective mechanosensing responses and elevated YAP signaling in LMNA-
mutated muscle precursors. J Cell Sci 2014; 127:2873–84.  
263.  Hale CM, Shrestha AL, Khatau SB, Stewart-Hutchinson PJ, Hernandez L, 
Stewart CL, Hodzic D, Wirtz D. Dysfunctional connections between the nucleus 
and the actin and microtubule networks in laminopathic models. Biophys J 2008; 
95:5462–75.  
113 
 
264.  Lim STS. Nuclear FAK: A new mode of gene regulation from cellular adhesions. 
Mol Cells 2013; 36:1–6.  
265.  Soiné JRD, Brand CA, Stricker J, Oakes PW, Gardel ML, Schwarz US. Model-
based Traction Force Microscopy Reveals Differential Tension in Cellular Actin 
Bundles. PLoS Comput Biol 2015; 11:1–16.  
266.  Beningo KA, Dembo M, Kaverina I, Small JV, Wang YL. Nascent focal adhesions 
are responsible for the generation of strong propulsive forces in migrating 
fibroblasts. J Cell Biol 2001; 153:881–7.  
267.  Stricker J, Aratyn-Schaus Y, Oakes PW, Gardel ML. Spatiotemporal constraints 
on the force-dependent growth of focal adhesions. Biophys J 2011; 100:2883–
93.  
268.  Chancellor TJ, Lee J, Thodeti CK, Lele T. Actomyosin tension exerted on the 
nucleus through nesprin-1 connections influences endothelial cell adhesion, 
migration, and cyclic strain-induced reorientation. Biophys J 2010; 99:115–23.  
269.  Kuo J, Lin J, Staddon JM, Hosoya H, Chen R. Uncoordinated regulation of stress 
fibers and focal adhesions by DAP kinase. J Cell Sci 2003; 116:4777–90.  
270.  Houle F, Poirier A, Dumaresq J, Huot J. DAP kinase mediates the 
phosphorylation of tropomyosin-1 downstream of the ERK pathway, which 
regulates the formation of stress fibers in response to oxidative stress. JCell Sci 
2007; 120:3666–77.  
271.  Lee JSH, Hale CM, Panorchan P, Khatau SB, George JP, Tseng Y, Stewart CL, 
Hodzic D, Wirtz D. Nuclear lamin A/C deficiency induces defects in cell 
mechanics, polarization, and migration. Biophys J 2007; 93:2542–52.  
272.  Foster CR, Robson JL, Simon WJ, Twigg J, Cruikshank D, Wilson RG, Hutchison 
CJ. The role of Lamin A in cytoskeleton organization in colorectal cancer cells: a 
proteomic investigation. Nucleus 2011; 2:434–43.  
273.  Schaller MD. FAK and paxillin: Regulators of N-cadherin adhesion and inhibitors 
of cell migration? J Cell Biol 2004; 166:157–9.  
274.  Salgia R, Li J, Ewaniuk DS, Wang Y, Sattler M, Chen W, Richards W, Pisick E, 
Shapiro GI, Rollins BJ, et al. Expression of the focal adhesion protein paxillin in 
lung cancer and its relation to cell motility. 1999;  
275.  Mierke CT. The Role of Vinculin in the Regulation of the Mechanical Properties 
of Cells. Cell Biochem Biophys 2009; 53:115–26.  
276.  Houben F, Willems CHMP, Declercq ILJ, Hochstenbach K, Kamps MA, Snoeckx 
LHEH, Ramaekers FCS, Broers JL V. Disturbed nuclear orientation and cellular 
migration in A-type lamin deficient cells. Biochim Biophys Acta - Mol Cell Res 
2009; 1793:312–24.  
277.  Veith C, Marsh LM, Wygrecka M, Rutschmann K, Seeger W, Weissmann N, 
Kwapiszewska G. Paxillin Regulates Pulmonary Arterial Smooth Muscle Cell 
Function in Pulmonary Hypertension. Am J Pathol 2012; 181:1621–33.  
278.  Wade R, Bohl J, Vande Pol S. Paxillin null embryonic stem cells are impaired in 
cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 
114 
 
2002; 21:96–107.  
279.  Khatau SB, Bloom RJ, Bajpai S, Razafsky D, Zang S, Giri A, Wu P-H, Marchand 
J, Celedon A, Hale CM, et al. The distinct roles of the nucleus and nucleus-
cytoskeleton connections in three-dimensional cell migration. Sci Rep 2012; 
2:488.  
280.  Krause M, Wolf K. Cancer cell migration in 3d tissue: Negotiating space by 
proteolysis and nuclear deformability. Cell Adhes Migr 2015; 9:357–66.  
281.  Cox J, Mann M. MaxQuant enables high peptide identification rates, 
individualized p.p.b.-range mass accuracies and proteome-wide protein 
quantification. Nat Biotechnol 2008; 26:1367–72.  
282.  Perkins DN, Pappin DJC, Creasy DM, Cottrell JS. Probability-based protein 
identification by searching sequence databases using mass spectrometry data. 
Electrophoresis 1999; 20:3351–567.  
283.  Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER 
version 10: expanded protein families and functions, and analysis tools. Nucleic 
Acids Res 2016; 44:D336-42.  
284.  Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery 
and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 
2009; 10:48.  
285.  Jonkman JEN, Cathcart J a., Xu F, Bartolini ME, Amon JE, Stevens KM, 
Colarusso P. An introduction to the wound healing assay using live-cell 
microscopy. Cell Adh Migr 2015; 8:440–51.  
286.  Grevesse T, Versaevel M, Circelli G, Desprez S, Gabriele S. A simple route to 
functionalize polyacrylamide hydrogels for the independent tuning of 
mechanotransduction cues. Lab Chip 2013; 13:777–80.  
287.  Versaevel M, Grevesse T, Gabriele S. Spatial coordination between cell and 
nuclear shape within micropatterned endothelial cells. Nat Commun 2012; 3:671.  
288.  Walle E Van De, Nieuwenhove I Van, Vanderleyden E, Declercq H, Gellynck K, 
Schaubroeck D, Ottevaere H, Thienpont H, Vos WH De, Cornelissen M, et al. 
Polydopamine–Gelatin as Universal Cell-Interactive Coating for Methacrylate-
Based Medical Device Packaging Materials: When Surface Chemistry Overrules 
Substrate Bulk Properties. Biomacromolecules 2016; 17:56–68.  
289.  Hollander M, Wolfe DA. Nonparametric statistical methods [Internet]. Wiley; 
1973.  
290.  Schie IW, Huser T. Methods and Applications of Raman Microspectroscopy to 
Single-Cell Analysis. focal point Rev 2013; 67:993–6.  
291.  Krafft C, Knetschke T, Siegner A, Funk RHW, Salzer R. Mapping of single cells 
by near infrared Raman microspectroscopy. Vib Spectrosc 2003; 32:75–83.  
292.  Beleites C, Sergo V. hyperSpec: a package to handle hyperspectral data sets in 
R [Internet]. 2014;  
293.  Lim NSJ, Hamed Z, Yeow CH, Chan C, Huang Z. Early detection of biomolecular 
changes in disrupted porcine cartilage using polarized Raman spectroscopy. J 
115 
 
Biomed Opt 2011; 16:17003.  
294.  Gelder J De, Gussem K De, Vandenabeele P, Moens L. Reference database of 
Raman spectra of biological molecules. 2007; :1133–47.  
295.  Apice MRD, Licata N, Novelli G. Skeletal phenotype of mandibuloacral dysplasia 
associated with mutations in. Bone 2010; 47:591–7.  
296.  Ran FA, Hsu PPD, Wright J, Agarwala V, Scott D a, Zhang F. Genome 
engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8:2281–308.  
297.  Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE, Church GM. RNA-
Guided Human Genome. 2013; :823–7.  
298.  Zhang X-H, Tee LY, Wang X-G, Huang Q-S, Yang S-H. Off-target Effects in 
CRISPR/Cas9-mediated Genome Engineering. Mol Ther Nucleic Acids 2015; 
4:e264.  
299.  Landry JJM, Pyl PT, Rausch T, Zichner T, Tekkedil MM, Stütz AM, Jauch A, 
Aiyar RS, Pau G, Delhomme N, et al. The genomic and transcriptomic landscape 
of a HeLa cell line. G3 (Bethesda) 2013; 3:1213–24.  
300.  Tauchi-Sato K, Ozeki S, Houjou T, Taguchi R, Fujimoto T. The surface of lipid 
droplets is a phospholipid monolayer with a unique fatty acid composition. J Biol 
Chem 2002; 277:44507–12.  
301.  Fujimoto T, Parton RG. Not just fat: The structure and function of the lipid droplet. 
Cold Spring Harb Perspect Biol 2011; 3:1–17.  
302.  Cheng J, Fujita A, Ohsaki Y, Suzuki M, Shinohara Y, Fujimoto T. Quantitative 
electron microscopy shows uniform incorporation of triglycerides into existing 
lipid droplets. Histochem Cell Biol 2009; 132:281–91.  
303.  Listenberger LL, Han X, Lewis SE, Cases S, Farese R V, Ory DS, Schaffer JE. 
Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc 
Natl Acad Sci U S A 2003; 100:3077–82.  
304.  Krahmer N, Farese R V, Walther TC. Balancing the fat: lipid droplets and human 
disease. EMBO Mol Med 2013; 5:905–15.  
305.  Thiam AR, Farese R V, Walther TC. The biophysics and cell biology of lipid 
droplets. Nat Rev Mol Cell Biol 2013; 14:775–86.  
306.  Igal RA, Wang S, Gonzalez-Baró M, Coleman RA. Mitochondrial Glycerol 
Phosphate Acyltransferase Directs the Incorporation of Exogenous Fatty Acids 
into Triacylglycerol. J Biol Chem 2001; 276:42205–12.  
307.  Lindén D, William-Olsson L, Rhedin M, Asztély A-K, Clapham JC, Schreyer S. 
Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased 
fatty acid oxidation and increased glycerolipid biosynthesis. J Lipid Res 2004; 
45:1279–88.  
308.  Wilfling F, Wang H, Haas JT, Krahmer N, Gould TJ, Cheng J, Graham M, 
Christiano R, Fröhlich F, Buhman KK, et al. Growth by Relocalizing from the ER 
to Lipid Droplets. 2013; 24:384–99.  
309.  Cohen B-C, Shamay A, Argov-Argaman N. Regulation of lipid droplet size in 
116 
 
mammary epithelial cells by remodeling of membrane lipid composition-a 
potential mechanism. PLoS One 2015; 10:e0121645.  
310.  Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor ?? 
coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 
2006; 27:728–35.  
311.  Mormeneo E, Jimenez-Mallebrera C, Palomer X, de Nigris V, Vázquez-Carrera 
M, Orozco A, Nascimento A, Colomer J, Lerín C, Gómez-Foix AM. PGC-1?? 
induces mitochondrial and myokine transcriptional programs and lipid droplet 
and glycogen accumulation in cultured human skeletal muscle cells. PLoS One 
2012; 7.  
312.  Sánchez P, Infante A, Ruiz de Eguino G, Fuentes-Maestre J a., Manuel García-
Verdugo J, Rodríguez CI. Age-related lipid metabolic signature in human LMNA 
-lipodystrophic stem cell derived adipocytes. J Clin Endocrinol Metab 2015; 
:jc.2014-4528.  
313.  Mariño G, Ugalde AP, Salvador-Montoliu N, Varela I, Quirós PM, Cadiñanos J, 
van der Pluijm I, Freije JMP, López-Otín C. Premature aging in mice activates a 
systemic metabolic response involving autophagy induction. Hum Mol Genet 
2008; 17:2196–211.  
314.  Lopez-mejia IC, Toledo M De, Chavey C, Lapasset L, Cavelier P, Lopez-herrera 
C, Chebli K, Fort P, Beranger G, Fajas L, et al. Antagonistic functions of LMNA 
isoforms in energy expenditure and lifespan. 2014; :1–11.  
315.  Shackleton S, Smallwood DT, Clayton P, Wilson LC, Agarwal  a K, Garg  a, 
Trembath RC. Compound heterozygous ZMPSTE24 mutations reduce prelamin 
A processing and result in a severe progeroid phenotype. J Med Genet 2005; 
42:e36.  
316.  Agarwal  a. K, Fryns J-P, Auchus RJ, Garg A. Zinc metalloproteinase, 
ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 2003; 
12:1995–2001.  
317.  Ruiz de Eguino G, Infante A, Schlangen K, Aransay AM, Fullaondo A, Soriano 
M, Garcia-Verdugo JM, Martin AG, Rodriguez CI. Sp1 transcription factor 
interaction with accumulated prelamin a impairs adipose lineage differentiation 
in human mesenchymal stem cells: essential role of sp1 in the integrity of lipid 
vesicles. Stem Cells Transl Med 2012; 1:309–21.  
318.  Hernandez-Vallejo SJ, Beaupere C, Larghero J, Capeau J, Lagathu C. HIV 
protease inhibitors induce senescence and alter osteoblastic potential of human 
bone marrow mesenchymal stem cells: beneficial effect of pravastatin. Aging 
Cell 2013; :1–11.  
319.  Caron M, Auclair M, Sterlingot H, Kornprobst M, Capeau J. Some HIV protease 
inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization 
and adipocyte differentiation. AIDS 2003; 17:2437–44.  
320.  Meng Z, Petrov GI, Yakovlev V V. Pure electrical, highly-efficient and sidelobe 
free coherent Raman spectroscopy using acousto-optics tunable filter (AOTF). 
Sci Rep 2016; 6:20017.  
117 
 
321.  Inui M, Miyado M, Igarashi M, Tamano M, Kubo A, Yamashita S, Asahara H, 
Fukami M, Takada S. Rapid generation of mouse models with defined point 
mutations by the CRISPR /. 2014; :1–8.  
322.  Petrini S, Borghi R, Oria VD, Restaldi F, Moreno S, Novelli A, Bertini E, 
Compagnucci C. Aged induced pluripotent stem cell ( iPSCs ) as a new cellular 
model for studying premature aging. 2017; 9:1453–66.  
323.  Chen Z, Chang WY, Etheridge A, Strickfaden H, Jin Z, Palidwor G, Cho J, Wang 
K, Kwon SY, Dor C, et al. Reprogramming progeria fibroblasts re-establishes a 
normal epigenetic landscape. 2017; :1–18.  
324.  Sui H, Zhou M, Chen Q, Lane HC, Imamichi T. siRNA enhances DNA-mediated 
interferon lambda-1 response through crosstalk between RIG-I and IFI16 
signalling pathway. Nucleic Acids Res 2014; 42:583–98.  
325.  Olejniczak M, Galka P, Krzyzosiak WJ. Sequence-non-specific effects of RNA 
interference triggers and microRNA regulators. Nucleic Acids Res 2010; 38:1–
16.  
326.  Jackson AL, Linsley PS. Recognizing and avoiding siRNA off-target effects for 
target identification and therapeutic application. Nat Rev Drug Discov 2010; 
9:57–67.  
327.  Cao J, Wu L, Zhang S, Lu M, Cheung WKC, Cai W, Gale M, Xu Q, Yan Q. An 
easy and efficient inducible CRISPR / Cas9 platform with improved specificity for 
multiple gene targeting. 2016; 44:1–10.  
328.  Verstraeten VLRM, Caputo S, Steensel MAM Van, Duband-goulet I, Zinn-justin 
S, Kamps M, Kuijpers HJH, Ostlund C, Worman HJ, Briedé JJ, et al. The R439C 
mutation in LMNA causes lamin oligomerization and susceptibility to oxidative 
stress. 2009; 13:959–71.  
329.  Christie D a, Lemke CD, Elias IM, Chau L a, Kirchhof MG, Li B, Ball EH, Dunn 
SD, Hatch GM, Madrenas J. Stomatin-like protein 2 binds cardiolipin and 
regulates mitochondrial biogenesis and function. Mol Cell Biol 2011; 31:3845–
56.  
330.  Choi JC, Muchir A, Wu W, Iwata S, Homma S, Morrow JP, Worman HJ. 
Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by 
Lamin A/C Gene Mutation. Sci Transl Med 2012; 4:144ra102-144ra102.  
331.  Marushige Y, Marushige K. Alterations in focal adhesion and cytoskeletal 
proteins during apoptosis. Anticancer Res 1998; 18:301—307.  
332.  Shim SR, Kook S, Kim JI, Song WK. Degradation of focal adhesion proteins 
paxillin and p130cas by caspases or calpains in apoptotic rat-1 and L929 cells. 
Biochem Biophys Res Commun 2001; 286:601–8.  
333.  Zhu X, Ohtsubo M, Bhmer RM, Roberts JM, Assoian RK. Adhesion-dependent 
Cell Cycle Progression Linked to the Expression of Cyclin D1, Activation of 
Cyclin E-cdk2, and Phosphorylation of the Retinoblastoma Protein. 1996; 
133:391–403.  
334.  Kang HT, Park JT, Choi K, Choi HJC, Jung CW, Kim GR, Lee YS, Park SC. 
Chemical screening identifies ROCK as a target for recovering mitochondrial 
118 
 
function in Hutchinson-Gilford progeria syndrome. Aging Cell 2017; :541–50.  
335.  Xiong Z-M, Choi JY, Wang K, Zhang H, Tariq Z, Wu D, Ko E, LaDana C, Sesaki 
H, Cao K. Methylene blue alleviates nuclear and mitochondrial abnormalities in 
progeria. Aging Cell 2015; :n/a-n/a.  
336.  Willer MK, Carroll CW. Substrate stiffness-dependent regulation of SRF/Mkl1 
requires the inner nuclear membrane protein Emerin. J Cell Sci 2017;  
337.  Vaughan O a, Alvarez-Reyes M, Bridger JM, Broers JL, Ramaekers FC, 
Wehnert M, Morris GE, WGF W, Hutchison CJ. Both emerin and lamin C depend 
on lamin A for localization at the nuclear envelope. [Internet]. J. Cell Sci.2001; 
114:2577–90.  
338.  Ramachandran C, Patil R V, Combrink K, Sharif NA, Srinivas SP. Rho-Rho 
kinase pathway in the actomyosin contraction and cell-matrix adhesion in 
immortalized human trabecular meshwork cells. Mol Vis 2011; 17:1877–90.  
339.  Herms A, Bosch M, Reddy BJN, Schieber NL, Fajardo A, Rupérez C, Fernández-
Vidal A, Ferguson C, Rentero C, Tebar F, et al. AMPK activation promotes lipid 
droplet dispersion on detyrosinated microtubules to increase mitochondrial fatty 
acid oxidation. Nat Commun 2015; 6:7176.  
340.  Li J, Cheng J-X. Direct Visualization of De novo Lipogenesis in Single Living 
Cells. Sci Rep 2014; 4:6807.  
341.  Frock RL, Chen SC, Da DF, Frett E, Lau C, Brown C, Pak DN, Wang Y, Muchir 
A, Worman HJ, et al. Cardiomyocyte-specific expression of lamin A improves 
cardiac function in Lmna-/- mice. PLoS One 2012; 7.  
342.  Pampaloni F, Reynaud EG, Stelzer EHK. The third dimension bridges the gap 
between cell culture and live tissue. Nat Rev Mol Cell Biol 2007; 8:839–45.  
343.  Frade MAC, de Andrade TAM, Aguiar AFCL, Guedes FA, Leite MN, Passos WR, 
Coelho EB, Das PK. Prolonged viability of human organotypic skin explant in 
culture method (hOSEC). An Bras Dermatol 2015; 90:347–50.  
344.  Fraley SI, Feng Y, Krishnamurthy R, Kim D, Celedon A, Longmore GD, Wirtz D, 
Louis S. A distinctive role for focal adhesion proteins in three-dimensional cell 
motility. Nat Cell Biol 2010; 12:598–604.  
 
  
  
  
  
Ir. Ing. Tobias Corne 
 
Wijnbergstraat 52  
8560 Wevelgem, Belgium  
Phone: +32484159829  
Email: tobi.corne@gmail.com  
Last updated April, 2017 
 
WORKING EXPERIENCE 
PROFESSIONAL EXPERIENCE 
2016-Present Innovation engineer at CREAX, Kortrijk. 
2012-Present  PhD Student in Applied Biological Sciences, Cell and Gene 
Biotechnology at Cell Systems & Imaging, Department Molecular 
Biotechnology, Ghent University and the University of Antwerp 
(Joint PhD). 
INTERNSHIP EXPERIENCE 
March 2014  Working visit to learn data analysis of confocal Raman datasets in 
the laboratory of Prof. Christophe Krafft at the Institute of 
Photonic Technology (IPHT), Jena, Germany. 
September 2013  Working visit to enhance expertise in confocal Raman 
microspectroscopy with  Prof. Andre Skirtach at the Max Planck 
institute of Colloids and Interfaces, Potsdam, Germany. 
 
2011-2012 Master thesis “Structurele en functionele analyse van telomeer-
lamine interacties.” At Ghent University, faculty of Bioscience 
Engineering, Department of Molecular Biotechnology, Gent, 
Belgium. 
 
2010 Performance  of  cytotoxicity  assays  in  the  context  of  the  master  
thesis “Implementatie van in vitro methoden voor het bepalen van 
de carcinogene eigenschappen van vleeswaren.” At 
University College West-Vlaanderen, Department Simon 
Stevin, Brugge, Belgium. 
 
2009-2010 Performance of Ames tests in the context of the master thesis 
“Implementatie van in vitro methoden voor het bepalen van de 
carcinogene eigenschappen van vleeswaren.” At University 
College West-Vlaanderen, Campus Graaf Karel de Goedelaan, 
Kortrijk, Belgium. 
 
2009 Implementation of in vitro meat digestion in the context of the 
master thesis “Implementatie van in vitro methoden voor het 
bepalen van de carcinogene eigenschappen van vleeswaren.” At 
  
Ghent University, Department of Animal Production, Laboratory for 
Animal Nutrition and Animal Product Quality, Melle, Belgium. 
TEACHING EXPERIENCE 
2015-Present Tutor of Frederick Tison. Master thesis entitled “Moleculaire 
karakterisatie van ZMPSTE24 deficiënte cellen met Raman 
microspectroscopie”. 
 
October 2015 Demo  practicum  Cell  Biology  Course  3rd  Bachelor  Bioscience  
engineering, “Introduction to confocal microscopy”. 
February 2015 BVLT Molecular Biology and Cytometry Course, “Basic 
microscopy and image processing.” at University College of Karel 
De Grote, Campus of Industrial Science and Technology, 
Hoboken, Belgium. 
2014-2015 Tutor of Niels De Brandt. Master thesis entitled “Moleculaire 
karakterisatie van laminopathie modelcellen”. 
May 2013 BVAC Molecular Biology and Cytometry Course, “Introduction 
to advanced proteomics.” At SCK-CEN, Mol, Belgium. 
October 2013 Demo  practicum  Cell  Biology  Course  3rd  Bachelor  Bioscience  
engineering, “Introduction to confocal microscopy”. 
 
EDUCATION  
2012-Present Ghent University and University of Antwerp (Joint PhD), Doctor of 
Applied Biological Sciences. 
2010-2012 Ghent University, Master of Science in Bioscience Engineering, 
Cell and Gene Biotechnology. Thesis: “Structurele en 
functionele analyse van telomeer-lamine interacties.” 
 *Optional course “Biopharmacy of Biotechnological Drugs”, 
lectured by Prof. Dr. Stefaan De Smedt. 
2006-2010 University  College  West-Vlaanderen,  Master  of  Science  in  
Biochemical Engineering Technology. Thesis: “Implementatie 
van in vitro methoden voor het bepalen van de carcinogene 
eigenschappen van vleeswaren.” 
 
SPECIALIST COURSES  
November 2012 “Mass spectrometry data processing”, VIB Bioinformatics Training 
& Service Facility (BITS), Gent, Belgium. 
October 2012 “Introduction to Linux for bioinformatics”, VIB Bioinformatics 
Training & Service Facility (BITS), Gent, Belgium. 
 
 
  
CONGRESS PARTICIPATION 
1. T. Corne, T. Sieprath and W. De Vos (2013). MIMICKING LAMINOPATHIES 
WITH MODEL CELL LINES. In The BSCDB Autumn Meeting, Abstracts. Liège, 
Belgium. [Poster] 
 
2. T. Corne, P. Wuytens, C. Beleites, A. Skirtach and W. De Vos (2014). 
IDENTIFICATION OF SUBCELLULAR STRUCTURES WITH RAMAN 
MICROSPECTROSCOPY. In BioImage Informatics, Abstracts. The BioImage 
Informatics communication network. Leuven, Belgium. [Poster] 
 
3. T. Corne, T. Sieprath, J. Vandenbussche, K. Gevaert and W. De Vos (2014). 
QUANTITATIVE PROTEOMICS REVEALS DIFFERENTIAL EFFECTS OF 
ZMPSTE24 AND LMNA KNOCKDOWN ON HUMAN FIBROBLASTS. In 
Systems-Level View of Cytoskeletal Function, EMBO workshop, Abstracts. 
Stockholm, Sweden. [Poster] 
 
4. T. Sieprath, T. Corne, W.J. Koopman, P.H. Willems and W. De Vos (2014). 
CHEMICALLY AND GENETICALLY INDUCED ACCUMULATION OF 
FARNESYLATED PRELAMIN A DIFFERENTIALLY AFFECT OXIDATIVE 
STRESS AND MITOCHONDRIAL POTENTIAL. In Systems-Level View of 
Cytoskeletal Function, EMBO workshop, Abstracts. Stockholm, Sweden. 
[Poster] 
 
 
5. T. Sieprath, T. Corne, W.J. Koopman, P.H. Willems and W. De Vos (2014). 
HIGH-CONTENT ANALYSIS OF CELLULAR OXIDATIVE STRESS. In 
BioImage Informatics, Abstracts. In BioImage Informatics, Abstracts. The 
BioImage Informatics communication network. Leuven, Belgium. [Poster] 
 
 
6. T. Corne, T. Sieprath, J. Vandenbussche, K. Gevaert and W. De Vos (2015). 
QUANTITATIVE PROTEOMICS  REVEALS ALTERED EXPRESSION OF  
ACTIN  BINDING  PROTEINS AFTER LMNA KNOCKDOWN IN HUMAN 
DERMAL FIBROBLASTS. In Nuclear structure and dynamics, EMBO 
conference, Abstracts. Isle sur Sorgue, France. [Poster] 
 
7. T. Corne, T. Sieprath, J. Vandenbussche, K. Gevaert, M. Kea-te Lindert, K. 
Wolf and W. De Vos (2016). LAMIN A/C REGULATES SUBSTRATE 
ADHESION VIA THE ARP2/3 COMPLEX. In European Cytoskeletal Forum - 
Cell Adheson and Migration, Abstracts. Cambridge, United Kingdom. [Flash 
poster presentation] 
 
 
 
 
 
  
PEER-REVIEWED PUBLICATIONS 
 
1. T. Sieprath*, T. Corne*, M. Noteboom , C. Grootaert , A. Rajkovic , B. 
Buysschaert, J. Robijns, J. Broers, F. Ramaekers, W. Koopman, P. Willems and 
W. De Vos (2015). SUSTAINED ACCUMULATION OF PRELAMIN A AND 
DEPLETION OF LAMIN A/C BOTH CAUSE OXIDATIVE STRESS AND 
MITOCHONDRIAL DYSFUNCTION BUT INDUCE DIFFERENT CELL FATES. 
Nucleus, p1-11. DOI:10.1080/19491034.2015.1050568. (* equal contribution) 
 
2. T. Sieprath, T. Corne, P. Willems, W. Koopman and W. De Vos (2016). 
INTEGRATED HIGH-CONTENT QUANTIFICATION OF INTRACELLULAR 
ROS LEVELS AND MITOCHONDRIAL MORPHOFUNCTION. Advances in 
Anatomy, Embryology and Cell Biology, 219, p149-177. DOI:10.1007/978-3-
319-28549-8. 
 
3. M. Versaevel, M. Riaz, T. Corne, T. Grevesse, J. Lantoine, D. 
Mohammed, C. Bruyère, L. Alaimo, W. De Vos and S. Gabriele (2016). 
PROBING CYTOSKELETAL PRE-STRESS AND NUCLEAR 
MECHANICS IN ENDOTHELIAL CELLS WITH SPATIOTEMPORALLY 
CONTROLLED ATTACHMENT AND DETACHMENT KINETICS ON 
MICROPATTERNED SUBSTRATES. Cell Adhesion & Migration, p98-
109. DOI:10.1080/19336918.2016.1182290. 
 
4. J. Robijns, F. Molenberghs, T. Sieprath, T. D. J. Corne, M. Verschuuren and 
W. H. De Vos (2016). IN SILICO SYNCHRONISATION REVEALS 
REGULATORS OF NUCLEAR RUPTURES IN LAMIN A/C DEFICIENT MODEL 
CELLS. Scientific Reports, 6:30325. DOI:10.1038/srep30325. 
 
5. T. D. J. Corne, T. Sieprath, J. Vandenbussche, D. Mohammed, M. te Lindert, 
K. Gevaert, S. Gabriele, K. Wolf and W. H. De Vos (2016). DEREGULATION 
OF FOCAL ADHESION FORMATION AND CYTOSKELETAL TENSION DUE 
TO LOSS OF A-TYPE LAMINS. Cell Adhesion & Migration, p1-17. 
DOI:10.1080/19336918.2016.1247144. 
 
6. T. Sieprath, T. Corne, J. Robijns, W. J. Koopman and W. H. De Vos (2017). 
CELLULAR REDOX PROFILING USING HIGH-CONTENT MICROSCOPY. 
Journal of Visual Experiments. DOI:10.3791/55449. 
 
7. T. D. J. Corne, F. Tison, P. Wuytens, T. Sieprath, J. Robijns, C. Beleites, A. 
G. Skirtach and W. H. De Vos (2017). ZMPSTE24 DEFICIENCY IMPAIRS 
INTRACELLULAR LIPID STORAGE AS REVEALED BY RAMAN 
MICROSPECTROSCOPY. PLoS ONE. In preparation.   
 
  
 
 
 
 
 
